2004, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, 2004

Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78: 2454-2459 (2004). *
Abal'masov DV, Pozharitskaia MM, Starosel'tseva LK, Afanas'ev VV. Study of free-radical processes and antioxidant defense parameters during hirudotherapy of patients with diseases of salivary glands. Stomatologiia (Mosk.) 83: 27-29 (2004).
Abbas AK, Lohr J, Knoechel B, Nagabhushanam V. T cell tolerance and autoimmunity. Autoimmun. Rev. 3: 471-475 (2004).
Abbas Z, Khan R, Abid S, Hamid S, Shah H, Jafri W. Is Crohn's disease in Pakistan less severe than in the West? Trop. Doct. 34: 39-41 (2004).
Abbott DW, Wilkins A, Asara JM, Cantley LC. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14: 2217-2227 (2004). *
Abbott JD, Moreland LW. Rheumatoid arthritis: developing pharmacological therapies. Expert Opin. Investig. Drugs 13: 1007-1018 (2004).
Abboud P, Zejli A, Mansour G, Birembaut P. Neonatal haemochromatosis: a rare cause of neonatal death. Eur. J. Obstet. Gynecol. Reprod. Biol. 116: 233-234 (2004).
Abdelrazeq AS, Lund JN, Leveson SH. Pouchitis-associated pyoderma gangrenosum following restorative proctocolectomy for ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 16: 1057-1058 (2004).
Abdulkarim AS, Petrovic LM, Kim WR, Angulo P, Lloyd RV, Lindor KD. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? J. Hepatol. 40: 380-384 (2004). *
Abe H, Tsuboi N, Yukawa S, Tsuji S, Hayashi H, Yukawa N, Takanashi H, Tahara K, Tonozuka N, Hayashi T. Thrombotic thrombocytopenic purpura complicating Sjogren's syndrome with crescentic glomerulonephritis and membranous nephritis. Mod. Rheumatol. 14: 174-178 (2004).
Abe T, Arai T, Ogawa A, Hiromatsu T, Masuda A, Matsuguchi T, Nimura Y, Yoshikai Y. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice. Hepatology 40: 414-423 (2004). *
Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, Schuster B, Kallen KJ, Saftig P, Rose-John S, Ludwig A. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 172: 6362-6372 (2004). *
Abeyama K, Maruyama I. Inflammation and its regulatory system. Nippon Rinsho 62: 2229-2235 (2004).
Ablassmaier B, Hartmann J. A case of severe gangrenous ischemic colitis following nonsteroidal anti-inflammatory drug intake. Zentralbl. Chir. 129: 510-512 (2004).
Abraham LA, Charles JA, Holloway SA. Effect of oral ursodeoxycholic acid on bile acids tolerance tests in healthy dogs. Aust. Vet. J. 82: 157-160 (2004).
Abraham NS, Fallone CA, Mayrand S, Huang J, Wieczorek P, Barkun AN. Sedation versus no sedation in the performance of diagnostic upper gastrointestinal endoscopy: a Canadian randomized controlled cost-outcome study. Am. J. Gastroenterol. 99: 1692-1699 (2004). *
Abraham RT, Weiss A. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat. Rev. Immunol. 4: 301-308 (2004). *
Abraham S, Begum S, Isenberg D. Hepatic manifestations of autoimmune rheumatic diseases. Ann. Rheum. Dis. 63: 123-129 (2004). *
Abrams GA, Kunde SS, Lazenby AJ, Clements RH. Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease. Hepatology 40: 475-483 (2004). *
Abrams SI. Role of anti-CTLA-4 therapies in the treatment of cancer. Curr. Opin. Mol. Ther. 6: 71-77 (2004).
Abreu MT. Choosing therapy on the basis of disease classifications in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 7: 169-179 (2004).
Abreu MT, Arditi M. Innate immunity and Toll-like receptors: clinical implications of basic science research. J. Pediatr. 144: 421-429 (2004). *
Abreu MT, Kantorovich V, Vasiliauskas EA, Gruntmanis U, Matuk R, Daigle K, Chen S, Zehnder D, Lin YC, Yang H, Hewison M, Adams JS. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 53: 1129-1136 (2004). *
Abreu MT, Yang H. Is genetic testing in IBD ready for prime time? Am. J. Gastroenterol. 99: 316-318 (2004). *
Abt PL, Rapaport-Kelz R, Desai NM, Frank A, Sonnad S, Rand E, Markmann JF, Shaked A, Olthoff KM. Survival among pediatric liver transplant recipients: impact of segmental grafts. Liver Transpl. 10: 1287-1293 (2004). *
Abu-Hamda EM, Baron TH. Endoscopic management of cholangiocarcinoma. Semin. Liver Dis. 24: 165-175 (2004).
Abu-Suboh Abadia M, Casellas F, Vilaseca J, Malagelada J. Response of first attack of inflammatory bowel disease requiring hospital admission to steroid therapy. Rev. Esp. Enferm. Dig. 96: 539-547 (2004).
Accomando S, Cataldo F. The global village of celiac disease. Dig. Liver Dis. 36: 492-498 (2004).
Achenbach P, Fuchtenbusch M. Modulating the autoimmune response in type 1 diabetes: a report on the 64th Scientific Sessions of the ADA, June 2004, Orlando, FL, USA. Rev. Diabet. Stud. 1: 137-140 (2004). *
Acheson DW, Luccioli S. Mucosal immune responses. Best Pract. Res. Clin. Gastroenterol. 18: 387-404 (2004).
Achkar E. Colorectal cancer screening in primary care: the long and short of it. Am. J. Gastroenterol. 99: 837-838 (2004). *
Achkar JP, Stevens T, Easley K, Brzezinski A, Seidner D, Lashner B. Indicators of clinical response to treatment with 6-mercaptopurine or azathioprine in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 10: 339-345 (2004). *
Ackerman Z, Einbinder Y, Stalnikowicz R. Recurrent postpartum exacerbation of chronic ulcerative colitis. J. Clin. Gastroenterol. 38: 914 (2004).
Actis GC, Lagget M, Rizzetto M, Fadda M, Palmo A, Pinna-Pintor M, Morino F. Long-term efficacy of oral microemulsion cyclosporin for refractory ulcerative colitis. Minerva Med. 95: 65-70 (2004).
Actis GC, Rossetti S, Rizzetto M, Fadda M, Palmo A. Need for hospital admission in patients with ulcerative colitis during maintenance with azathioprine. Minerva Gastroenterol. Dietol. 50: 97-101 (2004).
Adams AE, Zwicker J, Curiel C, Kadin ME, Falchuk KR, Drews R, Kupper TS. Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. J. Am. Acad. Dermatol. 51: 660-662 (2004).
Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 291: 1127-1131 (2004). *
Adams LA, Feldstein A, Lindor KD, Angulo P. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology 39: 909-914 (2004). *
Adams LA, Lindor KD. Treatment of hyperlipidemia in nonalcoholic fatty liver disease: fat for thought. Indian J. Gastroenterol. 23: 127-128 (2004). *
Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am. J. Gastroenterol. 99: 1316-1320 (2004). *
Adams LA, Zein CO, Angulo P, Lindor KD. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am. J. Gastroenterol. 99: 2365-2368 (2004). *
Adams PC. Hemochromatosis. Clin. Liver Dis. 8: 735-753, vii (2004).
Adams PC. Haemochromatosis: find them or forget about them? Eur. J. Gastroenterol. Hepatol. 16: 857-858 (2004).
Adams PC, Arthur MJ, Boyer TD, DeLeve LD, Di Bisceglie AM, Hall M, Levin TR, Provenzale D, Seeff L. Screening in liver disease: report of an AASLD clinical workshop. Hepatology 39: 1204-1212 (2004). *
Adamson KA, Pearce SH, Lamb JR, Seckl JR, Howie SE. A comparative study of mRNA and protein expression of the autoimmune regulator gene (Aire) in embryonic and adult murine tissues. J. Pathol. 202: 180-187 (2004). *
Adani GL, Baccarani U, Risaliti A, Hallas J, Gaist D, Vach W, Sorensen HT. The role of age in the protection of appendicectomy against ulcerative colitis * Author's reply. Gut 53: 1719-1720 (2004). *
Ademoglu E, Erbil Y, Tam B, Barbaros U, Ilhan E, Olgac V, Mutlu-Turkoglu U. Do vitamin E and selenium have beneficial effects on trinitrobenzenesulfonic acid-induced experimental colitis. Dig. Dis. Sci. 49: 102-108 (2004). *
Adhami E. Calculating the etiology of systemic lupus erythematosus. Med. Hypotheses 62: 237-246 (2004).
Adhami T, Goldblum JR, Richter JE, Vaezi MF. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am. J. Gastroenterol. 99: 2098-2106 (2004). *
Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4: 553-564 (2004). *
Adler EM. Focus issue - tailoring the immune response. Sci. STKE 241: EG9 (2004). *
Adolfsson O, Meydani SN, Russell RM. Yogurt and gut function. Am. J. Clin. Nutr. 80: 245-256 (2004). *
Adorini L. Antigen-based immunointervention in human autoimmune diseases. Trends Biotechnol. 22: 547-549 (2004). *
Adrain AL, Ramberan H, Weaver GJ. Evaluation of common liver problems. J. Am. Podiatr. Med. Assoc. 94: 149-156 (2004).
Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am. J. Gastroenterol. 99: 1160-1174 (2004). *
Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, Davies S, Murch S, Derkx B, Heuschkel R, Fell JM. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment. Pharmacol. Ther. 20: 167-172 (2004). *
Aganna E, Hawkins PN, Ozen S, Pettersson T, Bybee A, McKee SA, Lachmann HJ, Karenko L, Ranki A, Bakkaloglu A, Besbas N, Topaloglu R, Hoffman HM, Hitman GA, Woo P, McDermott MF. Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis. Genes Immun. 5: 289-293 (2004). *
Agarwal B, Kuehn S, Collins BT. Dilated pancreatic duct and common bile duct in a patient with abdominal pain and weight loss. Am. J. Gastroenterol. 99: 1623-1625 (2004). *
Agca E, Akcay A, Simsek H. Ursodeoxycholic acid and terbinafine-induced toxic hepatitis. Ann. Pharmacother. 38: 1088-1089 (2004).
Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208 (2004). *
Aggarwal BB, Shishodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann. N. Y. Acad. Sci. 1030: 434-441 (2004). *
Aggarwal BB, Takada Y, Oommen OV. From chemoprevention to chemotherapy: common targets and common goals. Expert Opin. Investig. Drugs 13: 1327-1338 (2004).
Aggarwal BB, Takada Y, Shishodia S, Gutierrez AM, Oommen OV, Ichikawa H, Baba Y, Kumar A. Nuclear transcription factor NF-kappaB: role in biology and medicine. Indian J. Exp. Biol. 42: 341-353 (2004).
Aghamohammadi A, Farhoudi A, Nikzad M, Moin M, Pourpak Z, Rezaei N, Gharagozlou M, Movahedi M, Atarod L, Afshar AA, Bazargan N, Hosseinpoor AR. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Ann. Allergy Asthma Immunol. 92: 60-64 (2004).
Agius LM. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis. J. Theor. Biol. 227: 219-228 (2004). *
Agnholt J, Kelsen J, Brandsborg B, Jakobsen NO, Dahlerup JF. Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease - a possible target for infliximab treatment. Eur. J. Gastroenterol. Hepatol. 16: 649-655 (2004).
Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20: 319-325 (2004). *
Agou F, Courtois G, Chiaravalli J, Baleux F, Coic YM, Traincard F, Israel A, Veron M. Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (NEMO) oligomerization. J. Biol. Chem. 279: 54248-54257 (2004). *
Aguilera I, Sousa JM, Gavilan F, Bernardos A, Wichmann I, Nunez-Roldan A. Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl. 10: 1166-1172 (2004). *
Aguilera-Montilla N, Perez-Blas M, Valeri AP, Lopez-Santalla M, Rodriguez-Juan C, Mencia A, Castellano G, Manzano ML, Casis B, Sanchez F, Martin-Villa JM. Higher proliferative capacity of T lymphocytes from patients with Crohn disease than from ulcerative colitis is disclosed by use of Herpesvirus saimiri-transformed T-cell lines. Scand. J. Gastroenterol. 39: 1236-1242 (2004). *
Aguirre-Garcia J. Inflammatory pseudotumor of the liver. Ann. Hepatol. 3: 34 (2004). *
Aguzzi A, Sigurdson CJ. Antiprion immunotherapy: to suppress or to stimulate? Nat. Rev. Immunol. 4: 725-736 (2004). *
Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 351: 1972-1977 (2004). *
Ahlenstiel G, Woitas RP, Rockstroh J, Spengler U. CC-chemokine receptor 5 (CCR5) in hepatitis C - at the crossroads of the antiviral immune response? J. Antimicrob. Chemother. 53: 895-898 (2004). *
Ahluwalia A, Clodfelter KH, Waxman DJ. Sexual dimorphism of rat liver gene expression: regulatory role of growth hormone revealed by deoxyribonucleic acid microarray analysis. Mol. Endocrinol. 18: 747-760 (2004). *
Ahluwalia J, Tinker A, Clapp LH, Duchen MR, Abramov AY, Pope S, Nobles M, Segal AW. The large-conductance Ca2+-activated K+ channel is essential for innate immunity. Nature 427: 853-858 (2004). *
Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP). Am. J. Hematol. 77: 171-176 (2004). *
Ahmad T. Phenotype-determining genes in inflammatory bowel disease. Novartis Found. Symp. 263: 17-29 (2004).
Ahmad T, Pesi Tamboli C, Jewell D, Colombel JF. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 126: 1533-1549 (2004). *
Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, Klotz M, Werfel T, Herz U, Heeg K, Neumaier M, Renz H. The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J. Allergy Clin. Immunol. 113: 565-567 (2004). *
Ahman T. Molecular classification of IBD. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 27. May 7-8 (2004). *
Ahmed M, Jenkins HR. Vitamin B-12 in Crohn's disease patients with small bowel surgery. Arch. Dis. Child. 89: 293 (2004). *
Ahmed N, Thornalley PJ, Luthen R, Haussinger D, Sebekova K, Schinzel R, Voelker W, Heidland A. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J. Hepatol. 41: 913-919 (2004). *
Ahmed S, Siddiqui AK, Chandrasekaran V. Correlation of thrombotic thrombocytopenic purpura disease activity with Von Willibrand factor-cleaving protease level in ulcerative colitis. Am. J. Med. 116: 786-787 (2004). *
Ahmed SF, Horrocks IA, Patterson T, Zaidi S, Ling SC, McGrogan P, Weaver LT. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area. J. Pediatr. Gastroenterol. Nutr. 38: 276-280 (2004). *
Ahn BK, Kim SC. Pyodermatitis-pyostomatitis vegetans with circulating autoantibodies to bullous pemphigoid antigen 230. J. Am. Acad. Dermatol. 50: 785-788 (2004).
Ahn SC, Kim GY, Kim JH, Baik SW, Han MK, Lee HJ, Moon DO, Lee CM, Kang JH, Kim BH, Oh YH, Park YM. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. Biochem. Biophys. Res. Commun. 313: 148-155 (2004). *
Ahuja V. Crohn's disease and mycobacteria: 'the Thomson brothers' or 'back to the future'. Trop. Gastroenterol. 25: 151-155 (2004).
Ai T, Bompadre SG, Sohma Y, Wang X, Li M, Hwang TC. Direct effects of 9-anthracene compounds on cystic fibrosis transmembrane conductance regulator gating. Pflugers Arch. 449: 88-95 (2004). *
Ai T, Bompadre SG, Wang X, Hu S, Li M, Hwang TC. Capsaicin potentiates wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride-channel currents. Mol. Pharmacol. 65: 1415-1426 (2004). *
Ai Y, Liu SY, Yao Q. Clinical characteristics of 1241 cases of intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 39: 217-220 (2004).
Aiello M, Chetta A, Marangio E, Zompatori M, Olivieri D. Pleural involvement in systemic disorders. Curr. Drug Targets Inflamm. Allergy 3: 441-447 (2004).
Ainsworth AP, Rafaelsen SR, Wamberg PA, Pless T, Durup J, Mortensen MB. Cost-effectiveness of endoscopic ultrasonography, magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography in patients suspected of pancreaticobiliary disease. Scand. J. Gastroenterol. 39: 579-583 (2004). *
Aisen P. Transferrin receptor 1. Int. J. Biochem. Cell. Biol. 36: 2137-2143 (2004). *
Aisenberg J, Legnani PE, Nilubol N, Cobrin GM, Ellozy SH, Hegazi RAF, Yager J, Bodian C, Gorfine SR, Bauer JJ, Plevy SE, Sachar DB. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am. J. Gastroenterol. 99: 432-441 (2004). *
Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JBS, Alexander G, Kenna JG, Caldwell J, Day CP. Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 39: 1430-1440 (2004). *
Ajamieh HH, Menendez S, Martinez-Sanchez G, Candelario-Jalil E, Re L, Giuliani A, Fernandez OS. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver Int. 24: 55-62 (2004). *
Ajjan RA, Weetman AP. New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy. J. Endocrinol. Invest. 27: 237-245 (2004).
Akabane H, Miyagawa N, Nii H, Inami Y, Togawa M, Tanaka H, Inagaki N, Nagai H. The effect of a newly synthesized indazole compound, TAS-3-124, on experimental autoimmune disease. Biol. Pharm. Bull. 27: 1218-1223 (2004). *
Akahoshi M, Ishihara M, Remus N, Uno K, Miyake K, Hirota T, Nakashima K, Matsuda A, Kanda M, Enomoto T, Ohno S, Nakashima H, Casanova JL, Hopkin JM, Tamari M, Mao XQ, Shirakawa T. Association between IFNA genotype and the risk of sarcoidosis. Hum. Genet. 114: 503-509 (2004). *
Akahoshi M, Yoshimoto G, Nakashima H, Miyake K, Inoue Y, Tanaka Y, Tsukamoto H, Horiuchi T, Otsuka T, Harada M. MPO-ANCA-positive Wegener's granulomatosis presenting with hypertrophic cranial pachymeningitis: case report and review of the literature. Mod. Rheumatol. 14: 179-183 (2004).
Akaogi J, Yamada H, Kuroda Y, Nacionales DC, Reeves WH, Satoh M. Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. J. Leukoc. Biol. 76: 227-236 (2004). *
Akar A, Orkunoglu FE, Ozata M, Sengul A, Gur AR. Lack of association between vitamin D receptor FokI polymorphism and alopecia areata. Eur. J. Dermatol. 14: 156-158 (2004). *
Akbar AN, Beverley PC, Salmon M. Will telomere erosion lead to a loss of T-cell memory? Nat. Rev. Immunol. 4: 737-743 (2004). *
Akbas SH, Yavuz A, Tuncer M, Yurdakonar E, Akcit F, Gurkan A, Demirbas A, Gultekin M, Ersoy F, Akaydin M. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients. Transplant. Proc. 36: 86-88 (2004). *
Akbiyik F, Cinar K, Demirpence E, Ozsullu T, Tunca R, Haziroglu R, Yurdaydin C, Uzunalimoglu O, Bozkaya H. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver. Eur. J. Clin. Invest. 34: 429-435 (2004).
Akbulut S, Yavuz B, Koseoglu T, Gokoz A, Saritas U. Crohn's disease with isolated esophagus and gastric involvement. Turk. J. Gastroenterol. 15: 196-200 (2004). *
Akerlund JE, Lofberg R. Pouchitis. Curr. Opin. Gastroenterol. 20: 341-344 (2004).
Akilesh S, Petkova S, Sproule TJ, Shaffer DJ, Christianson GJ, Roopenian D. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J. Clin. Invest. 113: 1328-1333 (2004). *
Akin EB, Vitellas KM, Rajab A, Pelletier RP, Davies EA, Bumgardner GL, Henry ML, Ferguson RM, Elkhammas EA. Magnetic resonance cholangiography with mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after T-tube removal in liver transplantation. J. Comput. Assist. Tomogr. 28: 613-616 (2004).
Akira S, Takeda K. Functions of Toll-like receptors: lessons from KO mice. C. R. Biol. 327: 581-589 (2004).
Akira S, Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511 (2004). *
Akiyoshi H, Hatakeyama S, Pitkanen J, Mouri Y, Doucas V, Kudoh J, Tsurugaya K, Uchida D, Matsushima A, Oshikawa K, Nakayama KI, Shimizu N, Peterson P, Matsumoto M. Subcellular expression of autoimmune regulator is organized in a spatiotemporal manner. J. Biol. Chem. 279: 33984-33991 (2004). *
Akobeng A, Zachos M. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. Cochrane Database Syst. Rev. 1: CD003574 (2004). *
Akobeng AK, Gardener E. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease Cochrane Database Syst. Rev. 1: CD003715 (2004). *
Akoume MY, Tuchweber B, Plaa GL, Yousef IM. The role of mdr2 in manganese-bilirubin induced cholestasis in mice. Toxicol. Lett. 148: 41-51 (2004). *
Aktas A, Koyuncu A, Yalcin H. Acceleration of hepatobiliary dynamics in liver transplant donors. Transplant. Proc. 36: 206-209 (2004). *
Al Jumah M, Majumdar R, Al Rajeh S, Awada A, Al Zaben A, Al Traif I, Al Jumah AR, Rehana Z. A clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutations. Eur. J. Neurol. 11: 121-124 (2004). *
Al-Ghamdi AS, Al-Mofleh IA, Al-Rashed RS, Al-Amri SM, Aljebreen AM, Isnani AC, El-Badawi R. Epidemiology and outcome of Crohn's disease in a teaching hospital in Riyadh. World J. Gastroenterol. 10: 1341-1344 (2004). *
Al-Harbi EM, Abbassi AJ, Tamim H, al-Jenaidi F, Kooheji M, Kamal M, al-Mahroos S, al-Nasir F, Motala AA, Almawi WY. Specific HLA-DRB and -DQB alleles and haplotypes confer disease susceptibility or resistance in Bahraini type 1 diabetes patients. Clin. Diagn. Lab. Immunol. 11: 292-296 (2004). *
Al-Mukhaizeem KA, Rosenberg A, Sherker AH. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am. J. Hematol. 75: 225-230 (2004). *
Al-Mutawa SA, Hegab SM. Behcet's disease. Clin. Exp. Med. 4: 103-131 (2004). *
Al-Osaimi AM, Berg CL. Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature. Dig. Dis. Sci. 49: 438-443 (2004). *
Al-Ratrout JT, Ansari NA. Epidermolysis bullosa acquisita and Crohn's disease. Saudi Med. J. 25: 1736-1738 (2004).
Al-Tonbary Y, Abdel-Razek N, Zaghloul H, Metwaly S, El-Deek B, El-Shawaf R. HLA class II polymorphism in Egyptian children with lymphomas. Hematology 9: 139-145 (2004).
Ala A, Schilsky ML. Wilson disease: pathophysiology, diagnosis, treatment, and screening. Clin. Liver Dis. 8: 787-805, viii (2004).
Ala A, Schilsky ML. Inherited metabolic liver disease. Curr. Opin. Gastroenterol. 20: 198-207 (2004).
Aladag M, Gurakar A, Jalil S, Wright H, Alamian S, Rashwan S, Sebastian A, Nour B. A liver transplant center experience with liver dialysis in the management of patients with fulminant hepatic failure: a preliminary report. Transplant. Proc. 36: 203-205 (2004). *
Aladesanmi OA. Sarcoidosis: an update for the primary care physician. MedGenMed. 6: 7 (2004). *
Alam I, Nolan N, Geoghegan J. Isolated Crohn's disease of the appendix. Ir. J. Med. Sci. 173: 114 (2004).
Alamanos Y, Papadopoulos NG, Voulgari PV, Karakatsanis A, Siozos C, Drosos AA. Epidemiology of ankylosing spondylitis in Northwest Greece, 1983-2002. Rheumatology (Oxford) 43: 615-618 (2004). *
Alansari A, Gul A, Inanc M, Ordi J, Teh LS, Ollier WE, Gonzalez-Gay MA, Hajeer AH. Fc receptor gamma subunit polymorphisms and systemic lupus erythematosus. Saudi Med. J. 25: 1445-1448 (2004).
Alarcon de la Lastra C, Sanchez-Fidalgo S, Villegas I, Motilva V. New pharmacological perspectives and therapeutic potential of PPAR-gamma agonists. Curr. Pharm. Des. 10: 3505-3524 (2004).
Alarcon-Riquelme ME. Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus. Arthritis Res. Ther. 6: 169-173 (2004). *
Albert C, Vandenbos F, Brocq O, Carles D, Euller-Ziegler L. Legionellosis in patient treated with infliximab. Rev. Med. Interne. 25: 167-168 (2004).
Albert D, Clarkin C, Komoroski J, Brensinger CM, Berlin JA. Wegener's granulomatosis: possible role of environmental agents in its pathogenesis. Arthritis Rheum. 51: 656-664 (2004). *
Albert ML. Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat. Rev. Immunol. 4: 223-231 (2004). *
Alberti S, Bohse K, Arndt V, Schmitz A, Hohfeld J. The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator. Mol. Biol. Cell 15: 4003-4010 (2004). *
Albillos A, de-la-Hera A, Alvarez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet 363: 1608-1610 (2004). *
Albrecht K, Schumann R, Peitgen K, Walz MK. Laparoscopic therapy of appendicovesical fistula - two case reports. Zentralbl. Chir. 129: 396-398 (2004).
Alcala MJ, Casellas F, Fontanet G, Prieto L, Malagelada JR. Shortened questionnaire on quality of life for inflammatory bowel disease. Inflamm. Bowel Dis. 10: 383-391 (2004). *
Alderuccio F, Toh BH. Induction of tolerance to self-antigens using genetically modified bone marrow cells. Expert Opin. Biol. Ther. 4: 1007-1014 (2004).
Alehan D, Dogan OF. Pediatric surgical image. A rare case: celiac artery compression syndrome in an asymptomatic child. J. Pediatr. Surg. 39: 645-647 (2004).
Aleman G, Torres N, Tovar AR. Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development. Rev. Invest. Clin. 56: 351-367 (2004).
Aleman M, Schierloh P, De La Barrera SS, Musella RM, Saab MA, Baldini M, Abbate E, Sasiain MC. Mycobacterium tuberculosis triggers apoptosis in peripheral neutrophils involving Toll-like receptor 2 and p38 mitogen protein kinase in tuberculosis patients. Infect. Immun. 72: 5150-5158 (2004). *
Alenius GM, Friberg C, Nilsson S, Wahlstrom J, Dahlqvist SR, Samuelsson L. Analysis of 6 genetic loci for disease susceptibility in psoriatic arthritis. J. Rheumatol. 31: 2230-2235 (2004). *
Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, Langelier B, Aid S, Poumes-Ballihaut C, Champeil-Potokar G, Lavialle M. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod. Nutr. Dev. 44: 509-538 (2004).
Alessandrini F, Pfister S, Kremmer E, Gerber JK, Ring J, Behrendt H. Alterations of glucosylceramide-beta-glucosidase levels in the skin of patients with psoriasis vulgaris. J. Invest. Dermatol. 123: 1030-1036 (2004). *
Alessio AC, Annichino-Bizzacchi JM, Bydlowski SP, Eberlin MN, Vellasco AP, Hoehr NF. Polymorphisms in the methylenetetrahydrofolate reductase and methionine synthase reductase genes and homocysteine levels in Brazilian children. Am. J. Med. Genet. A. 128A: 256-260 (2004).
Alexakis C, Caruelle JP, Sezeur A, Cosnes J, Gendre JP, Mosnier H, Beaugerie L, Gallot D, Malafosse M, Barritault D, Kern P. Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents. Gut 53: 85-90 (2004). *
Alexander S, Bramson J, Foley R, Xing Z. Protection from endotoxemia by adenoviral-mediated gene transfer of human bactericidal/permeability-increasing protein. Blood 103: 93-99 (2004). *
Alexander WS, Hilton DJ. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22: 503-529 (2004). *
Alexis AF, Dudda-Subramanya R, Sinha AA. Alopecia areata: autoimmune basis of hair loss. Eur. J. Dermatol. 14: 364-370 (2004). *
Alfven G. Plasma oxytocin in children with recurrent abdominal pain. J. Pediatr. Gastroenterol. Nutr. 38: 513-517 (2004). *
Algood HM, Flynn JL. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J. Immunol. 173: 3287-3296 (2004). *
Alhopuro P, Ahvenainen T, Mecklin JP, Juhola M, Jarvinen HJ, Karhu A, Aaltonen LA. NOD2 3020insC alone is not sufficient for colorectal cancer predisposition. Cancer Res. 64: 7245-7247 (2004). *
Ali A, Santisi JM, Vargo J. Video capsule endoscopy: a voyage beyond the end of the scope. Cleve. Clin. J. Med. 71: 415-425 (2004). *
Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study. Arch. Intern. Med. 164: 963-968 (2004). *
Alimohamadi SM, Malekzadeh R, Mirmadjless SH, Mohamadnejad M, Zamani F. Herpes simplex virus encephalistis during immunosuppressive treatment of ulcerative colitis. MedGenMed. 6: 7 (2004). *
Alizadeh BZ, Njajou OT, Houwing-Duistermaat JJ, Jong Gd G, Vergeer JM, Hofman A, Pols HA, Duijn CM. Does bilirubin protect against hemochromatosis gene (HFE) related mortality? Am. J. Med. Genet. 129A: 39-43 (2004). *
Alkan SS. Monoclonal antibodies: the story of a discovery that revolutionized science and medicine. Nat. Rev. Immunol. 4: 153-156 (2004). *
Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A. Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients. Clin. Chim. Acta 350: 51-55 (2004). *
Allcock RJ, Windsor L, Gut IG, Kucharzak R, Sobre L, Lechner D, Garnier JG, Baltic S, Christiansen FT, Price P. High-density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: implications for haplotype tagging. Hum. Mutat. 24: 517-525 (2004).
Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 53: 1566-1570 (2004). *
Allen KJ, Cheah DM, Lee XL, Pettigrew-Buck NE, Vadolas J, Mercer JF, Ioannou PA, Williamson R. The potential of bone marrow stem cells to correct liver dysfunction in a mouse model of Wilson's disease. Cell Transplant. 13: 765-773 (2004).
Allen KJ, Cheah DM, Wright PF, Gazeas S, Pettigrew-Buck NE, Deal YH, Mercer JF, Williamson R. Liver cell transplantation leads to repopulation and functional correction in a mouse model of Wilson's disease. J. Gastroenterol. Hepatol. 19: 1283-1290 (2004). *
Allen RL, Trowsdale J. Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors. Curr. Mol. Med. 4: 59-65 (2004).
Allen S, Okoko B, Martinez E, Gregorio G, Dans L. Probiotics for treating infectious diarrhoea. Cochrane Database Syst. Rev. 2: CD003048 (2004). *
Allenspach K, Luckschander N, Styner M, Seibold F, Doherr M, Aeschbach D, Gaschen F. Evaluation of assays for perinuclear antineutrophilic cytoplasmic antibodies and antibodies to Saccharomyces cerevisiae in dogs with inflammatory bowel disease. Am. J. Vet. Res. 65: 1279-1283 (2004).
Allez M, Brimnes J, Shao L, Dotan I, Nakazawa A, Mayer L. Activation of a unique population of CD8+ T cells by intestinal epithelial cells. Ann. N. Y. Acad. Sci. 1029: 22-35 (2004). *
Allez M, Mayer L. Regulatory T cells: peace keepers in the gut. Inflamm. Bowel Dis. 10: 666-676 (2004). *
Allocca M, Crosignani A, Battezzati PM, Gritti A, Podda M. Hypercholesterolaemia is not associated with increased carotid-artery intima and media thickness in primary biliary cirrhosis. J. Hepatol. 40 Suppl. 1: 159 (2004).
Allotey RA, Mohan V, McDermott MF, Deepa R, Premalatha G, Hassan Z, Cassell PG, North BV, Vaxillaire M, Mein CA, Swan DC, O'Grady E, Ramachandran A, Snehalatha C, Sinnot PJ, Hemmatpour SK, Froguel P, Hitman GA. The EIF2AK3 gene region and type I diabetes in subjects from South India. Genes Immun. 5: 648-652 (2004). *
Almeras L, Lefranc D, Drobecq H, De Seze J, Dubucquoi S, Vermersch P, Prin L. New antigenic candidates in multiple sclerosis: identification by serological proteome analysis. Proteomics 4: 2184-2194 (2004). *
Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 291: 1875-1879 (2004). *
Alper OM, Wong LJ, Young S, Pearl M, Graham S, Sherwin J, Nussbaum E, Nielson D, Platzker A, Davies Z, Lieberthal A, Chin T, Shay G, Hardy K, Kharrazi M. Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients. Hum. Mutat. 24: 353 (2004). *
Alpers D. The elusive causes of relapse in ulcerative colitis. Inflamm. Bowel Dis. 10: 170-171 (2004). *
Alpers DH. Why, how, and to which part of the gastrointestinal tract should forced enteral feedings be delivered in patients?. Curr. Opin. Gastroenterol. 20: 104-109 (2004).
Alpert JE, Papakostas G, Mischoulon D, Worthington JJ 3rd, Petersen T, Mahal Y, Burns A, Bottiglieri T, Nierenberg AA, Fava M. S-Adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J. Clin. Psychopharmacol. 24: 661-664 (2004).
Alpini G, Kanno N, Phinizy JL, Glaser S, Francis H, Taffetani S, LeSage G. Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G973-G982 (2004). *
Als-Nielsen B, Gluud LL, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ 328: 1046 (2004). *
Alter HJ. Hepatology highlights. Hepatology 40: 771 (2004). *
Altes A, Ruiz A, Barcelo MJ, Remacha AF, Puig T, Maya AJ, Castell C, Amate JM, Saz Z, Baiget M. Prevalence of the C282Y, H63D, and S65C mutations of the HFE gene in 1,146 newborns from a region of Northern Spain. Genet. Test. 8: 407-410 (2004).
Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303: 1201-1204 (2004). *
Altschuler EL, Kast RE. Bupropion for Blau syndrome. Med. Hypotheses 62: 297-298 (2004).
Altucci L, Gronemeyer H. Retinoids and TRAIL: two cooperating actors to fight against cancer. Vitam. Horm. 67: 319-345 (2004).
Alustiza JM, Artetxe J, Castiella A, Agirre C, Emparanza JI, Otazua P, Garcia-Bengoechea M, Barrio J, Mujica F, Recondo JA. MR quantification of hepatic iron concentration. Radiology 230: 479-484 (2004). *
Alvarez BV, Kieller DM, Quon AL, Markovich D, Casey JR. Slc26a6: a cardiac chloride-hydroxyl exchanger and predominant chloride-bicarbonate exchanger of the mouse heart. J. Physiol. 561: 721-734 (2004). *
Alvarez F. Treatment of autoimmune hepatitis: current and future therapies. Curr. Treat. Options Gastroenterol. 7: 413-420 (2004).
Alvarez F. Round table: controversies in the treatment of autoimmune liver diseases in children. Cyclosporine indication in �autoimmune hepatitis (AIH)�. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 95-96 (2004). *
Alvarez F. Clinical and diagnostics aspects in children. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 87-88 (2004). *
Alvarez L, Jara P, Sanchez-Sabate E, Hierro L, Larrauri J, Diaz MC, Camarena C, De La Vega A, Frauca E, Lopez-Collazo E, Lapunzina P. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1. Hum. Mol. Genet. 13: 2451-2460 (2004). *
Alvarez R, Vega MJ, Kammerer S, Rossin A, Germain P, Gronemeyer H, de Lera AR. 9-cis-Retinoic acid analogues with bulky hydrophobic rings: new RXR-selective agonists. Bioorg. Med. Chem. Lett. 14: 6117-6122 (2004). *
Alvaro D, Invernizzi P, Onori P, Franchitto A, De Santis A, Crosignani A, Sferra R, Ginanni-Corradini S, Mancino MG, Maggioni M, Attili AF, Podda M, Gaudio E. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J. Hepatol. 41: 905-912 (2004). *
Alves A, Panis Y, Joly F, Pocard M, Lavergne-Slove A, Bouhnik Y, Valleur P. Could immunosuppressive drugs reduce recurrence rate after second resection for Crohn disease? Inflamm. Bowel Dis. 10: 491-495 (2004). *
Alves MB, Motta AC, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence Int. 35: 392-396 (2004).
Alzoghaibi MA, Walsh SW, Willey A, Yager DR, Fowler AA 3rd, Graham MF. Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G528-G537 (2004). *
Amano K, Leung PS, Xu Q, Marik J, Quan C, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M, Coppel RL, Gershwin ME. Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J. Immunol. 172: 6444-6452 (2004). *
Amaral MD. CFTR and chaperones: processing and degradation. J. Mol. Neurosci. 23: 41-48 (2004).
Amaral MD, Clarke LA, Ramalho AS, Beck S, Broackes-Carter F, Rowntree R, Mouchel N, Williams SH, Harris A, Tzetis M, Steiner B, Sanz J, Gallati S, Nissim-Rafinifa M, Kerem B, Hefferon T, Cutting GR, Goina E, Pagani F. Quantitative methods for the analysis of CFTR transcripts/splicing variants. J. Cyst. Fibros. 3 Suppl. 2: 17-23 (2004).
Amarapurkar AD, Kher A, Agrawal R, Meenakshi B, Kandalkar BM, Deshpande JR. A rare cause of steatohepatitis. Trop. Gastroenterol. 25: 176-177 (2004).
Amarapurkar DN, Patel ND. Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values. Trop. Gastroenterol. 25: 130-134 (2004).
Amarapurkar DN, Patel ND, Amarapurkar AD, Agal S, Baigal R, Gupte P. Tissue polymerase chain reaction in diagnosis of intestinal tuberculosis and Crohn's disease. J. Assoc. Physicians India 52: 863-867 (2004).
Amasheh S, Barmeyer C, Koch CS, Tavalali S, Mankertz J, Epple HJ, Gehring MM, Florian P, Kroesen AJ, Zeitz M, Fromm M, Schulzke JD. Cytokine-dependent transcriptional down-regulation of epithelial sodium channel in ulcerative colitis. Gastroenterology 126: 1711-1720 (2004). *
Amat di San Filippo C, Longo N. Tyrosine residues affecting sodium stimulation of carnitine transport in the OCTN2 carnitine/organic cation transporter. J. Biol. Chem. 279: 7247-7253 (2004). *
Amcheslavsky A, Zou W, Bar-Shavit Z. Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms: implications for osteoclastogenesis. J. Biol. Chem. 279: 54039-54045 (2004). *
Amela-Peris R, Aladro Y, Conde-Sendin MA, Alemany-Rodriguez MJ, Munoz-Fernandez C, Reyes-Yanez MP, Deniz-Naranjo MC, Sanchez-Garcia F. Familial multiple sclerosis in Canary Islands. Rev. Neurol. 39: 911-914 (2004).
Amer OT, Abd El-Rahma HA, Sherief LM, Hussein HF, Zeid AF, Abd El-Aziz AM. Role of some viral infections in neonatal cholestasis. Egypt. J. Immunol. 11: 149-155 (2004).
Amin MG, Wolf MP, Tenbrook JA Jr, Freeman RB Jr, Cheng SJ, Pratt DS, Wong JB. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl. 10: 1468-1475 (2004). *
Amino N, Kimura M, Tanaka S, Izumi Y, Ikemoto M, Tatsumi KI, Takano T, Hidaka Y. Differential diagnosis of hepatitis: development of new laboratory tests for autoimmune hepatitis and progress in pathophysiology. Rinsho Byori 52: 44-50 (2004).
Amital H, Applbaum YH, Aamar S, Daniel N, Rubinow A. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford) 43: 658-661 (2004). *
Ammann RW, Renner EC, Gottstein B, Grimm F, Eckert J, Renner EL; Swiss Echinococcosis Study Group. Immunosurveillance of alveolar echinococcosis by specific humoral and cellular immune tests: long-term analysis of the Swiss chemotherapy trial (1976-2001). J. Hepatol. 41: 551-559 (2004).
Amoli MM, Gonzalez-Gay MA, Zeggini E, Salway F, Garcia-Porrua C, Ollier WE. Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis. J. Rheumatol. 31: 2413-2417 (2004). *
Amos J, Grody W. Development and integration of molecular genetic tests into clinical practice: the US experience. Expert Rev. Mol. Diagn. 4: 465-477 (2004).
Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117: 515-526 (2004). *
Amundsen SS, Naluai AT, Ascher H, Ek J, Gudjonsdottir AH, Wahlstrom J, Lie BA, Sollid LM. Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease. Tissue Antigens 64: 593-599 (2004). *
An J, Muoio DM, Shiota M, Fujimoto Y, Cline GW, Shulman GI, Koves TR, Stevens R, Millington D, Newgard CB. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat. Med. 10: 268-274 (2004). *
Anagnostopoulos G, Sakorafas GH, Grigoriadis K, Margantinis G, Kostopoulos P, Tsiakos S, Arvanitidis D. Hepatitis caused by occupational chronic exposure to trichloroethylene. Acta Gastroenterol. Belg. 67: 355-357 (2004).
Anakk S, Kalsotra A, Kikuta Y, Huang W, Zhang J, Staudinger JL, Moore DD, Strobel HW. CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11. Pharmacogenomics J. 4: 91-101 (2004). *
Anant S, Murmu N, Houchen CW, Mukhopadhyay D, Riehl TE, Young SG, Morrison AR, Stenson WF, Davidson NO. Apobec-1 protects intestine from radiation injury through posttranscriptional regulation of cyclooxygenase-2 expression. Gastroenterology 127: 1139-1149 (2004). *
Ananthanarayanan M, Li S, Balasubramaniyan N, Suchy FJ, Walsh MJ. Ligand-dependent activation of the farnesoid-X-receptor directs arginine methylation of histone H3 by CARM1. J. Biol. Chem. 279: 54348-54357 (2004). *
Andersen JN, Jansen PG, Echwald SM, Mortensen OH, Fukada T, Del Vecchio R, Tonks NK, Moller NP. A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. FASEB J. 18: 8-30 (2004). *
Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Hemochromatosis mutations in the general population: iron overload progression rate. Blood 103: 2914-2919 (2004). *
Andersen-Ranberg K, HOier-Madsen M, Wiik A, Jeune B, Hegedus L. High prevalence of autoantibodies among Danish centenarians. Clin. Exp. Immunol. 138: 158-163 (2004). *
Anderson AC, Reddy J, Nazareno R, Sobel RA, Nicholson LB, Kuchroo VK. IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J. Immunol. 173: 828-834 (2004). *
Anderson AD, McNaught CE, Jain PK, MacFie J. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53: 241-245 (2004). *
Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J. Gastrointest. Surg. 8: 90-97 (2004).
Anderson CM, Grenade DS, Boll M, Foltz M, Wake KA, Kennedy DJ, Munck LK, Miyauchi S, Taylor PM, Campbell FC, Munck BG, Daniel H, Ganapathy V, Thwaites DT. H+/amino acid transporter 1 (PAT1) is the imino acid carrier: an intestinal nutrient/drug transporter in human and rat. Gastroenterology 127: 1410-1422 (2004). *
Anderson G, Ramm G, Subramaniam V, Powell L. HFE gene and hemochromatosis. J. Gastroenterol. Hepatol. 19: 712 (2004). *
Anderson GM, Nakada MT, DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr. Opin. Pharmacol. 4: 314-320 (2004).
Anderson JP, Mueller JL, Rosengren S, Boyle DL, Schaner P, Cannon SB, Goodyear CS, Hoffman HM. Structural, expression, and evolutionary analysis of mouse CIAS1. Gene 338: 25-34 (2004). *
Anderson MJ, Fritsche KL. Dietary polyunsaturated fatty acids modulate in vivo, antigen-driven CD4+ T-cell proliferation in mice. J. Nutr. 134: 1978-1983 (2004). *
Anderson NG, Garcia-Valenzuela E, Martin DF. Hypopyon uveitis and relapsing polychondritis: a report of 2 patients and review of autoimmune hypopyon uveitis. Ophthalmology 111: 1251-1254 (2004).
Anderson P, Phillips K, Stoecklin G, Kedersha N. Post-transcriptional regulation of proinflammatory proteins. J. Leukoc. Biol. 76: 42-47 (2004). *
Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, Frank JA. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann. Neurol. 55: 654-659 (2004). *
Anderson SP, Dunn C, Laughter A, Yoon L, Swanson C, Stulnig TM, Steffensen KR, Chandraratna RA, Gustafsson JA, Corton JC. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor and liver X receptor in mouse liver. Mol. Pharmacol. 66: 1440-1452 (2004). *
Anderson SP, Howroyd P, Liu J, Qian X, Bahnemann R, Swanson C, Kwak MK, Kensler TW, Corton JC. The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes. J. Biol. Chem. 279: 52390-52398 (2004). *
Andersson A, Kokkola R, Wefer J, Erlandsson-Harris H, Harris RA. Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility. J. Leukoc. Biol. 76: 1118-1124 (2004). *
Andersson KE. Mechanisms of disease: central nervous system involvement in overactive bladder syndrome. Nat. Clin. Pract. Urol. 1: 103-108 (2004). *
Andersson U, Erlandsson-Harris H. HMGB1 is a potent trigger of arthritis. J. Intern. Med. 255: 344-350 (2004). *
Andersson U, Tracey KJ. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis. Rheum. Dis. Clin. North Am. 30: 627-637, xi (2004).
Andersson UG, Tracey KJ. HMGB1, a pro-inflammatory cytokine of clinical interest: introduction. J. Intern. Med. 255: 318-319 (2004). *
Ando H, Tsuruoka S, Yamamoto H, Takamura T, Kaneko S, Fujimura A. Effects of pravastatin on the expression of ATP-binding cassette transporter A1. J. Pharmacol. Exp. Ther. 311: 420-425 (2004). *
Andoh A, Fujino S, Hirai Y, Fujiyama Y. Epimorphin expression in human colonic myofibroblasts. Int. J. Mol. Med. 13: 57-61 (2004).
Andoh A, Ogawa A, Kitamura K, Inatomi O, Fujino S, Tsujikawa T, Sasaki M, Mitsuyama K, Fujiyama Y. Suppression of interleukin-1beta- and tumor necrosis factor-.-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis. J. Gastroenterol. 39: 1150-1157 (2004). *
Andrade RJ, Lucena MI, Alonso A, Garcia-Cores M, Garcia-Ruiz E, Benitez R, Fernandez MC, Pelaez G, Romero M, Corpas R, Duran JA, Jimenez M, Rodrigo L, Nogueras F, Martin-Vivaldi R, Navarro JM, Salmeron J, de la Cuesta FS, Hidalgo R. HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology 39: 1603-1612 (2004). *
Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N. Engl. J. Med. 350: 2343-2351 (2004). *
Andre T, Louvet C, de Gramont A. Colon cancer: what is new in 2004? Bull. Cancer 91: 75-80 (2004).
Andreakos E. Common and uncommon features of rheumatoid arthritis and chronic obstructive pulmonary disease: clues to a future therapy. Curr. Drug Targets Immune Endocr. Metabol. Disord. 4: 85-92 (2004).
Andreakos E, Foxwell B, Feldmann M. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol. Rev. 202: 250-265 (2004). *
Andreoni KA, Lin JI, Groben PA. Liver transplantation 27 years after bone marrow transplantation from the same living donor. N. Engl. J. Med. 350: 2624-2625 (2004).
Andrews PI. Autoimmune myasthenia gravis in childhood. Semin. Neurol. 24: 101-110 (2004).
Andrieu N, Launoy G, Guillois R, Ory-Paoletti C, Gignoux M. Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study). Gut 53: 1322-1328 (2004). *
Andriulli A, Annese V, Latiano A, Palmieri O, Fortina P, Ardizzone S, Cottone M, D'inca R, Riegler G. The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis: an *IG-IBD study. Gastroenterology 126: 625-627 (2004). *
Andriulli A, de Sio I, Solmi L, De Carlis L, Troisi R, Grasso A, Festa V, Caturelli E, Giacomoni A, Del Vecchio Blanco C, De Hemptinne B, Burroughs A, Perri F. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation. Liver Transpl. 10: 1355-1363 (2004). *
Andrulionyte L, Zacharova J, Chiasson JL, Laakso M; for the STOP-NIDDM Study Group. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia 47: 2176-2184 (2004). *
Anelli PL, Lattuada L, Lorusso V, Lux G, Morisetti A, Morosini P, Serleti M, Uggeri F. Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging. J. Med. Chem. 47: 3629-3641 (2004). *
Ang CW, Jacobs BC, Laman JD. The Guillain-Barre syndrome: a true case of molecular mimicry. Trends Immunol. 25: 61-66 (2004). *
Angel B, Santos JL, Carrasco E, Albala C, Perez-Bravo F. Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in Chilean subjects: a case-parent study. Eur. J. Epidemiol. 19: 1085-1087 (2004). *
Angelin B, Eriksson M, Parini P, Rudling M. Bile acids and lipoproteins. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 31. June 18-19 (2004). *
Angeloni G, Latteri M, Manna R, Rumi C, Gasbarrini G, Navarra P. Circulating levels of cyclosporin A in inflammatory bowel disease: relationships with lymphocyte inhibition and the age of patients. Eur. J. Clin. Pharmacol. 60: 161-164 (2004). *
Angeloni S, Merli M, Salvatori FM, De Santis A, Fanelli F, Pepino D, Attili AF, Rossi P, Riggio O. Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results. Am. J. Gastroenterol. 99: 280-285 (2004). *
Anglicheau D, Legendre C, Thervet E. Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives. Transplantation 78: 311-315 (2004).
Anglicheau D, Thervet E, Etienne I, Hurault De Ligny B, Le Meur Y, Touchard G, Buchler M, Laurent-Puig P, Tregouet D, Beaune P, Daly A, Legendre C, Marquet P. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin. Pharmacol. Ther. 75: 422-433 (2004). *
Anglin I, Passaniti A. Runx protein signaling in human cancers. Cancer Treat. Res. 119: 189-215 (2004).
Angulo P, Alba LM, Petrovic LM, Adams LA, Lindor KD, Jensen MD. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J. Hepatol. 41: 943-949 (2004). *
Anhalt GJ. Paraneoplastic pemphigus. J. Investig. Dermatol. Symp. Proc. 9: 29-33 (2004). *
Anjos S, Polychronakos C. Mechanisms of genetic susceptibility to type I diabetes: beyond HLA. Mol. Genet. Metab. 81: 187-195 (2004). *
Anjos SM, Tessier MC, Polychronakos C. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. J. Clin. Endocrinol. Metab. 89: 6257-6265 (2004). *
Anke J, Ramzan I. Kava hepatotoxicity: are we any closer to the truth? Planta Med. 70: 193-196 (2004).
Annereau JP, Szakacs G, Tucker CJ, Arciello A, Cardarelli C, Collins J, Grissom S, Zeeberg B, Reinhold W, Weinstein J, Pommier Y, Paules RS, Gottesman MM. Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance. Mol. Pharmacol. 66: 1397-1405 (2004). *
Annese V, Palmieri O, Latiano A, Ardizzone S, Castiglione F, Cottone M, D'Inca R, Gionchetti P, Papi C, Riegler G, Vecchi M, Andriulli A; Italian Group for Inflammatory Bowel Disease. Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. Dig. Liver Dis. 36: 121-124 (2004).
Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features. Aliment Pharmacol. Ther. 20: 1143-1152 (2004). *
Annilo T, Dean M. Degeneration of an ATP-binding cassette transporter gene, ABCC13, in different mammalian lineages. Genomics 84: 34-46 (2004). *
Anolik J, Sanz I. B cells in human and murine systemic lupus erythematosus. Curr. Opin. Rheumatol. 16: 505-512 (2004).
Ansaldo GL, Varaldo E, Assalino M, Borgonovo G. Artificial nutrition in inflammatory bowel disease. Ann. Ital. Chir. 75: 629-634 (2004).
Ansari AA. Autoimmunity, anergy, lentiviral immunity and disease. Autoimmun. Rev. 3: 530-540 (2004).
Antebi H, Mansoor O, Ferrier C, Tetegan M, Morvan C, Rangaraj J, Alcindor LG. Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsions. JPEN J. Parenter. Enteral Nutr. 28: 142-148 (2004). *
Antoniazi S, Price HP, Kropf P, Freudenberg MA, Galanos C, Smith DF, Muller I. Chemokine gene expression in Toll-like receptor-competent and -deficient mice infected with Leishmania major. Infect. Immun. 72: 5168-5174 (2004). *
Antunes F, Boveris A, Cadenas E. On the mechanism and biology of cytochrome oxidase inhibition by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 101: 16774-16779 (2004). *
Anwar MA, Rampling MW. Erythrocyte hyper-aggregation in a patient undergoing orthotopic transplantation for primary sclerosing cholangitis complicated by biliary stricture. Clin. Hemorheol. Microcirc. 31: 169-172 (2004).
Anwer MS. Cellular regulation of hepatic bile acid transport in health and cholestasis. Hepatology 39: 581-590 (2004). *
Aoki A, Kirino Y, Ishigatsubo Y, Senuma A, Nagaoka S. Liver involvement in primary Sjogren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi 27: 397-401 (2004).
Aoki S, Watanabe M, Hasegawa H, Nishibori H, Mukai M, Kitajima M. Rectal carcinoid arising in ulcerative colitis associated with rectal adenocarcinoma. J. Gastroenterol. 39: 697-698 (2004). *
Aoki V, Millikan RC, Rivitti EA, Hans-Filho G, Eaton DP, Warren SJ, Li N, Hilario-Vargas J, Hoffmann RG, Diaz LA; Cooperative Group for Fogo Selvagem Research. Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem). J. Investig. Dermatol. Symp. Proc. 9: 34-40 (2004). *
Aoun NY, Velez E, Aggarwal A, Hayes GB, Kenney LA. Fatal acute interstitial pneumonitis complicating polymyositis in a 41-year-old man. Respir. Care 49: 1515-1521 (2004). *
Aouthmany A, Horattas MC. Ileal pouch perforation in pregnancy: report of a case and review of the literature. Dis. Colon Rectum 47: 243-245 (2004).
Appel H, Kuon W, Kuhne M, Wu P, Kuhlmann S, Kollnberger S, Thiel A, Bowness P, Sieper J. Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis. Arthritis Res. Ther. 6: R521-R534 (2004). *
Appleyard CB, Hernandez G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm. Bowel Dis. 10: 106-111 (2004). *
Aqel BA, Machicao V, Rosser B, Satyanarayana R, Harnois DM, Dickson RC. Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis. J. Clin. Gastroenterol. 38: 805-809 (2004).
Ara C, Devirgiliis LC, Massimi M. Influence of retinoic acid on adhesion complexes in human hepatoma cells: a clue to its antiproliferative effects. Cell Commun. Adhes. 11: 13-23 (2004).
Arai I, Takano N, Hashimoto Y, Futaki N, Sugimoto M, Takahashi N, Inoue T, Nakaike S. Prostanoid DP(1) receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. Eur. J. Pharmacol. 505: 229-235 (2004). *
Arai M, Yokosuka O, Fukai K, Kanda T, Kojima H, Kawai S, Imazeki F, Hirasawa H, Saisho H. A case of severe acute hepatitis of unknown etiology treated with the Chinese herbal medicine Inchinko-to. Hepatol. Res. 28: 161-165 (2004).
Arai T, Esaki Y, Sawabe M, Honma N, Nakamura KI, Takubo K. Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly differentiated colorectal adenocarcinoma in the elderly. Mod. Pathol. 17: 172-179 (2004). *
Arakawa Y, Amaki S, Miyakawa H, Sakai T, Gotou I, Tanaka N, Moriyama M, Iwasaki A, Sugitani M, Arakawa Y. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody. J. Gastroenterol. 39: 490-495 (2004). *
Arakawa Y, Moriyama M, Arakawa Y. Liver cirrhosis and metabolism (sugar, protein, fat and trace elements). Hepatol. Res. 30S: 46-58 (2004).
Araki Y, Andoh A, Takizawa J, Takizawa W, Fujiyama Y. Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats. Int. J. Mol. Med. 13: 577-580 (2004).
Araki Y, Noake T, Kanazawa M, Yamada K, Momosaki K, Nozoe Y, Inoue A, Ishibashi N, Ogata Y, Shirouzu K. Clipless hand-assisted laparoscopic total colectomy using Ligasure Atlas. Kurume Med. J. 51: 105-108 (2004).
Aranda V, Martinez I, Melero S, Lecanda J, Banales JM, Prieto J, Medina JF. Shared apical sorting of anion exchanger isoforms AE2a, AE2b1, and AE2b2 in primary hepatocytes. Biochem. Biophys. Res. Commun. 319: 1040-1046 (2004). *
Arasaradnam RP, Riley SA, Corfe BM. Diet and colorectal cancer: fibre back on the menu? Gut 53: 155-156 (2004). *
Araujo MB, Leonardi LS, Boin IF, Leonardi MI, Magna LA, Donadi EA, Kraemer MH. Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes. Transplant. Proc. 36: 953-955 (2004). *
Arayssi T, Hamdan A. New insights into the pathogenesis and therapy of Behcet's disease. Curr. Opin. Pharmacol. 4: 183-188 (2004).
Araz C, Pirat A, Torgay A, Zeyneloglu P, Arslan G. Early postoperative complications of pediatric liver transplantation: experience at one center. Transplant. Proc. 36: 214-217 (2004). *
Arbour L, Field L, Ross P, Erikson A, Yoshida E. The mystery of primary biliary cirrhosis in British Columbia's First Nations people. Int. J. Circumpolar Health 63 Suppl. 2: 185-188 (2004). *
Ardehali H, Qasim A, Cappola T, Howard D, Hruban R, Hare JM, Baughman KL, Kasper EK. Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. Am. Heart J. 147: 919-923 (2004). *
Ardizzone G, Arrigo A, Panaro F, Ornis S, Colombi R, Distefano S, Jarzembowski TM, Cerruti E. Cerebral hemodynamic and metabolic changes in patients with fulminant hepatic failure during liver transplantation. Transplant. Proc. 36: 3060-3064 (2004). *
Ardizzone S, Maconi G, Colombo E, Manzionna G, Bollani S, Porro GB. Perianal fistulae following infliximab treatment: clinical and endosonographic outcome. Inflamm. Bowel Dis. 10: 91-96 (2004). *
Ardizzone S, Maconi G, Sampietro GM, Russo A, Radice E, Colombo E, Imbesi V, Molteni M, Danelli PG, Taschieri AM, Bianchi Porro G. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 127: 730-740 (2004). *
Arend LJ, Springate JE. Interstitial nephritis from mesalazine: case report and literature review. Pediatr. Nephrol. 19: 550-553 (2004). *
Arents NL, Thijs JC, Van Zwet AA, Kleibeuker JH. Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period. Eur. J. Gastroenterol. Hepatol. 16: 779-783 (2004).
Arentz-Hansen H, Fleckenstein B, Molberg O, Scott H, Koning F, Jung G, Roepstorff P, Lundin KE, Sollid LM. The molecular basis for oat intolerance in patients with celiac disease. Plos. Med. 1: e1 (2004). *
Argast GM, Campbell JS, Brooling JT, Fausto N. Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J. Biol. Chem. 279: 34530-34536 (2004). *
Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127: 514-523 (2004). *
Argov S, Sahu RK, Bernshtain E, Salman A, Shohat G, Zelig U, Mordechai S. Inflamatory bowel diseases as an intermediate stage between normal and cancer: a FTIR-microspectroscopy approach. Biopolymers 75: 384-392 (2004). *
Arguelles-Arias F, Caunedo A, Romero J, Sanchez A, Rodriguez-Tellez M, Pellicer FJ, Arguelles-Martin F, Herrerias JM. The value of capsule endoscopy in pediatric patients with a suspicion of Crohn's disease. Endoscopy 36: 869-873 (2004).
Argyropoulos C, Nikiforidis GC, Theodoropoulou M, Adamopoulos P, Boubali S, Georgakopoulos TN, Paliogianni F, Papavassiliou AG, Mouzaki A. Mining microarray data to identify transcription factors expressed in naive resting but not activated T lymphocytes. Genes Immun. 5: 16-25 (2004). *
Arico M. Langerhans cell histiocytosis in adults: more questions than answers? Eur. J. Cancer 40: 1467-1473 (2004). *
Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113: 451-463 (2004). *
Arii S. Role of vascular endothelial growth factor on the invasive potential of hepatocellular carcinoma. J. Hepatol. 41: 333-335 (2004). *
Arikura J, Inagaki M, Huiling X, Ozaki A, Onodera K, Ogawa K, Kasai S. Colonization of albumin-producing hepatocytes derived from transplanted F344 rat bone marrow cells in the liver of congenic Nagase's analbuminemic rats. J. Hepatol. 41: 215-221 (2004). *
Aringer M. Periodic fever syndromes - a clinical overview. Acta Med. Austriaca 31: 8-12 (2004).
Aringer M, Graninger WB, Steiner G, Smolen JS. Safety and efficacy of tumor necrosis factor blockade in systemic lupus erythematosus: an open-label study. Arthritis Rheum. 50: 3161-3169 (2004). *
Arluk GM, Pickhardt PJ. Images in clinical medicine. Inflammatory pseudopolyposis in Crohn's disease. N. Engl. J. Med. 350: 923 (2004). *
Armenakas NA, Pareek G, Fracchia JA. Iatrogenic bladder perforations: longterm followup of 65 patients. J. Am. Coll. Surg. 198: 78-82 (2004). *
Armitage EL, Aldhous MC, Anderson N, Drummond HE, Riemersma RA, Ghosh S, Satsangi J. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 127: 1051-1057 (2004). *
Armstrong VW, Shipkova M, von Ahsen N, Oellerich M. Analytic aspects of monitoring therapy with thiopurine medications. Ther. Drug Monit. 26: 220-226 (2004).
Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A. Infliximab in the treatment of steroid-dependent ulcerative colitis. Eur. Rev. Med. Pharmacol. Sci. 8: 231-233 (2004).
Arnold KA, Eichelbaum M, Burk O. Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptor. Nucl. Recept. 2: 1 (2004). *
Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am. J. Gastroenterol. 99: 2376-2384 (2004). *
Arnott ID, Lo SK. The clinical utility of wireless capsule endoscopy. Dig. Dis. Sci. 49: 893-901 (2004). *
Arnott ID, Nimmo ER, Drummond HE, Fennell J, Smith BR, MacKinlay E, Morecroft J, Anderson N, Kelleher D, O'Sullivan M, McManus R, Satsangi J. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun. 5: 417-425 (2004). *
Arora V, Verma J, Dutta R, Marwah V, Kumar A, Das N. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus. Mol. Immunol. 41: 449-456 (2004). *
Arostegui JI, Aldea A, Modesto C, Rua MJ, Arguelles F, Gonzalez-Ensenat MA, Ramos E, Rius J, Plaza S, Vives J, Yague J. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Arthritis Rheum. 50: 4045-4050 (2004). *
Arrese M, Ananthanarayanan M. The bile salt export pump: molecular properties, function and regulation. Pflugers Arch. 449: 123-131 (2004). *
Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC. CD14 and Toll-like receptor 4: a link between infection and acute coronary events? Heart 90: 983-988 (2004). *
Arthur GL, Schwartz MZ, Kuenzler KA, Birbe R. Glucagonlike peptide-2 analogue: a possible new approach in the management of inflammatory bowel disease. J. Pediatr. Surg. 39: 448-452 (2004).
Arthur LG, Schwartz MZ, Kuenzler KA, Birbe R. Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease. J. Pediatr. Surg. 39: 139-143 (2004). *
Arts J, D'Haens G, Zeegers M, Van Assche G, Hiele M, D'Hoore A, Penninckx F, Vermeire S, Rutgeerts P. Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis. Inflamm. Bowel Dis. 10: 73-78 (2004). *
Arvand M, Feldhues R, Mieth M, Kraus T, Vandamme P. Chronic cholangitis caused by Bordetella hinzii in a liver transplant recipient. J. Clin. Microbiol. 42: 2335-2337 (2004). *
Arya N, Nelles SE, Haber GB, Kim YI, Kortan PK. Electrohydraulic lithotripsy in 111 patients: a safe and effective therapy for difficult bile duct stones. Am. J. Gastroenterol. 99: 2330-2334 (2004). *
Asaka M, Dragosics BA. Helicobacter pylori and gastric malignancies. Helicobacter 9 Suppl. 1: 35-41 (2004).
Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. J. Clin. Invest. 113: 253-264 (2004). *
Asashima N, Fujimoto M, Jinnin M, Ihn H, Kikuchi K, Takamizawa M, Tamaki K. A female case of hyper-IgM immunodeficiency syndrome with uncommon skin manifestations. Nihon Rinsho Meneki Gakkai Kaishi 27: 350-355 (2004).
Asatsuma M, Ito S, Watanabe M, Takeishi H, Nomura S, Wada Y, Nakano M, Gejyo F, Igarashi A. Increase in the ratio of matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 in saliva from patients with primary Sjogren's syndrome. Clin. Chim. Acta 345: 99-104 (2004). *
Asghar T, Yoshida S, Kennedy S, Negoro K, Zhuo W, Hamana S, Motoyama S, Nakago S, Barlow D, Maruo T. The tumor necrosis factor-alpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum. Reprod. 19: 2509-2514 (2004). *
Ashamiss F, Wierzbicki Z, Chrzanowska A, Scibior D, Pacholczyk M, Kosieradzki M, Lagiewska B, Porembska Z, Rowinski W. Clinical significance of arginase after liver transplantation. Ann. Transplant. 9: 58-60 (2004).
Ashikawa K, Shishodia S, Fokt I, Priebe W, Aggarwal BB. Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem. Pharmacol. 67: 353-364 (2004). *
Ashino T, Oguro T, Shioda S, Horai R, Asano M, Sekikawa K, Iwakura Y, Numazawa S, Yoshida T. Involvement of interleukin-6 and tumor necrosis factor alpha in CYP3A11 and 2C29 down-regulation by Bacillus Calmette-Guerin and lipopolysaccharide in mouse liver. Drug Metab. Dispos. 32: 707-714 (2004). *
Ashkar AA, Yao XD, Gill N, Sajic D, Patrick AJ, Rosenthal KL. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J. Infect. Dis. 190: 1841-1849 (2004). *
Ashwood P, Anthony A, Torrente F, Wakefield AJ. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J. Clin. Immunol. 24: 664-673 (2004). *
Ashwood P, Harvey R, Verjee T, Wolstencroft R, Thompson RP, Powell JJ. Functional interactions between mucosal IL-1, IL-ra and TGF-beta 1 in ulcerative colitis. Inflamm. Res. 53: 53-59 (2004). *
Ashwood P, Van de Water J. Is autism an autoimmune disease? Autoimmun. Rev. 3: 557-562 (2004).
Asimakopoulos G. Pregnancy and inflammatory bowel disease. Rev. Med. Chir. Soc. Med. Nat. Iasi. 108: 46-50 (2004).
Aslaksen HK, Nossent HC. Fatal pulmonary hypertension in primary Sjogren's syndrome. Clin. Exp. Rheumatol. 22: 507 (2004).
Aspinall AI, Lee SS. Concurrence of primary biliary cirrhosis and antiphospholipid antibody syndrome. Am. J. Gastroenterol. 99: 2069-2070 (2004). *
Aspinall RJ. Are adherent Escherichia coli in Crohn's disease and colon cancer truly pathogenic? Gastroenterology 127: 1649-1650 (2004). *
Assche GV, Rutgeerts P. Medical management of postoperative recurrence in Crohn's disease. Gastroenterol. Clin. North Am. 33: 347-360 (2004).
Assem M, Schuetz EG, Leggas M, Sun D, Yasuda K, Reid G, Zelcer N, Adachi M, Strom S, Evans RM, Moore DD, Borst P, Schuetz JD. Interactions between hepatic Mrp4 and Sult2A as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J. Biol. Chem. 279: 22250-22257 (2004). *
Assenat E, Gerbal-Chaloin S, Larrey D, Saric J, Fabre JM, Maurel P, Vilarem MJ, Pascussi JM. Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 40: 951-960 (2004). *
Assies J, Lok A, Bockting CL, Weverling GJ, Lieverse R, Visser I, Abeling NG, Duran M, Schene AH. Fatty acids and homocysteine levels in patients with recurrent depression: an explorative pilot study. Prostaglandins Leukot. Essent. Fatty Acids 70: 349-356 (2004). *
Ates A, Kinikli G, Turgay M, Duman M. The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis. Clin. Rheumatol. 23: 421-425 (2004). *
Ates Y, Aslan M, Tuzun A, Bagci S, Dagalp K. Ulcerative colitis case beginning during pregnancy in a patient with antiphospholipid antibody syndrome. Turk. J. Gastroenterol. 15: 263-265 (2004). *
Athanasiadou S, Kyriazakis I. Plant secondary metabolites: antiparasitic effects and their role in ruminant production systems. Proc. Nutr. Soc. 63: 631-639 (2004). *
Athman R, Philpott D. Innate immunity via Toll-like receptors and Nod proteins. Curr. Opin. Microbiol. 7: 25-32 (2004). *
Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F, Storkel S, Seliger B. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma. Int. J. Cancer 109: 265-273 (2004). *
Atmaca G. Antioxidant effects of sulfur-containing amino acids. Yonsei Med. J. 45: 776-788 (2004). *
Atsumi T, Amengual O, Yasuda S, Koike T. Antiprothrombin antibodies-are they worth assaying? Thromb. Res. 114: 533-538 (2004). *
Atta AM, Sousa CP, Carvalho EM, Sousa-Atta ML. Immunoglobulin E and systemic lupus erythematosus. Braz. J. Med. Biol. Res. 37: 1497-1501 (2004). *
Attaran M, Schneider A, Grote C, Zwiens C, Flemming P, Gratz KF, Jochheim A, Bahr MJ, Manns MP, Ott M. Regional and transient ischemia/reperfusion injury in the liver improves therapeutic efficacy of allogeneic intraportal hepatocyte transplantation in low-density lipoprotein receptor deficient Watanabe rabbits. J. Hepatol. 41: 837-844 (2004). *
Attard TM, Horton KM, DeVito K, Darbari A, Oliva-Hemker M, Thompson R, Cuffari C. Pediatric jejunoileitis: a severe Crohn's disease phenotype that requires intensive nutritional management. Inflamm. Bowel Dis. 10: 357-360 (2004). *
Attwell A, Ludkowski M, Nash R, Kugelmas M. Treatment of Budd-Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Aliment. Pharmacol. Ther. 20: 867-873 (2004). *
Audrezet MP, Chen JM, Raguenes O, Chuzhanova N, Giteau K, Le Marechal C, Quere I, Cooper DN, Ferec C. Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms. Hum. Mutat. 23: 343-357 (2004). *
Augarten A, Paret G, Avneri I, Akons H, Aviram M, Bentur L, Blau H, Efrati O, Szeinberg A, Barak A, Kerem E, Yahav J. Systemic inflammatory mediators and cystic fibrosis genotype. Clin. Exp. Med. 4: 99-102 (2004).
Aune TM, Maas K, Parker J, Moore JH, Olsen NJ. Profiles of gene expression in human autoimmune disease. Cell. Biochem. Biophys. 40: 81-96 (2004).
Aune TM, Parker JS, Maas K, Liu Z, Olsen NJ, Moore JH. Co-localization of differentially expressed genes and shared susceptibility loci in human autoimmunity. Genet. Epidemiol. 27: 162-172 (2004). *
Aust S, Obrist P, Jaeger W, Klimpfinger M, Tucek G, Wrba F, Penner E, Thalhammer T. Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium. Lab. Invest. 84: 1024-1036 (2004). *
Austenaa LM, Carlsen H, Ertesvag A, Alexander G, Blomhoff HK, Blomhoff R. Vitamin A status significantly alters nuclear factor-kappaB activity assessed by in vivo imaging. FASEB J. 18: 1255-1257 (2004). *
Austin A, Campbell E, Lane P, Elias E. Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody. Gut 53: 1032-1034 (2004). *
Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS, Dove WF, Duyk G, Dymecki S, Eppig JT, Grieder FB, Heintz N, Hicks G, Insel TR, Joyner A, Koller BH, Lloyd KC, Magnuson T, Moore MW, Nagy A, Pollock JD, Roses AD, et al. The knockout mouse project. Nat. Genet. 36: 921-924 (2004). *
Autran B, Carcelain G, Combadiere B, Debre P. Therapeutic vaccines for chronic infections. Science 305: 205-208 (2004). *
Autret-Leca E, Jonville-Bera AP, Beau-Salinas F. Vaccines pharmacovigilance. Rev. Prat. 54: 526-531 (2004).
Auwerx J, Avner P, Baldock R, Ballabio A, Balling R, Barbacid M, Berns A, Bradley A, Brown S, Carmeliet P, Chambon P, Cox R, Davidson D, Davies K, Duboule D, Forejt J, Granucci F, Hastie N, De Angelis MH, Jackson I, Kioussis D, et al. The European dimension for the mouse genome mutagenesis program. Nat. Genet. 36: 925-927 (2004). *
Avezov SA, Mansurov FKh. Efficacy of combined administration of ursodeoxycholic acid and hepthral in the treatment of primary biliary cirrhosis. Klin. Med. (Mosk.) 82: 55-58 (2004).
Avezov SA, Mansurova FKh. Efficacy of combined use of ursodeoxycholic acid and heptral in the treatment of primary biliary cirrhosis. Klin. Med. (Mosk.) 82: 46-49 (2004).
Avgerinos A, Armonis A, Stefanidis G, Mathou N, Vlachogiannakos J, Kougioumtzian A, Triantos C, Papaxoinis C, Manolakopoulos S, Panani A, Raptis SA. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology 39: 1623-1630 (2004). *
Avril A, Pichard V, Bralet MP, Ferry N. Mature hepatocytes are the source of small hepatocyte-like progenitor cells in the retrorsine model of liver injury. J. Hepatol. 41: 737-743 (2004). *
Awotesu O, Missotten T, Pitcher MC, Lynn WA, Lightman S. Uveitis in a patient receiving rifabutin for Crohn's disease. J. R. Soc. Med. 97: 440-441 (2004). *
Axelrod D, Koffron A, Dewolf A, Baker A, Fryer J, Baker T, Frederiksen J, Horvath K, Abecassis M. Safety and efficacy of combined orthotopic liver transplantation and coronary artery bypass grafting. Liver Transpl. 10: 1386-1390 (2004). *
Axelrod DA, Guidinger MK, McCullough KP, Leichtman AB, Punch JD, Merion RM. Association of center volume with outcome after liver and kidney transplantation. Am. J. Transplant. 4: 920-927 (2004). *
Axelson M. Studies on biosynthetic pathways to bile acids in human liver cells. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 22. June 18-19 (2004). *
Ayadi H, Kacem HH, Rebai A, Farid NR. The genetics of autoimmune thyroid disease. Trends Endocrinol. Metab. 15: 234-239 (2004). *
Aycan Z, Berberoglu M, Adiyaman P, Ergur AT, Ensari A, Evliyaoglu O, Siklar Z, Ocal G. Latent autoimmune diabetes mellitus in children (LADC) with autoimmune thyroiditis and celiac disease. J. Pediatr. Endocrinol. Metab. 17: 1565-1569 (2004).
AydoGdu S, Ozgenc F, AtIk T, Unal F, Tokat Y, Yagci RV. Biliary atresia in Turkish children. Pediatr. Int. 46: 158-161 (2004). *
Ayed K, Gorgi Y, Sfar I, Khrouf M. Congenital heart block associated with maternal anti SSA/SSB antibodies: a report of four cases. Pathol. Biol. (Paris) 52: 138-147 (2004).
Ayensu WK, Tchounwou PB, McMurray RW. Molecular and cellular mechanisms associated with autoimmune diseases. Int. J. Environ. Res. Public Health 1: 39-73 (2004).
Ayuso JR, Ayuso C, Bombuy E, De Juan C, Llovet JM, De Caralt TM, Sanchez M, Pages M, Bruix J, Garcia-Valdecasas JC. Preoperative evaluation of biliary anatomy in adult live liver donors with volumetric mangafodipir trisodium enhanced magnetic resonance cholangiography. Liver Transpl. 10: 1391-1397 (2004). *
Azar D, Martin F. Paediatric uveitis: a Sydney clinic experience. Clin. Experiment. Ophthalmol. 32: 468-471 (2004).
Azer SA. Do recommended textbooks contain adequate information about bile salt transporters for medical students? Adv. Physiol. Educ. 28: 36-43 (2004). *
Azizah MR, Kuak SH, Ainol SS, Rahim MN, Normaznah Y, Norella K. Association of the tumor necrosis factor alpha gene polymorphism with susceptibility and clinical-immunological findings of systemic lupus erythematosus. Asian Pac. J. Allergy Immunol. 22: 159-163 (2004).
Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, Brown NJ, Reed MW. Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res. 6: R395-R400 (2004). *
Azmy IA, Hurlstone DP, Butt TF, Nasseri F, Bullimore DW, Sanders DS. Does surgical removal of mucosal associated lymphoid tissue protect against adult coeliac disease? A case controlled study. Dig. Liver Dis. 36: 187-190 (2004).
Azria D, Larbouret C, Garambois V, Gourgou S, Martineau P, Robert B, Dubois JB, Pelegrin A. A bispecific antibody to enhance radiotherapy by tumor necrosis factor-alpha in human CEA-expressing digestive tumors. Int. J. Radiat. Oncol. Biol. Phys. 58: 580-588 (2004).
Azzi A, Gysin R, Kempna P, Munteanu A, Negis Y, Villacorta L, Visarius T, Zingg JM. Vitamin E mediates cell signaling and regulation of gene expression. Ann. N. Y. Acad. Sci. 1031: 86-95 (2004). *
Azzi A, Gysin R, Kempna P, Munteanu A, Villacorta L, Visarius T, Zingg JM. Regulation of gene expression by alpha-tocopherol. Biol. Chem. 385: 585-591 (2004).
Babiuk S, Mookherjee N, Pontarollo R, Griebel P, Van Drunen Littel-Van Den Hurk S, Hecker R, Babiuk L. TLR9(+/+) and TLR9(-/-) mice display similar immune responses to a DNA vaccine. Immunology 113: 114-120 (2004). *
Babu TG, Boctor D, Davey A, Bond MC, Jacobson K. Cytomegalovirus-associated hemophagocytic syndrome in a child with Crohn disease receiving azathioprine. J. Pediatr. Gastroenterol. Nutr. 39: 418-421 (2004). *
Bacchella T, Figueira ER, Makdissi FF, Rocha-Santos V, Martino RB, Andraus W, Canedo LF, Machado MA, Machado MC. Biliary reconstruction without T-tube in liver transplantation. Transplant. Proc. 36: 951-952 (2004). *
Bacha EA, Hardin J, Cronin DC, Brady L, Millis MJ, Starr JP, Koenig P, Daves S, Kahana M. Open-heart surgery in pediatric patients with end-stage liver disease. Ann. Thorac. Surg. 78: E30-E33 (2004).
Bacher S, Schmitz ML. The NF-kappa B pathway as a potential target for autoimmune disease therapy. Curr. Pharm. Des. 10: 2827-2837 (2004).
Bachmann AS. The role of polyamines in human cancer: prospects for drug combination therapies. Hawaii Med. J. 63: 371-374 (2004).
Bachmann K, Patel H, Batayneh Z, Slama J, White D, Posey J, Ekins S, Gold D, Sambucetti L. PXR and the regulation of apoA1 and HDL-cholesterol in rodents. Pharmacol. Res. 50: 237-246 (2004). *
Bachmann MF, Schwarz K, Wolint P, Meijerink E, Martin S, Manolova V, Oxenius A. Cutting edge: distinct roles for T help and CD40/CD40 ligand in regulating differentiation of proliferation-competent memory CD8+ T cells. J. Immunol. 173: 2217-2221 (2004). *
Backstrom E, Kristensson K, Ljunggren HG. Activation of natural killer cells: underlying molecular mechanisms revealed. Scand. J. Immunol. 60: 14-22 (2004). *
Bacon BR. Metabolic liver diseases. Clin. Liver Dis. 8: xi-xii (2004).
Badakere SS, Pradhan VD, Almeida AF, Pawar AR. Use of immunofluorescence and confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificities to myeloperoxidase and proteinase3. J. Fluoresc. 14: 459-463 (2004). *
Badenhoop K. Genetic markers in thyroid autoimmune diseases. Z. Arztl. Fortbild. Qualitatssich. 98 Suppl. 5: 13-15 (2004).
Badenhoop K, Boehm BO. Genetic susceptibility and immunological synapse in type 1 diabetes and thyroid autoimmune disease. Exp. Clin. Endocrinol. Diabetes 112: 407-415 (2004).
Badet F, Bellis G, De Braekeleer M, Nove Josserand R, Vital Durand D; The Cystic Fibrosis Centre of ONM ; Durieu I. Phenotype and genotype of French cystic fibrosis patients with long survival and follow-up. Eur. J. Intern. Med. 15: 238-241 (2004).
Badizadegan K. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 126: 1493-1494 (2004). *
Badolato R, Fontana S, Barcella L, Moratto D, D'ippolito C, Crovella S, Notarangelo LD, Duse M. Toll-like receptor-4 genotype in children with respiratory infections. Allergy 59: 1018-1019 (2004). *
Badrising UA, Schreuder GM, Giphart MJ, Geleijns K, Verschuuren JJ, Wintzen AR, Maat-Schieman ML, van Doorn P, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, van Duinen SG; Dutch IBM Study Group. Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis. Neurology 63: 2396-2398 (2004).
Bae SC, Choi JK. Tumor suppressor activity of RUNX3. Oncogene 23: 4336-4340 (2004). *
Bae Y, Kemper JK, Kemper B. Repression of CAR-mediated transactivation of CYP2B genes by the orphan nuclear receptor, short heterodimer partner (SHP). DNA Cell Biol. 23: 81-91 (2004).
Baecher-Allan C, Hafler DA. Suppressor T cells in human diseases. J. Exp. Med. 200: 273-276 (2004). *
Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Moser K, Ortmann WA, Espe KJ, Balasubramanian S, Hughes KM, Chan JP, Begovich A, Chang SY, Gregersen PK, Behrens TW. Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun. 5: 347-353 (2004). *
Baecklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L. Rheumatoid arthritis and malignant lymphomas. Curr. Opin. Rheumatol. 16: 254-261 (2004).
Baerg J, Zuppan C, Klooster M. Biliary atresia-a fifteen-year review of clinical and pathologic factors associated with liver transplantation. J. Pediatr. Surg. 39: 800-803 (2004).
Baert F, Vermeire S, Noman M, Van Assche G, D'Haens G, Rutgeerts P. Management of ulcerative colitis and Crohn's disease. Acta Clin. Belg. 59: 304-314 (2004).
Baeten D, De Keyser F, Veys EM, Theate Y, Houssiau FA, Durez P. Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules. Ann. Rheum. Dis. 63: 489-493 (2004). *
Baeten D, Steenbakkers PG, Rijnders AM, Boots AM, Veys EM, De Keyser F. Detection of major histocompatibility complex/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker. Arthritis Rheum. 50: 444-451 (2004). *
Baetz A, Frey M, Heeg K, Dalpke AH. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate Toll-like receptor signaling in innate immune cells. J. Biol. Chem. 279: 54708-54715 (2004). *
Baglioni S, Genuardi M. Simple and complex genetics of colorectal cancer susceptibility. Am. J. Med. Genet. 129C: 35-43 (2004). *
Bagnoli S, Putignano AL, Melean G, Baglioni S, Sestini R, Milla M, d'Albasio G, Genuardi M, Pacini F, Trallori G, Papi L. Susceptibility to refractory ulcerative colitis is associated with polymorphism in the hMLH1 mismatch repair gene. Inflamm. Bowel Dis. 10: 705-708 (2004). *
Baguet A, Bix M. Chromatin landscape dynamics of the Il4-Il13 locus during T helper 1 and 2 development. Proc. Natl. Acad. Sci. U.S.A. 101: 11410-11415 (2004). *
Baharav E, Mor F, Halpern M, Weinberger A. Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J. Nutr. 134: 1964-1969 (2004). *
Bahn A, Ebbinghaus C, Ebbinghaus D, Ponimaskin EG, Fuzesi L, Burckhardt G, Hagos Y. Expression studies and functional characterization of renal human organic anion transporter 1 isoforms. Drug Metab. Dispos. 32: 424-430 (2004). *
Bahn A, Hagos Y, Rudolph T, Burckhardt G. Mutation of amino acid 475 of rat organic cation transporter 2 (rOCT2) impairs organic cation transport. Biochimie 86: 133-136 (2004).
Bahtiyar G, Shin JJ, Aytaman A, Sowers JR, McFarlane SI. Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights. Curr. Diab. Rep. 4: 194-198 (2004).
Bai S, Stepkowski SM, Kahan BD, Brunner LJ. Metabolic interaction between cyclosporine and sirolimus. Transplantation 77: 1507-1512 (2004).
Baik SK, Lee SS. Cirrhotic cardiomyopathy: causes and consequences. J. Gastroenterol. Hepatol. 19: S185-S190 (2004). *
Bailey DG, Dresser GK. Natural products and adverse drug interactions. CMAJ 170: 1531-1532 (2004). *
Bailey MA, Ingram MJ, Naughton DP. A novel anti-oxidant and anti-cancer strategy: a peptoid anti-inflammatory drug conjugate with SOD mimic activity. Biochem. Biophys. Res. Commun. 317: 1155-1158 (2004). *
Baisini O, Benini F, Petraglia F, Kuhnz W, Scalia S, Marschall HU, Brunetti G, Tauschel HD, Lanzini A. Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives. Eur. J. Clin. Pharmacol. 60: 481-487 (2004). *
Baisse B, Fontolliet C, Bian YS, Vuilleumier H, Benhattar J. Synchronous ileal and colonic adenocarcinomas associated with Crohn's disease: report of a case with a focus on genetic alterations and carcinogenesis. J. Clin. Pathol. 57: 885-887 (2004). *
Baixauli J, Delaney CP, Wu JS, Remzi FH, Lavery IC, Fazio VW. Functional outcome and quality of life after repeat ileal pouch-anal anastomosis for complications of ileoanal surgery. Dis. Colon Rectum 47: 2-11 (2004). *
Bajt ML, Knight TR, Lemasters JJ, Jaeschke H. Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicol. Sci. 80: 343-349 (2004). *
Baker A, Alonso ME, Aw MM, Ciocca M, Porta G, Rosenthal P. Hepatic failure and liver transplant: working group report of the second world congress of pediatric gastroenterology, hepatology, and nutrition. J. Pediatr. Gastroenterol. Nutr. 39: S632-S639 (2004). *
Baker DE. Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody. Rev. Gastroenterol. Disord. 4: 196-210 (2004). *
Baker DE. Therapeutic equivalence of mesalamine products. Rev. Gastroenterol. Disord. 4: 25-28 (2004). *
Baker DE, Kane S. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Rev. Gastroenterol. Disord. 4: 86-91 (2004). *
Baker KP. BLyS-an essential survival factor for B cells: basic biology, links to pathology and therapeutic target. Autoimmun. Rev. 3: 368-375 (2004).
Baker MJ, Hamilton KL. Genistein stimulates electrogenic Cl- secretion in the mouse jejunum. Am. J. Physiol. Cell. Physiol. 287: C1636-C1645 (2004). *
Bakke AC, Purtzer MZ, Wildin RS. Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX). Clin. Exp. Immunol. 137: 373-378 (2004). *
Baksh FK, Finkelstein SD, Ariyanayagam-Baksh SM, Swalsky PA, Klein EC, Dunn JC. Absence of Mycobacterium avium subsp. paratuberculosis in the microdissected granulomas of Crohn's disease. Mod. Pathol. 17: 1289-1294 (2004). *
Bakthavachalam S, Driver MS, Cox C, Spiegel JH, Grundfast KM, Merkel PA. Hearing loss in Wegener's granulomatosis. Otol. Neurotol. 25: 833-837 (2004).
Bal J, Sobczynska-Tomaszewska A, Czerska K, Obersztyn E, Sands D, Mazurczak T. Prenatal diagnostics of cystic fibrosis in risk families in Poland - results of the molecular analyses. Med. Wieku. Rozwoj. VIII: 871-883 (2004).
Balabaud C, Bioulac-Sage P, Desmouliere A. The role of hepatic stellate cells in liver regeneration. J. Hepatol. 40: 1023-1026 (2004). *
Balaji Raghavendra Rao H, Sathivel A, Devaki T. Antihepatotoxic nature of Ulva reticulata (Chlorophyceae) on acetaminophen-induced hepatoxicity in experimental rats. J. Med. Food 7: 495-497 (2004).
Balandraud N, Roudier J, Roudier C. Epstein-Barr virus and rheumatoid arthritis. Autoimmun. Rev. 3: 362-367 (2004).
Balasubramanian S, Chandraratna RA, Eckert RL. Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid. Carcinogenesis 25: 1377-1385 (2004). *
Baldan A, Relat J, Marrero PF, Haro D. Functional interaction between peroxisome proliferator-activated receptors-alpha and Mef-2C on human carnitine palmitoyltransferase 1beta (CPT1beta) gene activation. Nucleic Acids Res. 32: 4742-4749 (2004). *
Balding J, Livingstone WJ, Conroy J, Mynett-Johnson L, Weir DG, Mahmud N, Smith OP. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm.13: 181-187 (2004). *
Baldridge JR, McGowan P, Evans JT, Cluff C, Mossman S, Johnson D, Persing D. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin. Biol. Ther. 4: 1129-1138 (2004).
Baliga P, Alvarez S, Lindblad A, Zeng L. Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience. Liver Transpl. 10: 1364-1371 (2004). *
Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 4: 540-550 (2004). *
Ball CG, Gmora S, Vollmer CM Jr, Dixon E. An intraluminal lesion in the mid-common bile duct and right hepatic duct causing right portal vein obstruction. J. Hepatol. 41: 1060 (2004). *
Ballok DA, Woulfe J, Sur M, Cyr M, Sakic B. Hippocampal damage in mouse and human forms of systemic autoimmune disease. Hippocampus 14: 649-661 (2004).
Ballot E, Bandin O, Chazouilleres O, Johanet C, Poupon R. Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases. J. Autoimmun. 22: 153-158 (2004).
Balog A, Gal J, Gyulai Z, Zsilak S, Mandi Y. Tumour necrosis factor-alpha and heat-shock protein 70-2 gene polymorphisms in a family with rheumatoid arthritis. Acta Microbiol. Immunol. Hung. 51: 263-269 (2004).
Balog A, Klausz G, Gal J, Molnar T, Nagy F, Ocsovszky I, Gyulai Z, Mandi Y. Investigation of the prognostic value of TNF-alpha gene polymorphism among patients treated with infliximab, and the effects of infliximab therapy on TNF-alpha production and apoptosis. Pathobiology 71: 274-280 (2004).
Balogh A, Derzbach L, Vasarhelyi B. Hepcidin, the negative regulator of iron absorbtion. Orv. Hetil. 145: 1549-1552 (2004).
Baltes S, Nau H, Lampen A. All-trans retinoic acid enhances differentiation and influences permeability of intestinal Caco-2 cells under serum-free conditions. Dev. Growth Differ. 46: 503-514 (2004).
Bambou JC, Giraud A, Menard S, Begue B, Rakotobe S, Heyman M, Taddei F, Cerf-Bensussan N, Gaboriau-Routhiau V. In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. J. Biol. Chem. 279: 42984-42992 (2004). *
Bamm VV, Tsemakhovich VA, Shaklai M, Shaklai N. Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. Biochemistry 43: 3899-3906 (2004). *
Ban Y, Concepcion ES, Villanueva R, Greenberg DA, Davies TF, Tomer Y. Analysis of immune regulatory genes in familial and sporadic Graves' disease. J. Clin. Endocrinol. Metab. 89: 4562-4568 (2004). *
Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, Oashi T, Tomer Y. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun. 5: 203-208 (2004). *
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population. Clin. Endocrinol. (Oxf.) 61: 263-268 (2004). *
Banerjee S, Farquharson M, Cecil TD, Gold D, Moran BJ. Late-onset fistula presenting as buttock abscess in two patients with ileo-anal J-pouches for ulcerative colitis. Tech. Coloproctol. 8: 37-39 (2004). *
Baniyash M. TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat. Rev. Immunol. 4: 675-687 (2004). *
Banks MR, Golder M, Farthing MJ, Burleigh DE. Intracellular potentiation between two second messenger systems may contribute to cholera toxin induced intestinal secretion in humans. Gut 53: 50-57 (2004). *
Bannantine JP, Barletta RG, Stabel JR, Paustian ML, Kapur V. Application of the genome sequence to address concerns that Mycobacterium avium subspecies paratuberculosis might be a foodborne pathogen. Foodborne Pathog. Dis. 1: 3-15 (2004).
Banner KH, Cattaneo C, Net JL, Popovic A, Collins D, Gale JD. Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene. Br. J. Pharmacol.143: 590-598 (2004). *
Banner KH, Trevethick MA. PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease. Trends Pharmacol. Sci. 25: 430-436 (2004). *
Bannerjee K, Camacho-Hubner C, Babinska K, Dryhurst KM, Edwards R, Savage MO, Sanderson IR, Croft NM. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J. Pediatr. Gastroenterol. Nutr. 38: 270-275 (2004). *
Bannerman DD, Eiting KT, Winn RK, Harlan JM. FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharide. Am. J. Pathol. 165: 1423-1431 (2004). *
Banno T, Gazel A, Blumenberg M. Effects of tumor necrosis factor-alpha (TNFalpha) in epidermal keratinocytes revealed using global transcriptional profiling. J. Biol. Chem. 279: 32633-32642 (2004). *
Banos Madrid R, Salama Benerroch H, Moran Sanchez S, Gallardo Sanchez F, Albadalejo Merono A, Mercader Martinez J. Lactose malabsorption in patients with inflammatory bowel disease without activity: it would be necessary to exclude the lactose products in their diet to all the patients? An. Med. Interna 21: 212-214 (2004).
Bantel H, Lugering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, Manns MP, Schulze-Osthoff K. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 40: 1078-1087 (2004). *
Baptista-Gonzalez H, Gutierrez-Landeros F, Rosenfeld-Mann F, Trueba-Gomez R. Changes of coagulation inhibitors and fibrinolysis system in newborn infants with transitory neonatal cholestasis. Ann. Hepatol. 3: 26-29 (2004). *
Bar-Zohar D, Segal-Algranati D, Belson A, Reif S. Diagnosing cystic fibrosis - asthma and failure to thrive as indications for a sweat test. J. Med. 35: 93-103 (2004).
Barabas AZ, Cole CD, Barabas AD, Lafreniere R. Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model. Int. J. Exp. Pathol. 85: 321-334 (2004). *
Baragiotta A, Floreani A, Agarwal K, Venturi C, Craggs A, Jones DEJ, Donaldson PT, Bassendine MF. Chemokine receptor 5 and primary biliary cirrhosis: a two-centre genetic association study. Liver Int. 24: 646-650 (2004). *
Barbier O, Fontaine C, Fruchart JC, Staels B. Genomic and non-genomic interactions of PPARalpha with xenobiotic-metabolizing enzymes. Trends Endocrinol. Metab. 15: 324-330 (2004). *
Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, Grams SE, Walker K, Steiner LL, Cree BA, Stillman A, Lincoln RR, Pericak-Vance MA, Haines JL, Erlich HA, Hauser SL, Oksenberg JR. Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann. Neurol. 55: 793-800 (2004).
Barchana M, Liphshitz I, Rozen P. Trends in colorectal cancer incidence and mortality in the Israeli Jewish ethnic populations. Fam. Cancer 3: 207-214 (2004). *
Bardella MT, Cantu P, Cesana BM, Piodi LP. Severe heart disease in coeliac sprue and inflammatory bowel disease: a common pathogenesis? Scand. J. Gastroenterol. 39: 1304-1305 (2004). *
Bardella MT, Valenti L, Pagliari C, Peracchi M, Fare M, Fracanzani AL, Fargion S. Searching for coeliac disease in patients with non-alcoholic fatty liver disease. Dig. Liver Dis. 36: 333-336 (2004).
Bardin T. Current management of gout in patients unresponsive or allergic to allopurinol. Joint Bone Spine 71: 481-485 (2004).
Bardin T. Psoriatic rheumatism. Rev. Prat. 54: 60-68 (2004).
Baric I, Fumic K, Glenn B, Cuk M, Schulze A, Finkelstein JD, James SJ, Mejaski-Bosnjak V, Pazanin L, Pogribny IP, Rados M, Sarnavka V, Scukanec-Spoljar M, Allen RH, Stabler S, Uzelac L, Vugrek O, Wagner C, Zeisel S, Mudd SH. S-Adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc. Natl. Acad. Sci. U.S.A. 101: 4234-4239 (2004). *
Barisani D, Ceroni S, Del Bianco S, Meneveri R, Bardella MT. Hemochromatosis gene mutations and iron metabolism in celiac disease. Haematologica 89: 1299-1305 (2004). *
Barisic G, Krivokapic Z, Markovic V, Saranovic D, Masulovic D. Ulcerative colitis indications and timing for surgery. Acta Chir. Iugosl. 51: 123-126 (2004).
Barisic-Drusko V, Rucevic I. Trigger factors in childhood psoriasis and vitiligo. Coll. Antropol. 28: 277-285 (2004).
Barker CL, McHale MT, Gillies AK, Waller J, Pearce DM, Osborne J, Hutchinson PE, Smith GM, Pringle JH. The development and characterization of an in vitro model of psoriasis. J. Invest. Dermatol. 123: 892-901 (2004). *
Barland P. Antibodies to citrullinated peptides: current role in diagnosis, prognosis, and pathogenesis of rheumatoid arthritis. New Developments in Rheumatic Diseases 1: 6-9 (2004). *
Barmada MM, Brant SR, Nicolae DL, Achkar JP, Panhuysen CI, Bayless TM, Cho JH, Duerr RH. A genome scan in 260 inflammatory bowel disease-affected relative pairs. Inflamm. Bowel Dis. 10: 513-520 (2004). *
Barmada MM, Brant SR, Nicolae DL, Achkar JP, Panhuysen CI, Bayless TM, Cho JH, Duerr RH. A genome scan in 260 inflammatory bowel disease-affected relative pairs. Inflamm. Bowel Dis. 10: 15-22 (2004). *
Barmeyer C, Harren M, Schmitz H, Heinzel-Pleines U, Mankertz J, Seidler U, Horak I, Wiedenmann B, Fromm M, Schulzke JD. Mechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G244-G252 (2004). *
Barnes BH, Borowitz SM, Saulsbury FT, Hellems M, Sutphen JL. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine. J. Pediatr. Gastroenterol. Nutr. 38: 509-512 (2004). *
Barnes BJ, Richards J, Mancl M, Hanash S, Beretta L, Pitha PM. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J. Biol. Chem. 279: 45194-45207 (2004). *
Barnes KC, Caraballo L, Munoz M, Zambelli-Weiner A, Ehrlich E, Burki M, Jimenez S, Mathias RA, Stockton ML, Deindl P, Mendoza L, Hershey GK, Nickel R, Wills-Karp M. A novel promoter polymorphism in the gene encoding complement component 5 receptor 1 on chromosome 19q13.3 is not associated with asthma and atopy in three independent populations. Clin. Exp. Allergy 34: 736-744 (2004). *
Barnich N, Bringer MA, Claret L, Darfeuille-Michaud A. Involvement of lipoprotein NlpI in the virulence of adherent invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease. Infect. Immun. 72: 2484-2493 (2004). *
Baron RL, Brancatelli G. Computed tomographic imaging of hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S133-S143 (2004). *
Baron TH, Harewood GC. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am. J. Gastroenterol. 99: 1455-1460 (2004). *
Barra GB, Velasco LF, Pessanha RP, Campos AM, Moura FN, Dias SM, Polikarpov I, Ribeiro RC, Simeoni LA, Neves FA. Molecular mechanism of thyroid hormone action. Arq. Bras. Endocrinol. Metabol. 48: 25-39 (2004).
Barreau F, Cartier C, Ferrier L, Fioramonti J, Bueno L. Nerve growth factor mediates alterations of colonic sensitivity and mucosal barrier induced by neonatal stress in rats. Gastroenterology 127: 524-534 (2004). *
Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C, Martins B, Andreia R, Viana JF, Crespo F, Vasconcelos C, Ferreira C, Vicente AM. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur. J. Hum. Genet. 12: 620-626 (2004). *
Barry J, Kirby B. Novel biologic therapies for psoriasis. Expert Opin. Biol. Ther. 4: 975-987 (2004).
Barta Z, Csipo I, Mekkel G, Zeher M, Majoros L, Bernstein CN, Collins MT. Seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease. J. Clin. Microbiol. 42: 5432-5433 (2004). *
Barta Z, Toth L, Szabo GG, Szegedi G, Zeher M. Intravenous pulse cyclophosphamide therapy in Crohn's disease and ulcerative colitis. Gut 53: 1058 (2004). *
Bartha I, Danya T, Nemeth A. Surgical strategy in massive colorectal bleeding. Acta Chir. Iugosl. 51: 91-92 (2004).
Barthet M, Juhan V, Gasmi M, Grimaud JC. Imaging of perianal Crohn's disease. Gastroenterol. Clin. Biol. 28: S52-S60 (2004).
Bartke U, Venten I, Kreuter A, Gabbay S, Altmeyer P, Brockmeyer NH. Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab. Br. J. Dermatol. 150: 784-786 (2004).
Bartley J, Loddenkemper C, Lange J, Mechsner S, Radke C, Neuhaus P, Ebert AD. Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report. Arch. Gynecol. Obstet. 269: 290-293 (2004).
Barton A, Bowes J, Eyre S, Spreckley K, Hinks A, John S, Worthington J. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum. 50: 1117-1121 (2004). *
Barton A, Jury F, Eyre S, Bowes J, Hinks A, Ward D, Worthington J. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis Rheum. 50: 748-752 (2004). *
Barton A, Platt H, Salway F, Symmons D, Barrett E, Bukhari M, Lunt M, Zeggini E, Eyre S, Hinks A, Tellam D, Brintnell B, Ollier W, Worthington J, Silman A. Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis. Ann. Rheum. Dis. 63: 280-284 (2004). *
Barton A, Platt H, Salway F, Symmons D, Lunt M, Worthington J, Silman A. Polymorphisms in the mannose binding lectin (MBL) gene are not associated with radiographic erosions in rheumatoid or inflammatory polyarthritis. J. Rheumatol. 31: 442-447 (2004). *
Barton A, Woolmore JA, Ward D, Eyre S, Hinks A, Ollier WE, Strange RC, Fryer AA, John S, Hawkins CP, Worthington J. Association of protein kinase C alpha (PRKCA) gene with multiple sclerosis in a UK population. Brain 127: 1717-1722 (2004). *
Barton EH, Barton JC, Hollowell WW, Acton RT. Countries of ancestry reported by hemochromatosis probands and control subjects in central Alabama. Ethn. Dis. 14: 73-81 (2004).
Barton JC. Hemochromatosis, HFE C282Y homozygosity, and bariatric surgery: report of three cases. Obes. Surg. 14: 1409-1414 (2004).
Barton JC, Bertoli LF, Acton RT. HFE C282Y and H63D in adults with malignancies in a community medical oncology practice. BMC Cancer 4: 6 (2004). *
Barton JC, Rivers CA, Niyongere S, Bohannon SB, Acton RT. Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama population. BMC Med. Genet. 5: 29 (2004). *
Barton JC, West C, Lee P, Beutler E. A previously undescribed frameshift deletion mutation of HFE (c.del277; G93fs) associated with hemochromatosis and iron overload in a C282Y heterozygote. Clin. Genet. 66: 214-216 (2004). *
Barton P, Jobanputra P, Wilson J, Bryan S, Burls A. The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. Health Technol. Assess. 8: 1-104 (2004). *
Bartsch DK, Kress R, Sina-Frey M, Grutzmann R, Gerdes B, Pilarsky C, Heise JW, Schulte KM, Colombo-Benkmann M, Schleicher C, Witzigmann H, Pridohl O, Ghadimi MB, Horstmann O, von Bernstorff W, Jochimsen L, Schmidt J, Eisold S, Estevez-Schwarz L, et al. Prevalence of familial pancreatic cancer in Germany. Int. J. Cancer 110: 902-906 (2004). *
Bartsch H, Nair J. Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. Cancer Detect. Prev. 28: 385-391 (2004).
Bartzokis G, Tishler TA, Shin IS, Lu PH, Cummings JL. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann. N. Y. Acad. Sci. 1012: 224-236 (2004). *
Baseggio L, Bartholin L, Chantome A, Charlot C, Rimokh R, Salles G. Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-alpha promoter. Eur. J. Immunogenet. 31: 15-19 (2004). *
Basehore MJ, Howard TD, Lange LA, Moore WC, Hawkins GA, Marshik PL, Harkins MS, Meyers DA, Bleecker ER. A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects. J. Allergy Clin. Immunol. 114: 80-87 (2004).
Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez F, Rohrer J, Benninghoff AU, Hontecillas R. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127: 777-791 (2004). *
Bassendine MF. Infectious etiology of primary biliary cirrhosis (PBC). Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 45-46 (2004). *
Basset C, Holton J, Bazeos A, Vaira D, Bloom S. Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig. Dis. Sci. 49: 1425-1432 (2004). *
Basset C, Holton J, Gatta L, Ricci C, Bernabucci V, Liuzzi G, Vaira D. Helicobacter pylori infection: anything new should we know? Aliment. Pharmacol. Ther. 20 Suppl. 2: 31-41 (2004).
Bassett MH, Suzuki T, Sasano H, De Vries CJ, Jimenez PT, Carr BR, Rainey WE. The orphan nuclear receptor NGFIB regulates transcription of 3beta-hydroxysteroid dehydrogenase: implications for the control of adrenal functional zonation. J. Biol. Chem. 279: 37622-37630 (2004). *
Bassi A, Dodd S, Williamson P, Bodger K. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 53: 1471-1478 (2004). *
Bassi C, Falconi M. Discussion on prophylactic antibiotic treatment in patients with predicted severe pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology 127: 1015-1016 (2004). *
Bassotti G, De Roberto G, Chistolini F, Sietchiping-Nzepa F, Morelli O, Morelli A. Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions. Int. J. Colorectal Dis. 19: 493-497 (2004). *
Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328: 1-16 (2004). *
Bastone L, Reilly M, Rader DJ, Foulkes AS. MDR and PRP: a comparison of methods for high-order genotype-phenotype associations. Hum. Hered. 58: 82-92 (2004).
Basu SK, Govardhan CP, Jung CW, Margolin AL. Protein crystals for the delivery of biopharmaceuticals. Expert Opin. Biol. Ther. 4: 301-317 (2004).
Bat B, Lodowska J, Orchel A, Parfiniewicz B, Weglarz L, Dzierzewicz Z, Wilczok T. Evaluation of biotransformation of sulphasalazine in the colon epithelial Caco-2 cells. Acta Pol. Pharm. 61 Suppl.: 8-10 (2004).
Bataille F, Klebl F, Rummele P, Schroeder J, Farkas S, Wild PJ, Furst A, Hofstadter F, Scholmerich J, Herfarth H, Rogler G. Morphological characterisation of Crohn's disease fistulae. Gut 53: 1314-1321 (2004). *
Batbayar B, Nagy G, Kovesi G, Zelles T, Feher E. Morphological basis of sensory neuropathy and neuroimmunomodulation in minor salivary glands of patients with Sjogren's syndrome. Arch. Oral Biol. 49: 529-538 (2004).
Bateman EA, Ferry BL, Hall A, Misbah SA, Anderson R, Kelleher P. IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadin. Gut 53: 1274-1278 (2004). *
Battisti C, Dotti MT, Loudianos G, Dessi V V, Battistini S, Amato T, Rufa A, Federico A. Wilson's disease with Leu492Ser mutation and arylsulfatase A pseudodeficiency: just a coincidence? Neurol. Sci. 25: 18-20 (2004). *
Baudet JS, Medina A, Moreno A, Navazo L, Aviles J, Soriano A. Bronchobiliary fistula secondary to ruptured hepatocellular carcinoma into the bile duct. J. Hepatol. 41: 1066-1067 (2004). *
Bauditz J, Schachschal G, Wedel S, Lochs H. Thalidomide for treatment of severe intestinal bleeding. Gut 53: 609-612 (2004). *
Bauditz J, Schmidt HH, Dippe P, Lochs H, Pirlich M. Non-alcohol induced steatohepatitis in non-obese patients: treatment with ursodeoxycholic acid. Am. J. Gastroenterol. 99: 959-960 (2004). *
Baudouin C, Pisella PJ, Brignole F. Current treatments of xerophthalmia in Sjogren's syndrome. Rev. Med. Interne. 25: 376-382 (2004).
Bauer B, Hartz AM, Fricker G, Miller DS. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol. Pharmacol. 66: 413-419 (2004). *
Bauer K, Yu X, Wernhoff P, Koczan D, Thiesen HJ, Ibrahim SM. Identification of new quantitative trait loci in mice with collagen-induced arthritis. Arthritis Rheum. 50: 3721-3728 (2004). *
Bauer M, Hamm AC, Bonaus M, Jacob A, Jaekel J, Schorle H, Pankratz MJ, Katzenberger JD. Starvation response in mouse liver shows strong correlation with life-span-prolonging processes. Physiol. Genomics 17: 230-244 (2004). *
Baumgart DC, Dignass AU. Current biological therapies for inflammatory bowel disease. Curr. Pharm. Des. 10: 4127-4147 (2004).
Baumgart DC, Wiedenmann B, Dignass AU. Successful therapy of refractory pyoderma gangrenosum and periorbital phlegmona with tacrolimus (FK506) in ulcerative colitis. Inflamm. Bowel Dis. 10: 421-424 (2004). *
Baurmash HD. Diagnosing primary and secondary Sjogren's syndrome. J. Oral Maxillofac. Surg. 62: 764-765 (2004).
Bavdekar A. Therapeutic and management challenges in Wilson's disease. J. Gastroenterol. Hepatol. 19: S391-S395 (2004). *
Bayer EM, Schramm C, Kanzler S, Lohse AW. Autoimmune liver disease: diagnosis and therapy. Z. Gastroenterol. 42: 19-30 (2004).
Bayer Y, Neumann S, Meyer B, Ruschendorf F, Reske A, Brix T, Hegedus L, Langer P, Nurnberg P, Paschke R. Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter. J. Clin. Endocrinol. Metab. 89: 4044-4052 (2004). *
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find. Exp. Clin. Pharmacol. 26: 587-612 (2004).
Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun. 5: 315-329 (2004). *
Bayliffe AI, Brigandi RA, Wilkins HJ, Levick MP. Emerging therapeutic targets in psoriasis. Curr. Opin. Pharmacol. 4: 306-310 (2004).
Bayliss M, Somers G. Isolation and culture of human hepatocytes. Methods Mol. Med. 107: 249-268 (2004).
Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Galicier L, Lepelletier Y, Webster D, Levy Y, Eibl MM, Oksenhendler E, Hermine O, Kaveri SV. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 104: 2441-2443 (2004). *
Bazarah SM, Peltekian KM, McAlister VC, Bitter-Suermann H, MacDonald AS. Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant. Clin. Invest. Med. 27: 162-167 (2004).
Bazilio AP, Viana VS, Toledo R, Woronik V, Bonfa E, Monteiro RC. Fc gamma RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients. Nephrol. Dial. Transplant. 19: 1427-1431 (2004). *
Beani JC. Prescription of phototherapy in psoriasis. Rev. Prat. 54: 43-47 (2004).
Beaugerie L. Is the risk of lymphoma increased by immunosuppressive therapy in patients with inflammatory bowel disease? The missing link for considering early immunosuppressants. Gastroenterol. Clin. Biol. 28: 218-220 (2004).
Beaugerie L, Blain A, Brazier F, Gornet JM, Parc Y. Treatment of extended ulcerative colitis (severe colitis excluded). Gastroenterol. Clin. Biol. 28: 974-983 (2004).
Beaugerie L, Petit JC. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract. Res. Clin. Gastroenterol. 18: 337-352 (2004).
Beaugerie L, Thiefin G. Gastrointestinal complications related to NSAIDs. Gastroenterol. Clin. Biol. 28 Spec. No 3: C62-C72 (2004).
Beaumont C. Molecular mechanisms of iron homeostasis. Med. Sci. (Paris) 20: 68-72 (2004).
Beaven SW, Abreu MT. Biomarkers in inflammatory bowel disease. Curr. Opin. Gastroenterol. 20: 318-327 (2004).
Bebb JR, Scott BB. How effective are the usual treatments for Crohn's disease? Aliment. Pharmacol. Ther. 20: 151-159 (2004). *
Bebb JR, Scott BB. How effective are the usual treatments for ulcerative colitis? Aliment. Pharmacol. Ther. 20: 143-149 (2004). *
Bechade D, Desrame J, De Fuentes G, Camparo P, Raynaud JJ, Algayres JP. Common variable immunodeficiency and celiac disease. Gastroenterol. Clin. Biol. 28: 909-912 (2004).
Bechstein WO. Older livers-should they be used for transplantation? J. Hepatol. 41: 485-487 (2004). *
Beck PL, Xavier R, Wong J, Ezedi I, Mashimo H, Mizoguchi A, Mizoguchi E, Bhan AK, Podolsky DK. Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G137-G147 (2004). *
Beckebaum S, Cicinnati VR, Broelsch CE. Advances and limitations of liver transplantation in Germany. Verh. Dtsch. Ges. Pathol. 88: 45-50 (2004).
Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Galle PR, Blessing M, Rose-John S, Neurath MF. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21: 491-501 (2004). *
Becker KG. The common variants/multiple disease hypothesis of common complex genetic disorders. Med. Hypotheses 62: 309-317 (2004).
Becker-Weimann S, Wolf J, Kramer A, Herzel H. A model of the mammalian circadian oscillator including the REV-ERBalpha module. Genome Inform. 15: 3-12 (2004).
Beckstein O, Sansom MS. The influence of geometry, surface character, and flexibility on the permeation of ions and water through biological pores. Phys. Biol. 1: 42-52 (2004).
Beddy D, Watson RW, Fitzpatrick JM, O'Connell PR. Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease. Br. J. Surg. 91: 72-77 (2004). *
Beddy DJ, Watson WR, Fitzpatrick JM, O'Connell PR. Critical involvement of stress-activated mitogen-activated protein kinases in the regulation of intracellular adhesion molecule-1 in serosal fibroblasts isolated from patients with Crohn's disease. J. Am. Coll. Surg. 199: 234-242 (2004). *
Bederman IR, Kasumov T, Reszko AE, David F, Brunengraber H, Kelleher JK. In vitro modeling of fatty acid synthesis under conditions simulating the zonation of lipogenic [13C]acetyl-CoA enrichment in the liver. J. Biol. Chem. 279: 43217-43226 (2004). *
Bederman IR, Reszko AE, Kasumov T, David F, Wasserman DH, Kelleher JK, Brunengraber H. Zonation of labeling of lipogenic acetyl-CoA across the liver: implications for studies of lipogenesis by mass isotopomer analysis. J. Biol. Chem. 279: 43207-43216 (2004). *
Bednarczuk T, Hiromatsu Y, Seki N, Ploski R, Fukutani T, Kurylowicz A, Jazdzewski K, Chojnowski K, Itoh K, Nauman J. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy. Hum. Immunol. 65: 632-639 (2004).
Bedogni G, Bellentani S. Fatty liver: how frequent is it and why? Ann. Hepatol. 3: 63-65 (2004). *
Bedossa P. Images in hepatology. Telangiectatic adenoma: a variant of hepatocellular adenoma. Ann. Hepatol. 3: 163 (2004). *
Bedrine-Ferran H, Le Meur N, Gicquel I, Le Cunff M, Soriano N, Guisle I, Mottier S, Monnier A, Teusan R, Fergelot P, Le Gall JY, Leger J, Mosser J. Transcriptome variations in human CaCo-2 cells: a model for enterocyte differentiation and its link to iron absorption. Genomics 83: 772-789 (2004). *
Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75: 330-337 (2004). *
Begum NA, Kinoshita K, Kakazu N, Muramatsu M, Nagaoka H, Shinkura R, Biniszkiewicz D, Boyer LA, Jaenisch R, Honjo T. Uracil DNA glycosylase activity is dispensable for immunoglobulin class switch. Science 305: 1160-1163 (2004). *
Beharry S, Zhong M, Molday RS. N-Retinylidene-phosphatidylethanolamine is the preferred retinoid substrate for the photoreceptor-specific ABC transporter ABCA4 (ABCR). J. Biol. Chem. 279: 53972-53979 (2004). *
Behr MA, Semret M, Poon A, Schurr E. Crohn's disease, mycobacteria, and NOD2. Lancet Infect. Dis. 4: 136-137 (2004).
Beitz JM. Continent diversions: the new gold standards of ileoanal reservoir and neobladder. Ostomy Wound Manage. 50: 26-35 (2004).
Beji S, Kaaroud H, Ben Moussa F, Goucha R, Abderrahim E, El Younsi F, Ben Maiz H. Renal amyloidosis complicating the outcome of chronic inflammatory colitis. Presse. Med. 33: 862-865 (2004).
Beland K, Lapierre P, Marceau G, Alvarez F. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection. J. Autoimmun. 22: 159-166 (2004).
Belda A, Hinojosa J, Serra B, Garcia L, Merino C, Belda A, Moles JR. Systemic candidiasis and infliximab therapy. Gastroenterol. Hepatol. 27: 365-367 (2004).
Belfer I, Buzas B, Hipp H, Dean M, Evans C, Lorincz I, Max MB, Goldman D. Haplotype structure of inflammatory cytokines genes (IL1B, IL6 and TNF/LTA) in US Caucasians and African Americans. Genes Immun. 5: 505-512 (2004). *
Belic D, Ristic-Nikolic S, Damjan S, Ratkov I, Ceke M. Heredity of psoriasis. Med. Pregl. 57: 171-174 (2004).
Belkind-Gerson J, Fernandez-Peters A, Furnes R, Oliver M, Perrault J, Robertson M, Witt H; Latin American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Pancreatic disorders and cystic fibrosis: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J. Pediatr. Gastroenterol. Nutr. 39 Suppl. 2: S688-S694 (2004). *
Bell AJ, Nicholls RJ, Forbes A, Ellis HJ, Ciclitira PJ. Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole. Gut 53: 1801-1805 (2004). *
Bell J. Predicting disease using genomics. Nature 429: 453-456 (2004). *
Bellanti JA, Sabra A, Zeligs BJ. Gastrointestinal immunopathology and food allergy. Ann. Allergy Asthma Immunol. 93: S26-S32 (2004).
Belliard AM, Lacour B, Farinotti R, Leroy C. Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells. J. Pharm. Sci. 93: 1524-1536 (2004). *
Bellini C, Mazzella M, Scopesi F, Serra G. Spontaneous recovery in neonatal hemochromatosis. J. Hepatol. 41: 882-883 (2004). *
Bellmann R, Graziadei IW, Feistritzer C, Schwaighofer H, Stellaard F, Sturm E, Wiedermann CJ, Joannidis M. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. Liver Transpl. 10: 107-114 (2004). *
Belluzzi A. Polyunsaturated fatty acids (n-3 PUFAs) and inflammatory bowel disease (IBD): pathogenesis and treatment. Eur. Rev. Med. Pharmacol. Sci. 8: 225-229 (2004).
Belshaw R, Pereira V, Katzourakis A, Talbot G, Paces J, Burt A, Tristem M. Long-term reinfection of the human genome by endogenous retroviruses. Proc. Natl. Acad. Sci. U.S.A. 101: 4894-4899 (2004). *
Beltzner CC, Pollard TD. Identification of functionally important residues of Arp2/3 complex by analysis of homology models from diverse species. J. Mol. Biol. 336: 551-565 (2004). *
Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagn. Lab. Immunol. 11: 625-626 (2004). *
Ben-Ari Z. Ascites after transplantation - a mystery. Liver Transpl. 10: 1221 (2004). *
Ben-Ari Z, Weiss-Schmilovitz H, Sulkes J, Brown M, Bar-Nathan N, Shaharabani E, Yussim A, Shapira Z, Tur-Kaspa R, Mor E. Serum cholestasis markers as predictors of early outcome after liver transplantation. Clin. Transplant. 18: 130-136 (2004).
Ben-Neriah Y, Schmitz ML. Of mice and men. EMBO Rep. 5: 668-673 (2004). *
Benatti P, Peluso G, Nicolai R, Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J. Am. Coll. Nutr. 23: 281-302 (2004). *
Benazzato L, D'Inca R, Grigoletto F, Perissinotto E, Medici V, Angriman I, Sturniolo GC. Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment. Dig. Liver Dis. 36: 461-466 (2004).
Bendet N, Scapa E, Cohen O, Bloch O, Aharoni D, Ramot Y, Weiss M, Halevi A, Rapoport MJ. Enhanced glucose-dependent glucagon-like peptide-1 and insulin secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection. Scand. J. Gastroenterol. 39: 650-656 (2004). *
Bene L, Sapi Z, Bajtai A, Buzas E, Szentmihalyi A, Arato A, Tulassay Z, Falus A. Partial protection against dextran sodium sulphate induced colitis in histamine-deficient, histidine decarboxylase knockout mice. J. Pediatr. Gastroenterol. Nutr. 39: 171-176 (2004). *
Benjaminov FS, Heathcote J. Liver disease in pregnancy. Am. J. Gastroenterol. 99: 2479-2488 (2004). *
Bennett R. Fibromyalgia: present to future. Curr. Pain Headache Rep. 8: 379-384 (2004).
Bennink RJ, Peeters M, Rutgeerts P, Mortelmans L. Evaluation of early treatment response and predicting the need for colectomy in active ulcerative colitis with 99mTc-HMPAO white blood cell scintigraphy. J. Nucl. Med. 45: 1698-1704 (2004). *
Bennink RJ, van Montfrans C, de Jonge WJ, de Bruin K, van Deventer SJ, te Velde AA. Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model. Nucl. Med. Biol. 31: 93-101 (2004). *
Benoit S, Toksoy A, Brocker EB, Gillitzer R, Goebeler M. Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression. Br. J. Dermatol. 150: 1009-1012 (2004). *
Benos DJ, Berdiev BK, Ismailov II, Ostedgaard LS, Kogan I, Li C, Ramjeesingh M, Bear CE. Methods to study CFTR protein in vitro. J. Cyst. Fibros. 3 Suppl. 2: 79-83 (2004).
Bensaid M, Fruchon S, Mazeres C, Bahram S, Roth MP, Coppin H. Multigenic control of hepatic iron loading in a murine model of hemochromatosis. Gastroenterology 126: 1400-1408 (2004). *
Benson GD, Kikuchi K, Miyakawa H, Tanaka A, Watnik MR, Gershwin ME. Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis. Clin. Dev. Immunol. 11: 129-133 (2004). *
Bentley DR. Genomes for medicine. Nature 429: 440-445 (2004). *
Bento JL, Palmer ND, Mychaleckyj JC, Lange LA, Langefeld CD, Rich SS, Freedman BI, Bowden DW. Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 53: 3007-3012 (2004). *
Bento MC, Ribeiro ML, Relvas L. Gene symbol: HFE. Disease: haemochromatosis. Hum. Genet. 114: 405 (2004).
Benvenga S, Guarneri F, Vaccaro M, Santarpia L, Trimarchi F. Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. Thyroid 14: 964-966 (2004).
Benvenuti F, Hugues S, Walmsley M, Ruf S, Fetler L, Popoff M, Tybulewicz VL, Amigorena S. Requirement of Rac1 and Rac2 expression by mature dendritic cells for T cell priming. Science 305: 1150-1153 (2004). *
Berard AM, Dumon MF, Darmon M. Dietary fish oil up-regulates cholesterol 7alpha-hydroxylase mRNA in mouse liver leading to an increase in bile acid and cholesterol excretion. FEBS Lett. 559: 125-128 (2004). *
Berard F, Guillot I, Saad N, Nicolas JF. How to understand psoriasis? Rev. Prat. 54: 28-34 (2004).
Berdah SV, Barthet M, Emungania O, Orsoni P, Alliot P, Grimaud JC, Brunet C. Two stage videoassisted restorative proctocolectomy. Early experience of 12 cases. Ann. Chir. 129: 332-336 (2004).
Berdowska I. Cysteine proteases as disease markers. Clin. Chim. Acta 342: 41-69 (2004). *
Bergasa NV. Treatment of the pruritus of cholestasis. Curr. Treat. Options Gastroenterol. 7: 501-508 (2004).
Bergasa NV. An approach to the management of the pruritus of cholestasis. Clin. Liver Dis. 8: 55-66 (2004).
Bergasa NV. Pruritus in chronic liver disease: mechanisms and treatment. Curr. Gastroenterol. Rep. 6: 10-16 (2004).
Bergasa NV. Treatment of the pruritus of cholestasis: from unbearable lightness to substance. Hepatology 39: 1450-1453 (2004). *
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ. Primary biliary cirrhosis: report of a focus study group. Hepatology 40: 1013-1020 (2004). *
Bergen AA, Plomp AS, Gorgels TG, de Jong PT. From gene to disease; pseudoxanthoma elasticum and the ABCC6 gene. Ned. Tijdschr. Geneeskd. 148: 1586-1589 (2004).
Berger G. Hypotheses on a germline origin of antibody diversity. Possible applications: improvement of the efficiency of immune response and autoimmune disease treatment. Med. Hypotheses 63: 847-854 (2004).
Bergeron A, Lettre F, Russo P, Morissette J, Tanguay RM. No evidence of maternal cell colonization in reverted liver nodules of tyrosinemia type I patients. Gastroenterology 127: 1381-1385 (2004). *
Bergert H, Illert T, Friedrich K, Ockert D. Fulminant liver failure following infection by Clostridium perfringens. Surg. Infect. (Larchmt.) 5: 205-209 (2004).
Bergholdt R, Heding P, Nielsen K, Nolsoe R, Sparre T, Storling J, Nerup J, Pociot F, Mandrup-Poulsen T. Type 1 database mellitus: an inflammatory disease of the islet. Adv. Exp. Med. Biol. 552: 129-153 (2004).
Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, Klareskog L, Dahlqvist SR. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res. Ther. 6: R303-R308 (2004). *
Bergman Y, Cedar H. A stepwise epigenetic process controls immunoglobulin allelic exclusion. Nat. Rev. Immunol. 4: 753-761 (2004). *
Bergmann MM, Jacobs EJ, Hoffmann K, Boeing H. Agreement of self-reported medical history: comparison of an in-person interview with a self-administered questionnaire. Eur. J. Epidemiol. 19: 411-416 (2004).
Bergquist A, Saarinen S, Lindberg G, Broome U. Familial primary sclerosing cholangitis. J. Hepatol. 40 Suppl. 1: 158 (2004).
Beris P; Anemia Working Group. Erythropoietin and intravenous iron to save blood in surgery. Schweiz. Rundsch. Med. Prax. 93: 1905-1910 (2004).
Berka N, Nunlee-Bland G, Erabhaoui E, Belmamoun M, Dunston GM. IDDM2 and the polymorphism of the human tyrosine hydroxylase (hTH) gene in African Americans with type-1 diabetes. J. Natl. Med. Assoc. 96: 1042-1046 (2004).
Berkenstam A, Farnegardh M, Gustafsson JA. Convergence of lipid homeostasis through liver X and thyroid hormone receptors. Mech. Ageing Dev. 125: 707-717 (2004).
Berkovitch F, Nicolet Y, Wan JT, Jarrett JT, Drennan CL. Crystal structure of biotin synthase, an S-adenosylmethionine-dependent radical enzyme. Science 303: 76-79 (2004). *
Berlin D, Chong G, Chertkow H, Bergman H, Phillips NA, Schipper HM. Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI. Neurobiol. Aging 25: 465-474 (2004).
Bermejo F, Lopez-Sanroman A, Hinojosa J, Castro L, Jurado C, Gomez-Beldal AB. Infliximab induces clinical, endoscopic and histological responses in refractory ulcerative colitis. Rev. Esp. Enferm. Dig. 96: 94-101 (2004).
Bernacchi E, Amato L, Parodi A, Cottoni F, Rubegni P, De Pita O, Papini M, Rebora A, Bombardieri S, Fabbri P. Sjogren's syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. Clin. Exp. Rheumatol. 22: 55-62 (2004).
Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J. Hepatol. 40: 192-197 (2004). *
Bernardes-Silva CF, Damiao AO, Sipahi AM, Laurindo FR, Iriya K, Lopasso FP, Buchpiguel CA, Lordello ML, Agostinho CL, Laudanna AA. Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress. Dig. Dis. Sci. 49: 1569-1574 (2004). *
Berndtsson I, Oresland T, Hulten L. Sexuality in patients with ulcerative colitis before and after restorative proctocolectomy: a prospective study. Scand. J. Gastroenterol. 39: 374-379 (2004). *
Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, Manguso F, Cirillo P, Paparo F, Troncone R. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig. Liver Dis. 36: 467-470 (2004).
Berni Canani R, Terrin G, Cirillo P, Castaldo G, Salvatore F, Cardillo G, Coruzzo A, Troncone R. Butyrate as an effective treatment of congenital chloride diarrhea. Gastroenterology 127: 630-634 (2004). *
Bernig T, Taylor JG, Foster CB, Staats B, Yeager M, Chanock SJ. Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection. Genes Immun. 5: 461-476 (2004). *
Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, Henriksen M, Stray N, Kjellevold O, Vatn M, Moum B; IBSEN Study Group. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand. J. Gastroenterol. 39: 365-373 (2004). *
Bernstein CN. Ulcerative colitis with low-grade dysplasia. Gastroenterology 127: 950-956 (2004). *
Bernstein CN. A balancing view: dysplasia surveillance in ulcerative colitis - sorting the pro from the con. Am. J. Gastroenterol. 99: 1636-1637 (2004). *
Bernstein CN. Another look at fracture risk in IBD. Inflamm. Bowel Dis. 10: 886-887 (2004). *
Bernstein CN. Complementary and alternative medicine use by patients with inflammatory bowel disease: are Canadian physicians failing with conventional therapy, or not? Can. J. Gastroenterol. 18: 47-48 (2004).
Bernstein CN, Blanchard JF, Rawsthorne P, Collins MT. Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis. J. Clin. Microbiol. 42: 1129-1135 (2004). *
Bernstein CN, Leslie WD. Osteoporosis and inflammatory bowel disease. Aliment. Pharmacol. Ther. 19: 941-952 (2004). *
Bernstein H, Payne CM, Kunke K, Crowley-Weber CL, Waltmire CN, Dvorakova K, Holubec H, Bernstein C, Vaillancourt RR, Raynes DA, Guerriero V, Garewal H. A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis 25: 681-692 (2004). *
Bernstine H, Mor E, Ben Ari Z, Belinki A, Hardoff R. Scintigraphic patterns of veno-occlusive disease in liver transplantation. Clin. Nucl. Med. 29: 292-295 (2004).
Bernuau J. Acute liver failure: avoidance of deleterious cofactors and early specific medical therapy for the liver are better than late intensive care for the brain. J. Hepatol. 41: 152-155 (2004). *
Berquist WE, Andrus JP. The value of the PRISM scores in comparing pediatric liver transplant outcomes. Pediatr. Transplant. 8: 208-209 (2004).
Berr F. Photodynamic therapy for cholangiocarcinoma. Semin. Liver Dis. 24: 177-187 (2004).
Berry JD, Sidhu PS. Microbubble contrast-enhanced ultrasound in liver transplantation. Eur. Radiol. 14 Suppl. 8: P96-P103 (2004).
Bersani G, Rossi A, Suzzi A, Ricci G, De Fabritiis G, Alvisi V. Comparison between the two systems to evaluate the appropriateness of endoscopy of the upper digestive tract. Am. J. Gastroenterol. 99: 2128-2135 (2004). *
Berthiaume EP, Wands J. The molecular pathogenesis of cholangiocarcinoma. Semin. Liver Dis. 24: 127-137 (2004).
Bertok L. Bile acids in physico-chemical host defence. Pathophysiology 11: 139-145 (2004).
Bertola G, Balza G, Oriani A, Morganti D, Sironi C, Bonizzato S. Elevated concentration of serum carcinoembryonic antigen in hypothyroidism. Recenti Prog. Med. 95: 204-206 (2004).
Bertolino P, Bowen DG, Zen M, Holz L, Davis T, McCaughan GW. Hepatocytes as targets of autoreactivity. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 33 (2004). *
Bertone P, Stolc V, Royce TE, Rozowsky JS, Urban AE, Zhu X, Rinn JL, Tongprasit W, Samanta M, Weissman S, Gerstein M, Snyder M. Global identification of human transcribed sequences with genome tiling arrays. Science 306: 2242-2246 (2004). *
Bertram L, Tanzi RE. Alzheimer's disease: one disorder, too many genes? Hum. Mol. Genet. 13 Spec. No. 1: R135-R141 (2004). *
Bertrand-Philippe M, Ruddell RG, Arthur MJ, Thomas J, Mungalsingh N, Mann DA. Regulation of tissue inhibitor of metalloproteinase-1 gene transcription by RUNX1 and RUNX2. J. Biol. Chem. 279: 24530-24539 (2004). *
Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, Ginestier C, Charafe-Jauffret E, Loriod B, Bachelart L, Montfort J, Victorero G, Viret F, Ollendorff V, Fert V, Giovaninni M, Delpero JR, Nguyen C, Viens P, Monges G, Birnbaum D, Houlgatte R. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23: 1377-1391 (2004). *
Beskow LM, Botkin JR, Daly M, Juengst ET, Lehmann LS, Merz JF, Pentz R, Press NA, Ross LF, Sugarman J, Susswein LR, Terry SF, Austin MA, Burke W. Ethical issues in identifying and recruiting participants for familial genetic research. Am. J. Med. Genet. 130A: 424-431 (2004).
Besnard P, Landrier JF, Grober J, Niot I. Is the ileal bile acid-binding protein (I-BABP) gene involved in cholesterol homeostasis? Med. Sci. (Paris) 20: 73-77 (2004).
Besnard V, Wert SE, Hull WM, Whitsett JA. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr. Patterns 5: 193-208 (2004). *
Bessard G, Hardy G, Chartier A, Stanke-Labesque F. Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine. Therapie 59: 71-75 (2004).
Besselink MG, Timmerman HM, Buskens E, Nieuwenhuijs VB, Akkermans LM, Gooszen HG; Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949]. BMC Surg. 4: 12 (2004). *
Bessis D, Moles JP, Basset-Seguin N, Tesniere A, Arpin C, Guilhou JJ. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin. Br. J. Dermatol. 151: 737-745 (2004). *
Bettencourt R, Tanji T, Yagi Y, Ip YT. Toll and Toll-9 in Drosophila innate immune response. J. Endotoxin Res. 10: 261-268 (2004). *
Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome type 2: the tip of an iceberg? Clin. Exp. Immunol. 137: 225-233 (2004). *
Beuers U, Hohenester S, Wimmer R, Denk GU, Rust C. Mitogen activated protein kinases and protein kinase C: short-term mediators of the anticholestatic effect of tauroursodeoxycholic acid in bile acid-induced cholestasis? Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 61. June 18-19 (2004). *
Beuf O, Pilleul F, Armenean M, Hadour G, Saint-Jalmes H. In vivo colon wall imaging using endoluminal coils: feasibility study on rabbits. J. Magn. Reson. Imaging 20: 90-96 (2004). *
Beutler B. Innate immunity: an overview. Mol. Immunol. 40: 845-859 (2004). *
Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263 (2004). *
Beutler B, Hoebe K, Georgel P, Tabeta K, Du X. Genetic analysis of innate immunity: TIR adapter proteins in innate and adaptive immune responses. Microbes Infect. 6: 1374-1381 (2004). *
Beutler B, Hoebe K, Shamel L. Forward genetic dissection of afferent immunity: the role of TIR adapter proteins in innate and adaptive immune responses. C. R. Biol. 327: 571-580 (2004).
Beutler E. Iron absorption in carriers of the C282Y hemochromatosis mutation. Am. J. Clin. Nutr. 80: 799-800 (2004). *
Beutler E. Enzyme replacement in Gaucher disease. PLoS Med. 1: e21 (2004). *
Beutler E. Cell biology. "Pumping" iron: the proteins. Science 306: 2051-2053 (2004). *
Beutler E. Natural history of hemochromatosis. Mayo Clin. Proc. 79: 305-306 (2004). *
Beutler E, Beutler L, Lee PL, Barton JC. The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis. Blood Cells Mol. Dis. 33: 344-345 (2004).
Bevan MJ. Helping the CD8(+) T-cell response. Nat. Rev. Immunol. 4: 595-602 (2004). *
Bevins CL. The Paneth cell and the innate immune response. Curr. Opin. Gastroenterol. 20: 572-580 (2004).
Beyak MJ, Ramji N, Krol KM, Kawaja MD, Vanner SJ. Two TTX-resistant sodium currents in mouse colonic dorsal root ganglia neurons and their role in colitis induced hyperexcitability. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G845-G855 (2004). *
Beyer TP, Schmidt RJ, Foxworthy P, Zhang Y, Dai J, Bensch WR, Kauffman RF, Gao H, Ryan TP, Jiang XC, Karathanasis SK, Eacho PI, Cao G. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo. J. Pharmacol. Exp. Ther. 309: 861-868 (2004). *
Beylot C. Clinical aspects of psoriasis. Rev. Prat. 54: 19-27 (2004).
Beyrouti MI, Beyrouti R, Kharrat M, Kchaou I, Abbes M, Affes N, Tafech I, Ghorbel A, Krichene MS, Boudawara T, Sellami A. Intestinal Crohn disease: surgical aspects and predictive factors of risk of relapse. About 26 cases. Tunis. Med. 82: 927-940 (2004).
Bhalla S, Ozalp C, Fang S, Xiang L, Kemper JK. Ligand-activated PXR interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha: functional implications in hepatic cholesterol and glucose metabolism. J. Biol. Chem. 279: 45139-45147 (2004). *
Bharti AC, Takada Y, Shishodia S, Aggarwal BB. Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism. J. Biol. Chem. 279: 6065-6076 (2004). *
Bhat RM. Management of pyoderma gangrenosum - an update. Indian J. Dermatol. Venereol. Leprol. 70: 329-335 (2004).
Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure-a controlled clinical trial. J. Hepatol. 41: 89-96 (2004). *
Bhattacharyya KB. Wilson's disease. J. Assoc. Physicians India 52: 595 (2004).
Bi Y, Williams JA. Receptor biology and signal transduction in pancreatic acinar cells. Curr. Opin. Gastroenterol. 20: 427-434 (2004).
Biagi F, Campanella J, Martucci S, Pezzimenti D, Ciclitira PJ, Ellis HJ, Corazza GR. A milligram of gluten a day keeps the mucosal recovery away: a case report. Nutr. Rev. 62: 360-363 (2004).
Bian H, Hammer J. Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE. Methods 34: 468-475 (2004). *
Bianchi DW. Fetomaternal cell traffic, pregnancy-associated progenitor cells, and autoimmune disease. Best Pract. Res. Clin. Obstet. Gynaecol. 18: 959-975 (2004).
Bianco F, Fattapposta F, Locuratolo N, Pierallini A, Rossi M, Ruberto F, Bozzao L. Reversible diffusion MRI abnormalities and transient mutism after liver transplantation. Neurology 62: 981-983 (2004).
Biancofiore G, Bindi ML, Boldrini A, Consani G, Bisa M, Esposito M, Urbani L, Catalano G, Filipponi F, Mosca F. Intraabdominal pressure in liver transplant recipients: incidence and clinical significance. Transplant. Proc. 36: 547-549 (2004). *
Biancofiore G, Della Rocca G, Bindi L, Romanelli A, Esposito M, Meacci L, Urbani L, Filipponi F, Mosca F. Use of fenoldopam to control renal dysfunction early after liver transplantation. Liver Transpl. 10: 986-992 (2004). *
Biancone L, Tosti C, Geremia A, Fina D, Petruzziello C, Emerenziani S, Pallone F. Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial. Aliment. Pharmacol. Ther. 19: 755-764 (2004). *
Biasco G, Pantaleo MA, Di Febo G, Calabrese C, Brandi G, Bulow S. Risk of duodenal cancer in patients with familial adenomatous polyposis. Gut 53: 1547 (2004). *
Biasco G, Pantaleo MA, Nobili E, Monti C. Spontaneous regression of a desmoid intraabdominal tumor in a patient affected by familial adenomatous polyposis. Am. J. Gastroenterol. 99: 1621-1622 (2004). *
Biasiotto G, Roetto A, Daraio F, Polotti A, Gerardi GM, Girelli D, Cremonesi L, Arosio P, Camaschella C. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol. Dis. 33: 338-343 (2004).
Biecker E, Neef M, Sagesser H, Shaw S, Koshy A, Reichen J. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis. Liver Int. 24: 345-353 (2004). *
Biedermann T, R�cken M, Carballido JM. TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J. Investig. Dermatol. Symp. Proc. 9: 5-14 (2004). *
Bielory L. Complementary and alternative interventions in asthma, allergy, and immunology. Ann. Allergy Asthma Immunol. 93 (2 Suppl. 1): S45-S54 (2004).
Bieniasz PD. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 5: 1109-1115 (2004). *
Biernacka JM, Sun L, Bull SB. Simultaneous localization of two linked disease susceptibility genes. Genet. Epidemiol. 28: 33-47 (2004). *
Bilbao JI, Elorz M, Vivas I, Martinez-Cuesta A, Bastarrika G, Benito A. Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients. Cardiovasc. Intervent. Radiol. 27: 474-480 (2004). *
Bilbao JR, Villoslada P, Martin-Pagola A, Castano L. No evidence of pancreatic autoimmunity among patients with multiple sclerosis. Ann. N. Y. Acad. Sci. 1037: 133-137 (2004). *
Bilinska M, Frydecka I, Noga L, Dobosz T, Zoledziewska M, Suwalska K, Tutak A, Pokryszko-Dragan A. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism. Acta Neurol. Scand. 110: 67-71 (2004).
Bilodeau M, Tousignant J, Ethier C, Rocheleau B, Raymond VA, Lapointe R. Anti-apoptotic effect of insulin on normal hepatocytes in vitro and in vivo. Apoptosis 9: 609-617 (2004).
Bilsborough J, Viney JL. In vivo enhancement of dendritic cell function. Ann. N. Y. Acad. Sci. 1029: 83-87 (2004). *
Bilsborough J, Viney JL. Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease. Gastroenterology 127: 300-309 (2004). *
Bilsborough J, Viney JL. Out, out darn toxin: the role of MDR in intestinal homeostasis. Gastroenterology 127: 339-340 (2004). *
Binder RJ, Vatner R, Srivastava P. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 64: 442-451 (2004). *
Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract. Res. Clin. Gastroenterol. 18: 463-479 (2004).
Bingle CD, Craven CJ. Meet the relatives: a family of BPI- and LBP-related proteins. Trends Immunol. 25: 53-55 (2004). *
Bingle CD, Gorr SU. Host defense in oral and airway epithelia: chromosome 20 contributes a new protein family. Int. J. Biochem. Cell. Biol. 36: 2144-2152 (2004). *
Bingle CD, LeClair EE, Havard S, Bingle L, Gillingham P, Craven CJ. Phylogenetic and evolutionary analysis of the PLUNC gene family. Protein Sci. 13: 422-430 (2004). *
Birebent B, Lorho R, Lechartier H, de Guibert S, Alizadeh M, Vu N, Beauplet A, Robillard N, Semana G. Suppressive properties of human CD4(+)CD25(+) regulatory T cells are dependent on CTLA-4 expression. Eur. J. Immunol. 34: 3485-3496 (2004). *
Biro T, Griger Z, Kiss E, Papp H, Aleksza M, Kovacs I, Zeher M, Bodolay E, Csepany T, Szucs K, Gergely P, Kovacs L, Szegedi G, Sipka S. Abnormal cell-specific expressions of certain protein kinase C isoenzymes in peripheral mononuclear cells of patients with systemic lupus erythematosus: effect of corticosteroid application. Scand. J. Immunol. 60: 421-428 (2004). *
Birrenbach T, Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm. Bowel Dis. 10: 848-859 (2004). *
Birsner JH, Wan C, Cheng G, Evans ZP, Polito CC, Fiorini RN, Gilbert G, Haines JK, Schmidt MG, Chavin KD. Steatotic liver transplantation in the mouse: a model of primary nonfunction. J. Surg. Res. 120: 97-101 (2004). *
Bischoff S, Crowe SE. Food allergy and the gastrointestinal tract. Curr. Opin. Gastroenterol. 20: 156-161 (2004).
Bischoff SC, Schwengberg S, Lorentz A, Manns MP, Bektas H, Sann H, Levi-Schaffer F, Shanahan F, Schemann M. Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells. Neurogastroenterol. Motil. 16: 185-193 (2004).
Bisgaard ML, Ripa R, Knudsen AL, Bulow S. Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype. Gut 53: 266-270 (2004). *
Bishop GA. The multifaceted roles of TRAFs in the regulation of B-cell function. Nat. Rev. Immunol. 4: 775-786 (2004).
Bishop-Bailey D. FXR as a novel therapeutic target for vascular disease. Drug News Perspect. 17: 499-504 (2004).
Bishop-Bailey D, Walsh DT, Warner TD. Expression and activation of the farnesoid X receptor in the vasculature. Proc. Natl. Acad. Sci. U.S.A. 101: 3668-3673 (2004). *
Bisschop PH, Bandsma RH, Stellaard F, Ter Harmsel A, Meijer AJ, Sauerwein HP, Kuipers F, Romijn JA. Low-fat, high-carbohydrate and high-fat, low-carbohydrate diets decrease primary bile acid synthesis in humans. Am. J. Clin. Nutr. 79: 570-576 (2004). *
Bissell DM. Assessing fibrosis without a liver biopsy: are we there yet? Gastroenterology 127: 1847-1849 (2004). *
Bissinger AL, Oettle H, Jahn G, Neuhaus P, Sinzger C. Cytomegalovirus infection after orthotopic liver transplantation is restricted by a pre-existing antiviral immune response of the recipient. J. Med. Virol. 73: 45-53 (2004). *
Bissonnette EY, Proulx LI, Turmel V, Drouin R, Purcell M. PCT-233, a novel modulator of pro- and anti-inflammatory cytokine production. Clin. Exp. Immunol. 135: 440-447 (2004). *
Bister VO, Salmela MT, Karjalainen-Lindsberg ML, Uria J, Lohi J, Puolakkainen P, Lopez-Otin C, Saarialho-Kere U. Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer. Dig. Dis. Sci. 49: 653-661 (2004). *
Bittencourt PL, Farias AQ, Abrantes-Lemos CP, Goncalves LL, Goncalves PL, Magalhaes EP, Carrilho FJ, Laudanna AA, Cancado EL. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 19: 873-878 (2004). *
Bjerkeli V, Halvorsen B, Damas JK, Nordoy I, Yndestad A, Aukrust P, Froland SS. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis. Ann. Rheum. Dis. 63: 1659-1663 (2004). *
Bjorkkjaer T, Brunborg LA, Arslan G, Lind RA, Brun JG, Valen M, Klementsen B, Berstad A, Froyland L. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scand. J. Gastroenterol. 39: 1088-1094 (2004). *
Bjornsson E, Lindqvist-Ottosson J, Asztely M, Olsson R. Dominant strictures in patients with primary sclerosing cholangitis. Am. J. Gastroenterol. 99: 502-508 (2004). *
Bjornsson E, Olsson R. Dominant strictures in patients with primary sclerosing cholangitis-revisited. Am. J. Gastroenterol. 99: 2281 (2004). *
Bjornsson E, Simren M, Olsson R, Chapman RW. Fatigue in patients with primary sclerosing cholangitis. Scand. J. Gastroenterol. 39: 961-968 (2004). *
Bjoro K, Schrumpf E. Liver transplantation for primary sclerosing cholangitis. J. Hepatol. 40: 570-577 (2004). *
Bjursten M, Hultgren OH, Hultgren Hornquist E. Enhanced pro-inflammatory cytokine production in Galphai2-deficient mice on colitis prone and colitis resistant 129Sv genetic backgrounds. Cell. Immunol. 228: 77-80 (2004). *
Black D, Bird MA, Samson CM, Lyman S, Lange PA, Schrum LW, Qian T, Lemasters JJ, Brenner DA, Rippe RA, Behrns KE. Primary cirrhotic hepatocytes resist TGFbeta-induced apoptosis through a ROS-dependent mechanism. J. Hepatol. 40: 942-951 (2004). *
Black RA. TIMP3 checks inflammation. Nat. Genet. 36: 934-935 (2004). *
Blackburn CC, Manley NR. Developing a new paradigm for thymus organogenesis. Nat. Rev. Immunol. 4: 278-289 (2004). *
Blackburn GL, Mun EC. Effects of weight loss surgeries on liver disease. Semin. Liver Dis. 24: 371-379 (2004).
Blackwell J. Evaluation and treatment of hyperthyroidism and hypothyroidism. J. Am. Acad. Nurse Pract. 16: 422-425 (2004).
Blackwell NM, Sembi P, Newson JS, Lawrence T, Gilroy DW, Kabouridis PS. Reduced infiltration and increased apoptosis of leukocytes at sites of inflammation by systemic administration of a membrane-permeable IkappaBalpha repressor. Arthritis Rheum. 50: 2675-2684 (2004). *
Bladt V, Steengaard-Pedersen K, Poulsen LH, Petersen OB, Laursen B, d'Amore F. Late puerperal thrombohemorrhagic complications in a patient with antiphospholipid syndrome. Eur. J. Haematol. 73: 437-440 (2004). *
Blagaic AB, Blagaic V, Romic Z, Sikiric P. The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. Eur. J. Pharmacol. 499: 285-290 (2004). *
Blaisdell CJ, Howard TD, Stern A, Bamford P, Bleecker ER, Stine OC. CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity. BMC Med. Genet. 5: 26 (2004). *
Blaker M, Schmitz M, Gocht A, Burghardt S, Schulz M, Broring DC, Pace A, Greten H, De Weerth A. Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas. J. Hepatol. 41: 112-118 (2004). *
Blanch J, Sureda B, Flavia M, Marcos V, De Pablo J, De Lazzari E, Rimola A, Vargas V, Navarro V, Margarit C, Visa J. Psychosocial adjustment to orthotopic liver transplantation in 266 recipients. Liver Transpl. 10: 228-234 (2004). *
Blanchard SS, Bauman L, Czinn SJ. Treatment of Helicobacter pylori in pediatrics. Curr. Treat. Options Gastroenterol. 7: 407-412 (2004).
Blanchard TG, Drakes ML, Czinn SJ. Helicobacter infection: pathogenesis. Curr. Opin. Gastroenterol. 20: 10-15 (2004).
Blanchet E, Beau P, Frat JP. Bone marrow aplasia following dipyrone treatment in a patient with Crohn's disease receiving long-term methotrexate. Gastroenterol. Clin. Biol. 28: 502-503 (2004).
Blanchette M, Green ED, Miller W, Haussler D. Reconstructing large regions of an ancestral mammalian genome in silico. Genome Res. 14: 2412-2423 (2004). *
Blanco PG, Zaman MM, Junaidi O, Sheth S, Yantiss RK, Nasser IA, Freedman SD. Induction of colitis in cftr-/- mice results in bile duct injury. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G491-G496 (2004). *
Blank C, Sabri M, Di Lorenzo C. Pediatric gastric and duodenal disorders. Curr. Opin. Gastroenterol. 20: 551-555 (2004).
Blank M, Shani A, Goldberg I, Kopolovic J, Amigo MC, Magrini L, Shoenfeld Y. Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection. Thromb. Res. 114: 589-592 (2004). *
Blanquart C, Mansouri R, Paumelle R, Fruchart JC, Staels B, Glineur C. The protein kinase C signalling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha (PPARalpha). Mol. Endocrinol. 18: 1906-1918 (2004). *
Blaschke F, Bruemmer D, Law RE. Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting? Clin. Cardiol. 27: IV3-IV10 (2004).
Blasco A, Enrique E, Mateo JA, Castello JV, Ferriols R, Malek T. Positive patch test to azathioprine in inflammatory bowel disease. Allergy 59: 368-369 (2004). *
Blasi C. The role of the infectious agents in the pathogenesis and evolution of atherosclerosis. Ann. Ital. Med. Int. 19: 249-261 (2004).
Blattman JN, Greenberg PD. Cancer immunotherapy: a treatment for the masses. Science 305: 200-205 (2004). *
Blazovics A, Hagymasi K, Pronai L. Cytokines, prostaglandins, nutritive and non-nuitritive factors in inflammatory bowel diseases. Orv. Hetil. 145: 2523-2529 (2004).
Blazovics A, Szentmihalyi K, Pronai L, Hagymasi K, Lugasi A, Kovacs A, Feher J. Redox homeostasis in inflammatory bowel diseases. Orv. Hetil. 145: 1459-1166 (2004).
Blei AT. Who owns the data? Hepatology 40: 1237 (2004). *
Blei AT. Albumin dialysis for the treatment of hepatic encephalopathy. J. Gastroenterol. Hepatol. 19: S224-S228 (2004). *
Blei AT. Infection, inflammation and hepatic encephalopathy, synergism redefined. J. Hepatol. 40: 327-330 (2004). *
Bleiber G, May M, Suarez C, Martinez R, Marzolini C, Egger M, Telenti A; Swiss HIV Cohort Study. MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment. J. Infect. Dis. 189: 583-586 (2004). *
Bleich A, Mahler M, Most C, Leiter EH, Liebler-Tenorio E, Elson CO, Hedrich HJ, Schlegelberger B, Sundberg JP. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm. Genome 15: 865-871 (2004).
Blendis L, Dotan I. Anti-TNF therapy for severe acute alcoholic hepatitis: what went wrong? Gastroenterology 127: 1637-1639 (2004). *
Blendis L, Halpern Z. An increasing incidence of cholangiocarcinoma: why? Gastroenterology 127: 1008-1009 (2004). *
Blenman KR, Bahjat FR, Moldawer LL, Morel L. Aberrant signaling in the TNFalpha/TNF receptor 1 pathway of the NZM2410 lupus-prone mouse. Clin. Immunol. 110: 124-133 (2004). *
Blich M, Edoute Y. Clinical manifestations of sarcoid liver disease. J. Gastroenterol. Hepatol. 19: 732-737 (2004). *
Bliss CM Jr, Schroy PC 3rd. Endoscopic diagnosis and management of hereditary nonpolyposis colorectal cancer. Curr. Opin. Gastroenterol. 20: 468-473 (2004).
Bloks VW, Bakker-Van Waarde WM, Verkade HJ, Kema IP, Wolters H, Vink E, Groen AK, Kuipers F. Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes. Diabetologia 47: 104-112 (2004). *
Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Huseby ES, Undlien DE. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J. Clin. Endocrinol. Metab. 89: 3474-3476 (2004). *
Blomhoff HK. Vitamin A regulates proliferation and apoptosis of human T- and B-cells. Biochem. Soc. Trans. 32: 982-984 (2004). *
Blonska M, You Y, Geleziunas R, Lin X. Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells. Mol. Cell. Biol. 24: 10757-10765 (2004). *
Bloom S, Kiilerich S, Lassen MR, Forbes A, Leiper K, Langholz E, Irvine EJ, O'Morain C, Lowson D, Orm S. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment. Pharmacol. Ther. 19: 871-878 (2004). *
Bloquel C, Bessis N, Boissier MC, Scherman D, Bigey P. Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants. Hum. Gene Ther. 15: 189-201 (2004). *
Blossom SJ, Pumford NR, Gilbert KM. Activation and attenuation of apoptosis of CD4(+) T cells following in vivo exposure to two common environmental toxicants, trichloroacetaldehyde hydrate and trichloroacetic acid. J. Autoimmun. 23: 211-220 (2004).
Bluestone JA, Tang Q. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 101: 14622-14626 (2004). *
Blumenthal MN, Ober C, Beaty TH, Bleecker ER, Langefeld CD, King RA, Lester L, Cox N, Barnes K, Togias A, Mathias R, Meyers DA, Oetting W, Rich SS; CSGA. Genome scan for loci linked to mite sensitivity: the Collaborative Study on the Genetics of Asthma (CSGA). Genes Immun. 5: 226-231 (2004). *
Boberg KM, Schrumpf E. Prognosis of autoimmune liver diseases. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 81 (2004). *
Boberg KM, Schrumpf E. Diagnosis and treatment of cholangiocarcinoma. Curr. Gastroenterol. Rep. 6: 52-59 (2004).
Bobinski R, Olczyk K, Wisowski G, Janusz W. Genetic aspect of Dupuytren's diseases. Wiad. Lek. 57: 59-62 (2004).
Bock KW, Kohle C. Coordinate regulation of drug metabolism by xenobiotic nuclear receptors: UGTs acting together with CYPs and glucuronide transporters. Drug Metab. Rev. 36: 595-615 (2004).
Bodemar G, Kechagias S, Almer S, Danielson BG. Treatment of anaemia in inflammatory bowel disease with iron sucrose. Scand. J. Gastroenterol. 39: 454-458 (2004). *
Bodin K. Role of CYP3A4 as a cholesterol and bile acid metabolizing enzyme. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 25. June 18-19 (2004). *
Boehm BO, Bluestone JA. Differential roles of costimulatory signaling pathways in type 1 diabetes mellitus. Rev. Diabet. Stud. 1: 156-164 (2004). *
Boehncke WH. The alpha-defensins HNP-1 and HNP-2 are dominant self-peptides presented by HLA class-II molecules in lesional psoriatic skin. Eur. J. Dermatol. 14: 142-145 (2004).
Boes M, Ploegh HL. Translating cell biology in vitro to immunity in vivo. Nature 430: 264-271 (2004). *
Bogaard HJ, Erkelens GW, Faber WR, de Vries PJ. Cutaneous nocardiosis as an opportunistic infection. Ned. Tijdschr. Geneeskd. 148: 533-536 (2004).
Bogdanos D, Vergani D, Mieli-Vergani G. Overlap syndromes from pediatrics to adulthood. J. Gastroenterol. Hepatol. 19: S284-S286 (2004). *
Bogdanos D, Lenzi M, Okamoto M, Rigopoulou EI, Muratori P, Ma Y, Muratori L, Tsantoulas D, Mieli- Vergani G, Bianchi FB, Vergani D. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int. J. Immunopathol. Pharmacol. 17: 83-92 (2004).
Bogdanos DP, Baum H, Grasso A, Okamoto M, Butler P, Ma Y, Rigopoulou E, Montalto P, Davies ET, Burroughs AK, Vergani D. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J. Hepatol. 40: 31-39 (2004). *
Bogdanos DP, Baum H, Gunsar F, Arioli D, Polymeros D, Ma Y, Burroughs AK, Vergani D. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand. J. Gastroenterol. 39: 981-987 (2004). *
Bogdanos DP, Bianchi I, Baum H, Gunsar F, Arioli D, Ma Y, Burroughs AK, Vergani D. Extensive homology between the major immunodominant mitochondrial antigen of primary biliary cirrhosis and Helicobacter pylori does not lead to immunological crossreactivity. J. Hepatol. 40 Suppl. 1: 158-159 (2004).
Bogdanos DP, Bianchi I, Ma Y, Mitry RR, Mieli-Vergani G, Vergani D. Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis. Clin. Chem. 50: 682-683 (2004). *
Bogdanos DP, Gilbert D, Bianchi I, Leoni S, Mitry RR, Ma Y, Mieli-Vergani G, Vergani D. Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. J. Autoimmune Dis. 1: 4 (2004). *
Bogdanos DP, Pares A, Baum H, Caballeria L, Rigopoulou EI, Ma Y, Burroughs AK, Rodes J, Vergani D. Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. J. Autoimmun. 22: 353-362 (2004).
Bogdanos DP, Pares A, Rodes J, Vergani D. Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. Am. J. Gastroenterol. 99: 763-764 (2004). *
Bogdanos DP, Vergani D, Muratori P, Muratori L, Bianchi FB. Specificity of anti-sp100 antibody for primary biliary cirrhosis. Scand. J. Gastroenterol. 39: 405-406 (2004). *
Bogetti D, Panaro F, Jarzembowski T, Sankary H, Benedetti E, Testa G. Hepatic venous outflow reconstruction in adult living donor liver transplants without portal hypertension. Clin. Transplant. 18: 222-226 (2004).
Bogner J, Lutz B, Klein H, Pollerer C, Troendle U, Goebel F. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type. HIV Med. 5: 264-272 (2004).
Bohjanen KA, Prawer SE. New biologic therapies for psoriatic disease. Minn. Med. 87: 34-36 (2004).
Bohm A, Boos W. Gene regulation in prokaryotes by subcellular relocalization of transcription factors. Curr. Opin. Microbiol. 7: 151-156 (2004). *
Bohr UR, Glasbrenner B, Primus A, Zagoura A, Wex T, Malfertheiner P. Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J. Clin. Microbiol. 42: 2766-2768 (2004). *
Bohren KM, Nadkarni V, Song JH, Gabbay KH, Owerbach D. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem. 279: 27233-27238 (2004). *
Bohrer D, Do Nascimento PC, Ramirez AG, Mendonca JK, De Carvalho LM, Pomblum SC. Comparison of ultrafiltration and solid phase extraction for the separation of free and protein-bound serum copper for the Wilson's disease diagnosis. Clin. Chim. Acta 345: 113-121 (2004). *
Boin IF, Leonardi MI, Pinto AO, Leme RS, Udo E, Stucchi RS, Soares EC, Leonardi LS. Liver transplant recipients mortality on the waiting list: long-term comparison to Child-Pugh classification and MELD. Transplant. Proc. 36: 920-922 (2004). *
Bojar RA, Holland KT. Acne and Propionibacterium acnes. Clin. Dermatol. 22: 375-379 (2004).
Boland CR. Biology of cancer in ulcerative colitis and consequences for chemoprevention. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 82-83. May 7-8 (2004). *
Boland CR. Understanding familial colorectal cancer-finding the corner pieces and filling in the center of the puzzle. Gastroenterology 127: 334-338 (2004). *
Boleslawski E, Conti F, Sanquer S, Podevin P, Chouzenoux S, Batteux F, Houssin D, Weill B, Calmus Y. Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. Transplantation 77: 1815-1820 (2004).
Bolt HM. Rifampicin, a keystone inducer of drug metabolism: from Herbert Remmer's pioneering ideas to modern concepts. Drug Metab. Rev. 36: 497-509 (2004).
Bolz DD, Weis JJ. Molecular mimicry to Borrelia burgdorferi: pathway to autoimmunity? Autoimmunity 37: 387-392 (2004).
Bombail V, Taylor K, Gibson GG, Plant N. Role of Sp1, C/EBPalpha, HNF3, and PXR in the basal- and xenobiotic-mediated regulation of the CYP3A4 gene. Drug Metab. Dispos. 32: 525-535 (2004). *
Bombardieri M, Barone F, Pittoni V, Alessandri C, Conigliaro P, Blades MC, Priori R, McInnes IB, Valesini G, Pitzalis C. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res. Ther. 6: R447-R456 (2004). *
Bondanza A, Zimmermann VS, Dell'Antonio G, Cin ED, Balestrieri G, Tincani A, Amoura Z, Piette JC, Sabbadini MG, Rovere-Querini P, Manfredi AA. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum. 50: 1549-1560 (2004). *
Bonder CS, Ajuebor MN, Zbytnuik LD, Kubes P, Swain MG. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J. Immunol. 172: 45-53 (2004). *
Bonetti A, Reunanen K, Finnila S, Koivisto K, Wikstrom J, Sumelahti ML, Pirttila T, Elovaara I, Reunanen M, Saarela J, Peltonen L, Rantamaki T, Tienari PJ. A two-stage study on multiple sclerosis susceptibility and chromosome 2q33. Genes Immun. 5: 142-146 (2004). *
Bongi SM, Porfirio B, Rombola G, Palasciano A, Beneforti E, Bianucci G. Shared-epitope HLA-DRB1 alleles and sex ratio in Italian patients with rheumatoid arthritis. Joint Bone Spine 71: 24-28 (2004).
Bonhomme-Faivre L, Devocelle A, Saliba F, Chatled S, Maccario J, Farinotti R, Picard V. MDR-1 C3435T polymorphism influences cyclosporine A dose requirement in liver-transplant recipients. Transplantation 78: 21-25 (2004).
Bonifati DM, Willcox N, Vincent A, Beeson D. Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravis. Muscle Nerve 29: 436-439 (2004). *
Bonkowsky JL, Bohnsack JF, Pennington MJ, Viskochil D, Thompson JA. Leukoencephalopathy, arthritis, colitis, and hypogammaglobulinemia (LACH) in two brothers: a novel syndrome? Am. J. Med. Genet. 128A: 52-56 (2004). *
Bonner GF, Fakhri A, Vennamaneni SR. A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease. Inflamm. Bowel Dis. 10: 751-757 (2004). *
Bookman AA, Williams KS, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 171: 333-338 (2004). *
Boomkens SY, Kusters JG, Hoffmann G, Pot RG, Spee B, Penning LC, Egberink HF, van den Ingh TS, Rothuizen J. Detection of Helicobacter pylori in bile of cats. FEMS Immunol. Med. Microbiol. 42: 307-311 (2004). *
Boon M, Nolte IM, De Keyser J, Buys CH, te Meerman GJ. Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is stronger than additive. Hum. Genet. 115: 280-284 (2004). *
Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, Hurley P, Chien M, Chai S, Hitotsumatsu O, McNally E, Pickart C, Ma A. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5: 1052-1060 (2004). *
Booth A, Harper L, Hammad T, Bacon P, Griffith M, Levy J, Savage C, Pusey C, Jayne D. Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J. Am. Soc. Nephrol. 15: 717-721 (2004). *
Booth AD, Jayne DR, Kharbanda RK, McEniery CM, Mackenzie IS, Brown J, Wilkinson IB. Infliximab improves endothelial dysfunction in systemic vasculitis. A model of vascular inflammation. Circulation 109: 1718-1723 (2004). *
Booth AD, Wallace S, McEniery CM, Yasmin, Brown J, Jayne DR, Wilkinson IB. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum. 50: 581-588 (2004). *
Bor MV, Nexo E, Hvas AM. Holo-transcobalamin concentrations and transcobalamin saturation reflect recent vitamin B12 absorption better than does serum vitamin B12. Clin. Chem. 50: 1043-1049 (2004). *
Bora NS, Sohn JH, Kang SG, Cruz JM, Nishihori H, Suk HJ, Wang Y, Kaplan HJ, Bora PS. Type I collagen is the autoantigen in experimental autoimmune anterior uveitis. J. Immunol. 172: 7086-7094 (2004). *
Boraschi P, Braccini G, Gigoni R, Cartei F, Perri G. MR enteroclysis using iron oxide particles (ferristene) as an endoluminal contrast agent: an open phase III trial. Magn. Reson. Imaging 22: 1085-1095 (2004). *
Borchardt JK. Focus on small molecule inhibitors for treatment of inflammatory and autoimmune diseases. Drug News Perspect. 17: 607-614 (2004).
Borchers AT, Keen CL, Cheema GS, Gershwin ME. The use of methotrexate in rheumatoid arthritis. Semin. Arthritis Rheum. 34: 465-483 (2004). *
Borchers AT, Keen CL, Gershwin ME. Fatalities following allergen immunotherapy. Clin. Rev. Allergy Immunol. 27: 147-158 (2004).
Borchers AT, Keen CL, Gershwin ME. Mushrooms, tumors, and immunity: an update. Exp. Biol. Med. (Maywood) 229: 393-406 (2004). *
Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. Autoimmun. Rev. 3: 423-453 (2004).
Boren E, Gershwin ME. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun. Rev. 3: 401-406 (2004).
Borghaei RC, Rawlings PL Jr, Javadi M, Woloshin J. NF-kappaB binds to a polymorphic repressor element in the MMP-3 promoter. Biochem. Biophys. Res. Commun. 316: 182-188 (2004). *
Borgmann S, Haubitz M. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides. Clin. Exp. Rheumatol. 22 (6 Suppl. 36): S79-S86 (2004).
Borjesson L, Willen R, Haboubi N, Duff SE, Hulten L. The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: a long-term term follow-up study. Colorectal Dis. 6: 494-498 (2004). *
Bornstein SR, Schumann RR, Rettori V, McCann SM, Zacharowski K. Toll-like receptor 2 and Toll-like receptor 4 expression in human adrenals. Horm. Metab. Res. 36: 470-473 (2004).
Bornstein SR, Zacharowski P, Schumann RR, Barthel A, Tran N, Papewalis C, Rettori V, McCann SM, Schulze-Osthoff K, Scherbaum WA, Tarnow J, Zacharowski K. Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 101: 16695-16700 (2004). *
Borobio E, Arin A, Valcayo A, Inarrairaegui M, Nantes O, Prieto C. Isotretinoin and ulcerous colitis. An. Sist. Sanit. Navar. 27: 241-243 (2004).
Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S. Bacteriotherapy using fecal flora: toying with human motions. J. Clin. Gastroenterol. 38: 475-483 (2004).
Boros S, Kamps B, Wunderink L, de Bruijn W, de Jong WW, Boelens WC. Transglutaminase catalyzes differential crosslinking of small heat shock proteins and amyloid-beta. FEBS Lett. 576: 57-62 (2004). *
Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig. Liver Dis. 36: 342-347 (2004).
Borst P, Balzarini J, Ono N, Reid G, de Vries H, Wielinga P, Wijnholds J, Zelcer N. The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy. Antiviral Res. 62: 1-7 (2004). *
Borsutzky S, Cazac BB, Roes J, Guzman CA. TGF-beta receptor signaling is critical for mucosal IgA responses. J. Immunol. 173: 3305-3309 (2004). *
Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 (5 Suppl. 2): S5-S16 (2004). *
Bosch J, Thabut D, Bendtsen F, D'amico G, Albillos A, Gonzalez Abraldes J, Fabricius S, Erhardtsen E, De Franchis R. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127: 1123-1130 (2004). *
Bosselut R. CD4/CD8-lineage differentiation in the thymus: from nuclear effectors to membrane signals. Nat. Rev. Immunol. 4: 529-540 (2004). *
Bossi A, Casazza G, Padoan R, Milani S; Assemblea Dei Direttori Dei Centri. What is the incidence of cystic fibrosis in Italy? Data from the National Registry (1988-2001). Hum. Biol. 76: 455-467 (2004).
Bossowski A, Stasiak-Barmuta A, Urban M, Rinderle C. Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy. Endokrynol. Diabetol. Chor. Przemiany. Materii. Wieku. Rozw. 10: 93-101 (2004).
Bott C, Rudolph MW, Schneider AR, Schirrmacher S, Skalsky B, Petereit HU, Langguth P, Dressman JB, Stein J. In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system. Aliment. Pharmacol. Ther. 20: 347-353 (2004). *
Bottazzo GF, Locatelli M, Fierabracci A, Fruci D. The genetic basis of immune and autoimmune responses. Acta Paediatr. Suppl. 93: 38-42 (2004).
Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36: 337-338 (2004). *
Bottino C, Moretta L, Pende D, Vitale M, Moretta A. Learning how to discriminate between friends and enemies, a lesson from natural killer cells. Mol. Immunol. 41: 569-575 (2004). *
Bouchier-Hayes L, Martin SJ. CARDINAL roles in apoptosis and NFkappaB activation. Vitam. Horm. 67: 133-147 (2004).
Boudiaf M, Jaff A, Soyer P, Bouhnik Y, Hamzi L, Rymer R. Small-bowel diseases: prospective evaluation of multi-detector row helical CT enteroclysis in 107 consecutive patients. Radiology 233: 338-344 (2004). *
Boudiaf M, Soyer P, Rymer R. Imaging of inflammatory bowel disease. Gastroenterol. Clin. Biol. 28: S46-S51 (2004).
Bougacha-Elleuch N, Rebai A, Mnif M, Makni H, Bellassouad M, Jouida J, Abid M, Hammadi A. Analysis of MHC genes in a Tunisian isolate with autoimmune thyroid diseases: implication of TNF -308 gene polymorphism. J. Autoimmun. 23: 75-80 (2004).
Bouhnik Y, Alves A, Beau P, Carbonnel F, Levy P. Treatment of severe ulcerative colitis. Gastroenterol. Clin. Biol. 28: 984-991 (2004).
Boulton-Jones JR, Fenn RM, West J, Logan RF, Ryder SD. Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls. Aliment. Pharmacol. Ther. 20: 551-557 (2004). *
Bouneva I, Kirby DF. Management of nonalcoholic fatty liver disease: weight control. Clin. Liver Dis. 8: 693-713, xii (2004).
Bounou S, Giguere JF, Cantin R, Gilbert C, Imbeault M, Martin G, Tremblay MJ. The importance of virus-associated host ICAM-1 in human immunodeficiency virus type 1 dissemination depends on the cellular context. FASEB J. 18: 1294-1296 (2004). *
Bourges O, Dorgeret S, Alberti C, Hugot JP, Sebag G, Cezard JP. Low bone mineral density in children with Crohn's disease. Arch. Pediatr. 11: 800-806 (2004).
Bourne PC, Terzyan SS, Cloud G, Landolfi NF, Vasquez M, Edmundson AB. Three-dimensional structures of a humanized anti-IFN-gamma Fab (HuZAF) in two crystal forms. Acta Crystallogr. D. Biol. Crystallogr. 60: 1761-1769 (2004). *
Bournerias I. Methotrexate therapy in psoriasis. Rev. Prat. 54: 52-55 (2004).
Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging 8: 163-174 (2004).
Bourreille A, Humbert B, Maugere P, Galmiche JP, Darmaun D. Glutamine metabolism in Crohn's disease: a stable isotope study. Clin. Nutr. 23: 1167-1175 (2004).
Bourrie B, Bribes E, Derocq JM, Vidal H, Casellas P. Sigma receptor ligands: applications in inflammation and oncology. Curr. Opin. Investig. Drugs 5: 1158-1163 (2004).
Boursi B, Arber N. Small bowel malignancies: why are they so rare? Harefuah. 143: 727-732, 765 (2004).
Bousvaros A. Mucosal healing in children with Crohn's disease: appropriate therapeutic goal or medical overkill? Inflamm. Bowel Dis. 10: 481-483 (2004). *
Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K, Cruciat C, Eberhard D, Gagneur J, Ghidelli S, Hopf C, Huhse B, Mangano R, Michon AM, Schirle M, Schlegl J, Schwab M, Stein MA, Bauer A, Casari G, Drewes G, Gavin AC, et al. A physical and functional map of the human TNF-alpha/NF-kappaB signal transduction pathway. Nat. Cell Biol. 6: 97-105 (2004). *
Bouzaidi S, Ben Salem M, Mnif N, Ben Hammouda I, Ben Yedder J, Trabelsi S, Moussa A, Jemaa Y, Debbech R, Salem M, Najjar T, Hamza R. Bone mineral density in patients with Crohn's disease: about 53 cases. Tunis. Med. 82: 753-759 (2004).
Bove KE, Heubi JE, Balistreri WF, Setchell KD. Bile acid synthetic defects and liver disease: a comprehensive review. Pediatr. Dev. Pathol. 7: 315-334 (2004). *
Bovin LF, Rieneck K, Workman C, Nielsen H, Sorensen SF, Skjodt H, Florescu A, Brunak S, Bendtzen K. Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor. Immunol. Lett. 93: 217-226 (2004).
Bowcock AM. Psoriasis genetics: the way forward. J. Invest. Dermatol. 122: xv-xvii (2004). *
Bowcock AM, Cookson WO. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum. Mol. Genet. 13 Suppl. 1: R43-R55 (2004). *
Bowie VL, Snella KA, Gopalachar AS, Bharadwaj P. Listeria meningitis associated with infliximab. Ann. Pharmacother. 38: 58-61 (2004).
Bowles CJ, Leicester R, Romaya C, Swarbrick E, Williams CB, Epstein O. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut 53: 277-283 (2004). *
Bowman SJ, Booth DA, Platts RG. Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool. Rheumatology (Oxford) 43: 758-764 (2004). *
Bowman SJ, Ibrahim GH, Holmes G, Hamburger J, Ainsworth JR. Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK. Scand. J. Rheumatol. 33: 39-43 (2004).
Boxall S, McCormick J, Beverley P, Strobel S, De Filippi P, Dawes R, Klersy C, Clementi R, De Juli E, Ferster A, Wallace D, Arico M, Danesino C, Tchilian E. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr. Res. 55: 478-484 (2004). *
Boxall S, Stanton T, Hirai K, Ward V, Yasui T, Tahara H, Tamori A, Nishiguchi S, Shiomi S, Ishiko O, Inaba M, Nishizawa Y, Dawes R, Bodmer W, Beverley PC, Tchilian EZ. Disease associations and altered immune function in CD45 138G variant carriers. Hum. Mol. Genet. 13: 2377-2384 (2004). *
Boyanova L, Gergova G, Spassova Z, Koumanova R, Yaneva P, Mitov I, Derejian S, Krastev Z. Campylobacter infection in 682 Bulgarian patients with acute enterocolitis, inflammatory bowel disease, and other chronic intestinal diseases. Diagn. Microbiol. Infect. Dis. 49: 71-74 (2004).
Boyer JL, Denk G, Bohan A, Chen WS, Soroka C, Denson L. Adaptive regulation of bile salt transporters in cholestasis. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 46-47. June 18-19 (2004). *
Boyer O, Saadoun D, Abriol J, Dodille M, Piette JC, Cacoub P, Klatzmann D. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103: 3428-3430 (2004). *
Boyer TD. Aquaretics in cirrhotics with hyponatremia. J. Gastroenterol. Hepatol. 19: S191-S193 (2004). *
Boyer TD. HVPG measurement: is it mandatory for the management of portal hypertension? - Con. J. Gastroenterol. Hepatol. 19: S162-S164 (2004). *
Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J. Exp. Med. 199: 731-736 (2004). *
Boysen T, Clausen MR. A case of acute liver failure caused by herpes simplex type 2. Scand. J. Infect. Dis. 36: 529-532 (2004).
Bozkaya H, Bektas M, Metin O, Erkan O, Ibrahimoglu D, Dalva K, Akbiyik F, Gurel S, Bozdayi AM, Akay C, Yurdaydin C, Aslan O, Uzunalimoglu O. Screening for hemochromatosis in Turkey. Dig. Dis. Sci. 49: 444-449 (2004). *
Bozorgzadeh A, Jain A, Ryan C, Ornt D, Zand M, Mantry P, Lansing K, Orloff M. Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. Transplantation 77: 1066-1070 (2004).
Braat H, van den Brande J, van Tol E, Hommes D, Peppelenbosch M, van Deventer S. Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am. J. Clin. Nutr. 80: 1618-1625 (2004). *
Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin. Liver Dis. 8: 639-671, xi (2004).
Bradley PJ, Ferlito A, Devaney KO, Rinaldo A. Crohn's disease manifesting in the head and neck. Acta Otolaryngol. 124: 237-241 (2004).
Bradley RJ, Rosen MP. Subfertility and gastrointestinal disease: 'Unexplained' is often undiagnosed. Obstet. Gynecol. Surv. 59: 108-117 (2004).
Bralet MP, Duclos-Vallee JC, Castaing D, Samuel D, Guettier C. No hepatic iron overload 12 years after liver transplantation for hereditary hemochromatosis. Hepatology 40: 762 (2004). *
Bramstedt KA, Stowe J, Kotz M. Shopping for a transplant: when noncompliant patients seek wait listing at multiple hospitals. Prog. Transplant. 14: 217-221 (2004).
Brand DA, Viola D, Rampersaud P, Patrick PA, Rosenthal WS, Wolf DC. Waiting for a liver - hidden costs of the organ shortage. Liver Transpl. 10: 1001-1010 (2004). *
Brand DD, Kang AH, Rosloniec EF. The mouse model of collagen-induced arthritis. Methods Mol. Med. 102: 295-312 (2004).
Brand RE, Ross ME, Shuber AP. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection. Am. J. Gastroenterol. 99: 1338-1341 (2004). *
Brandhagen D. Can liver transplantation improve our understanding of the pathophysiology of iron overload? Liver Transpl. 10: 1218-1220 (2004). *
Brandlein S, Pohle T, Vollmers C, Wozniak E, Ruoff N, Muller-Hermelink HK, Vollmers HP. CFR-1 receptor as target for tumor-specific apoptosis induced by the natural human monoclonal antibody PAM-1. Oncol. Rep. 11: 777-784 (2004).
Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Oksanen A, Ericzon B-G, Hockerstedt K, Makisalo H, Kirkegaard P, Friman S, Bjoro K, Schrumpf E. Chemopreventive effect of URSO in primary sclerosing cholangitis? Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 78. June 18-19 (2004). *
Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Friman S, Bjoro K. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J. Hepatol. 40: 815-822 (2004). *
Brandsaeter B, Schrumpf E, Clausen OP, Abildgaard A, Hafsahl G, Bjoro K. Recurrent sclerosing cholangitis or ischemic bile duct lesions - a diagnostic challenge? Liver Transpl. 10: 1073-1074 (2004). *
Brandt J, Khariouzov A, Listing J, Haibel H, Sorensen H, Rudwaleit M, Sieper J, Braun J. Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept. J. Rheumatol. 31: 531-538 (2004).
Brandt J, Listing J, Sieper J, Rudwaleit M, Van Der Heijde D, Braun J. Development and preselection of criteria for short-term improvement after anti-TNFalpha therapy in ankylosing spondylitis. Ann. Rheum. Dis. 63: 1438-1444 (2004). *
Brandt S, Heller H, Schuster KD, Grote J. Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down-regulation of telomerase activity. Liver Int. 24: 46-54 (2004). *
Brandtzaeg P, Johansen FE, Baekkevold ES, Carlsen HS, Farstad IN. The traffic of mucosal lymphocytes to extraintestinal sites. J. Pediatr. Gastroenterol. Nutr. 39 Suppl. 3: S725-S726 (2004). *
Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol. 25: 570-577 (2004). *
Brant SR, Shugart YY. Inflammatory bowel disease gene hunting by linkage analysis - rationale, methodology, and present status of the field. Inflamm. Bowel Dis. 10: 300-311 (2004). *
Branten AJ, Swinkels DW, Klasen IS, Wetzels JF. Serum ferritin levels are increased in patients with glomerular diseases and proteinuria. Nephrol. Dial. Transplant. 19: 2754-2760 (2004). *
Braun J. Primativism, siderophilic bacteria, and Crohn's disease. Inflamm. Bowel Dis. 10: 884-885 (2004). *
Braun J. Epidemiology and prognosis of ankylosing spondylitis. Radiologe 44: 209-210, 212-216 (2004).
Braun J, Sieper J. Biological therapies in the spondyloarthritides - the current state. Rheumatology (Oxford) 43: 1072-1084 (2004). *
Braveman JM, Schoetz DJ Jr, Marcello PW, Roberts PL, Coller JA, Murray JJ, Rusin LC. The fate of the ileal pouch in patients developing Crohn's disease. Dis. Colon Rectum 47: 1613-1619 (2004).
Bray RA, Gebel HM, Ellis TM. Flow cytometric assessment of HLA alloantibodies. Curr. Protoc. Cytom. Chapter 6: Unit 6.16 (2004).
Breban M, Hacquard-Bouder C, Falgarone G. Animal models of HLA-B27-associated diseases. Curr. Mol. Med. 4: 31-40 (2004).
Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127 (5 Suppl. 2): S56-S61 (2004). *
Bredeson CN, Pavletic SZ. Considerations when designing a clinical trial of haematopoietic stem cell transplantation for autoimmune disease. Best Pract. Res. Clin. Haematol. 17: 327-343 (2004).
Breedveld FC, Emery P, Keystone E, Patel K, Furst DE, Kalden JR, St Clair EW, Weisman M, Smolen J, Lipsky PE, Maini RN. Infliximab in active early rheumatoid arthritis. Ann. Rheum. Dis. 63: 149-155 (2004). *
Breen CM, Sykes DB, Baehr C, Fricker G, Miller DS. Fluorescien-methotrexate transport in rat choroid plexus analyzed using confocal microscopy. Am. J. Physiol. Renal Physiol. 287: F562-F569 (2004). *
Breidert M, Zimmermann TF, Schneider R, Ehninger G, Brabant G. Ghrelin/leptin-imbalance in patients with primary biliary cirrhosis. Exp. Clin. Endocrinol. Diabetes 112: 123-126 (2004).
Bremner AR, Griffiths DM, Beattie RM. Current therapy of ulcerative colitis in children. Expert Opin. Pharmacother. 5: 37-53 (2004).
Bremner AR, Pridgeon J, Fairhurst J, Beattie RM. Ultrasound scanning may reduce the need for barium radiology in the assessment of small-bowel Crohn's disease. Acta Paediatr. 93: 479-481 (2004).
Bren L. Psoriasis: more than cosmetic. FDA Consum. 38: 10-16 (2004).
Brennan CA, Anderson KV. Drosophila: the genetics of innate immune recognition and response. Annu. Rev. Immunol. 22: 457-483 (2004). *
Brenner DA. Data from arrays: an embarrassment of riches. Gastroenterology 127: 1659 (2004). *
Brenner DA. Gastrointestinal basic science 2002-2003: the year in review. Clin. Gastroenterol. Hepatol. 2: 9-13 (2004). *
Brenner DA, Sigmund S. Pathogenesis of alcoholic hepatitis. J. Gastroenterol. Hepatol. 19: S229-S235 (2004). *
Brenner O, Levanon D, Negreanu V, Golubkov O, Fainaru O, Woolf E, Groner Y. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc. Natl. Acad. Sci. U.S.A. 101: 16016-16021 (2004). *
Bressler B, Paszat LF, Vinden C, Li C, He J, Rabeneck L. Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology 127: 452-456 (2004). *
Bridoux F, Kyndt X, Abou-Ayache R, Mougenot B, Baillet S, Bauwens M, Lemaitre V, Goujon JM, Touchard G, Vanhille P. Proximal tubular dysfunction in primary Sjogren's syndrome: a clinicopathological study of 2 cases. Clin. Nephrol. 61: 434-439 (2004).
Bridoux-Henno L, Maggiore G, Johanet C, Fabre M, Vajro P, Dommergues JP, Reinert P, Bernard O. Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody. Clin. Gastroenterol. Hepatol. 2: 825-830 (2004). *
Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890 (2004). *
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535 (2004). *
Brintnell W, Zeggini E, Barton A, Thomson W, Eyre S, Hinks A, Silman AJ, Worthington J. Evidence for a novel rheumatoid arthritis susceptibility locus on chromosome 6p. Arthritis Rheum. 50: 3823-3830 (2004). *
Brinton LA, Buckley LM, Dvorkina O, Lubin JH, Colton T, Murray MC, Hoover R. Risk of connective tissue disorders among breast implant patients. Am. J. Epidemiol. 160: 619-627 (2004). *
Brissot P, Troadec MB, Loreal O. Intestinal absorption of iron in HFE-1 hemochromatosis: local or systemic process? J. Hepatol. 40: 702-709 (2004). *
Brissot P, Troadec MB, Loreal O. The clinical relevance of new insights in iron transport and metabolism. Curr. Hematol. Rep. 3: 107-115 (2004).
Brittan M, Wright NA. Stem cell in gastrointestinal structure and neoplastic development. Gut 53: 899-910 (2004). *
Britto MT, Devellis RF, Hornung RW, Defriese GH, Atherton HD, Slap GB. Health care preferences and priorities of adolescents with chronic illnesses. Pediatrics 114: 1272-1280 (2004). *
Britton WJ, Lockwood DN. Leprosy. Lancet 363: 1209-1219 (2004). *
Brogan PA, Shah V, Klein N, Dillon MJ. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Arthritis Rheum. 50: 589-597 (2004). *
Bronner MP. Granulomatous appendicitis and the appendix in idiopathic inflammatory bowel disease. Semin. Diagn. Pathol. 21: 98-107 (2004).
Bronner MP, Goldblum JR. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Adv. Anat. Pathol. 11: 225-226 (2004).
Bronner MP, Goldblum JR, Kimmey MB, Brentnall TA, Rubin CE. Low-grade dysplasia in ulcerative colitis: natural history data still unknown. Gastroenterology 127: 362-363 (2004). *
Brookes MJ, Green JR. Maintenance of remission in Crohn's disease: current and emerging therapeutic options. Drugs 64: 1069-1089 (2004).
Brooks TA, Kennedy DR, Gruol DJ, Ojima I, Baer MR, Bernacki RJ. Structure-activity analysis of taxane-based broad-spectrum multidrug resistance modulators. Anticancer Res. 24: 409-415 (2004).
Broome U. Long term treatment with ursodeoxycholic acid in patients with primary sclerosing cholangitis (PSC). Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 71. June 18-19 (2004). *
Brophy S, Hickey S, Menon A, Taylor G, Bradbury L, Hamersma J, Calin A. Concordance of disease severity among family members with ankylosing spondylitis? J. Rheumatol. 31: 1775-1778 (2004).
Brotman DJ, O'Brien RG. Infallibility of a normal platelet count/spleen diameter ratio in ruling out oesophageal varices? Gut 53: 1721 (2004). *
Brouard J, Freymuth F, Bach N, Vabret A, Duhamel JF. Childhood infections: friends or foes? Arch. Pediatr. 11 Suppl. 2: 98s-102s (2004).
Broudy VC, Lin NL. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine 25: 52-60 (2004).
Broughton SS, Meyerhoff WE, Cohen SB. Immune-mediated inner ear disease: 10-year experience. Semin. Arthritis Rheum. 34: 544-548 (2004). *
Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N. Engl. J. Med. 350: 1505-1515 (2004). *
Brouwers A, Langlois M, Delanghe J, Billiet J, De Buyzere M, Vercaemst R, Rietzschel E, Bernard D, Blaton V. Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 176: 189-195 (2004).
Brown A. Prophylactic antibiotic use in severe acute pancreatitis: hemlock, help, or hype? Gastroenterology 126: 1195-1198 (2004). *
Brown AC, Valiere A. Probiotics and medical nutrition therapy. Nutr. Clin. Care 7: 56-68 (2004). *
Brown AM, Gordon D, Lee H, Caudy M, Hardy J, Haroutunian V, Blass JP. Association of the dihydrolipoamide dehydrogenase gene with Alzheimer's disease in an Ashkenazi Jewish population. Am. J. Med. Genet. 131B: 60-66 (2004). *
Brown C, Gaspar J, Pettit A, Lee R, Gu X, Wang H, Manning C, Voland C, Goldring SR, Goldring MB, Libermann TA, Gravalllese EM, Oettgen P. ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation. J. Biol. Chem. 279: 12794-12803 (2004). *
Brown IL. Applications and uses of resistant starch. J. AOAC Int. 87: 727-732 (2004).
Brown J, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman CB, Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279: 34674-34681 (2004). *
Brown JJ, Datta V, Browning MJ, Swift PG. Graves' disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion. J. Pediatr. Endocrinol. Metab. 17: 1575-1579 (2004).
Brown KA, Moonka D. Liver transplantation. Curr. Opin. Gastroenterol. 20: 264-269 (2004).
Brown RS, Rush SH, Rosen HR, Langnas AN, Klintmalm GB, Hanto DW, Punch JD. Liver and intestine transplantation. Am. J. Transplant. 4 Suppl. 9: 81-92 (2004).
Brown SJ, Miller AM, Cowan PJ, Slavin J, Connell WR, Moore GT, Bell S, Elliott PR, Desmond PV, d'Apice AJ. Altered immune system glycosylation causes colitis in alpha1,2-fucosyltransferase transgenic mice. Inflamm. Bowel Dis. 10: 546-556 (2004). *
Browning JD, Kumar KS, Saboorian MH, Thiele DL. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am. J. Gastroenterol. 99: 292-298 (2004). *
Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395 (2004). *
Broxmeyer L. Is mad cow disease caused by a bacteria? Med. Hypotheses 63: 731-739 (2004).
Brucet M, Marques L, Sebastian C, Lloberas J, Celada A. Regulation of murine Tap1 and Lmp2 genes in macrophages by interferon gamma is mediated by STAT1 and IRF-1. Genes Immun. 5: 26-35 (2004). *
Bruckner AL. Incontinentia pigmenti: a window to the role of NF-kappaB function. Semin. Cutan. Med. Surg. 23: 116-124 (2004).
Brudek T, Christensen T, Hansen HJ, Bobecka J, Moller-Larsen A. Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: implications for multiple sclerosis. AIDS Res. Hum. Retroviruses 20: 415-423 (2004).
Bruden DL, McMahon BJ, Hennessy TW, Christensen CJ, Homan CE, Williams JL, Sullivan DG, Gretch DR, Cagle HH, Bulkow LR. Estimating the date of hepatitis C virus infection from patient interviews and antibody tests on stored sera. Am. J. Gastroenterol. 99: 1517-1522 (2004). *
Bruey JM, Bruey-Sedano N, Newman R, Chandler S, Reed JC. PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kB and caspase-1 activation in macrophages. J. Biol. Chem. 279: 51897-51907 (2004). *
Brugge W. Advanced endoscopy: a personal perspective. Curr. Opin. Gastroenterol. 20: 459 (2004).
Brugge WR. Approaches to the drainage of pancreatic pseudocysts. Curr. Opin. Gastroenterol. 20: 488-492 (2004).
Bruhl H, Cihak J, Schneider MA, Plachy J, Rupp T, Wenzel I, Shakarami M, Milz S, Ellwart JW, Stangassinger M, Schlondorff D, Mack M. Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells. J. Immunol. 172: 890-898 (2004). *
Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S179-S188 (2004). *
Brun P. Prescription of retinoids in psoriasis. Rev. Prat. 54: 48-51 (2004).
Brunerova L, Bartakova H, Jankovska M, Cieslarova B, Hulek P, Kozak T, Andel M. The Budd-Chiari syndrome in a patient with primary thrombocythemia treated with interferon alfa and transjugular portosystemic shunt. Cas. Lek. Cesk. 143: 198-201 (2004).
Bruno M. Irritable bowel syndrome and inflammatory bowel disease in pregnancy. J. Perinat. Neonatal Nurs. 18: 341-350 (2004).
Bruno ME, West RB, Schneeman TA, Bresnick EH, Kaetzel CS. Upstream stimulatory factor but not c-Myc enhances transcription of the human polymeric immunoglobulin receptor gene. Mol. Immunol. 40: 695-708 (2004). *
Bruno O, Brullo C, Arduino N, Schenone S, Ranise A, Bondavalli F, Ottonello L, Dapino P, Dallegri F. Synthesis and biological evaluation of neutrophilic inflammation inhibitors. Farmaco 59: 223-235 (2004).
Brunt EM. Nonalcoholic steatohepatitis. Semin. Liver Dis. 24: 3-20 (2004).
Brunt EM, Di Bisceglie AM. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis. Hum. Pathol. 35: 509-512 (2004).
Brunt EM, Neuschwander-Tetri BA, Oliver D, Wehmeier KR, Bacon BR. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum. Pathol. 35: 1070-1082 (2004).
Brunt EM, Tiniakos DG. Metabolic storage diseases: amyloidosis. Clin. Liver Dis. 8: 915-930, x (2004).
Bruzzese E, Canani RB, De Marco G, Guarino A. Microflora in inflammatory bowel diseases: a pediatric perspective. J. Clin. Gastroenterol. 38: S91-S93 (2004).
Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V, Guarino A. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment. Pharmacol. Ther. 20: 813-819 (2004). *
Bryant PA, Trinder J, Curtis N. Sick and tired: does sleep have a vital role in the immune system? Nat. Rev. Immunol. 4: 457-467 (2004). *
Bryndova J, ZBankova S, Kment M, Pacha J. Colitis up-regulates local glucocorticoid activation and down-regulates inactivation in colonic tissue. Scand. J. Gastroenterol. 39: 549-553 (2004). *
Brynskov J, Feagan BG, Jewell D, McDonald JWD, Stange EF. Cyclosporine for maintenance of remission in Crohn�s disease. Cochrane Database Syst. Rev. 2: CD004377 (2004). *
Brzozowski T, Konturek PC, Pajdo R, Kwiecien S, Sliwowski Z, Drozdowicz D, Ptak-Belowska A, Pawlik M, Konturek SJ, Pawlik WW, Hahn GG. Importance of brain-gut axis in the gastroprotection induced by gastric and remote preconditioning. J. Physiol. Pharmacol. 55: 165-177 (2004). *
Bu-Ghanim M, Suriawinata A, Killackey M, Schwartz ME, Jaffe D, Fiel MI. Invasive colloid carcinoma arising from intraductal papillary neoplasm in a 50-year-old woman with primary sclerosing cholangitis. Semin. Liver Dis. 24: 209-213 (2004).
Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. NF-kappaB and JNK: an intricate affair. Cell Cycle 3: 1524-1529 (2004). *
Buch MH, Conaghan PG, Quinn MA, Bingham SJ, Veale D, Emery P. True infliximab resistance in rheumatoid arthritis; a role for lymphotoxin-alpha? Ann. Rheum. Dis. 63: 1344-1346 (2004). *
Buch MH, Marzo-Ortega H, Bingham SJ, Emery P. Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals. Rheumatology (Oxford) 43: 243-244 (2004). *
Buchanan FG, Chang W, Sheng H, Shao J, Morrow JD, D U Bois RN. Up-regulation of the enzymes involved in prostacyclin synthesis via Ras induces vascular endothelial growth factor. Gastroenterology 127: 1391-1400 (2004). *
Buchanan GN, Owen HA, Torkington J, Lunniss PJ, Nicholls RJ, Cohen CR. Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fistula. Br. J. Surg. 91: 476-480 (2004). *
Buchkremer F, Herrmann T, Stremmel W. Mild respiratory distress after wireless capsule endoscopy. Gut 53: 472 (2004). *
Buchman AL, Miller FH, Wallin A, Chowdhry AA, Ahn C. Videocapsule endoscopy versus barium contrast studies for the diagnosis of Crohn's disease recurrence involving the small intestine. Am. J. Gastroenterol. 99: 2171-2177 (2004). *
Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu. Rev. Immunol. 22: 625-655 (2004). *
Bucuvalas JC, Zeng L, Anand R, The Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Predictors of length of stay for pediatric liver transplant recipients. Liver Transpl. 10: 1011-1017 (2004). *
Budagian V, Bulanova E, Orinska Z, Ludwig A, Rose-John S, Saftig P, Borden EC, Bulfone-Paus S. Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17). J. Biol. Chem. 279: 40368-40375 (2004). *
Buderus S, Boone J, Lyerly D, Lentze MJ. Fecal lactoferrin: a new parameter to monitor infliximab therapy. Dig. Dis. Sci. 49: 1036-1039 (2004). *
Budzynska R, Zakliczynska H. Methotrexate in the treatment of the patients with rheumatoid arthritis. Postepy. Hig. Med. Dosw. (Online) 58: 108-117 (2004).
Buell JF, Woodle ES. Syndromic incidence of ovarian cancer after liver transplantation: is breast cancer an antecedent risk? Liver Transpl. 10: 156-157 (2004). *
Bueverov AO. Treatment of autoimmune hepatic diseases. Klin. Med. (Mosk.) 82: 62-66 (2004).
Bugianesi E, Marzocchi R, Villanova N, Marchesini G. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Best Pract. Res. Clin. Gastroenterol. 18: 1105-1116 (2004).
Buhr HJ, Utzig M, Stange E. Surgery in ulcerative colitis. Z. Gastroenterol. 42: 1026-1028 (2004).
Buijk SE, Gyssens IC, Mouton JW, Metselaar HJ, Groenland TH, Verbrugh HA, Bruining HA. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients. J. Antimicrob. Chemother. 54: 199-205 (2004). *
Buisson-Legendre N, Smith S, March L, Jackson C. Elevation of activated protein C in synovial joints in rheumatoid arthritis and its correlation with matrix metalloproteinase 2. Arthritis Rheum. 50: 2151-2156 (2004). *
Bullock NR, Booth JC, Gibson GR. Comparative composition of bacteria in the human intestinal microflora during remission and active ulcerative colitis. Curr. Issues Intest. Microbiol. 5: 59-64 (2004).
Bullock RE, Zaitoun AM, Aithal GP, Ryder SD, Beckingham IJ, Lobo DN. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. J. Hepatol. 41: 685-686 (2004). *
Bulteau AL, O'Neill HA, Kennedy MC, Ikeda-Saito M, Isaya G, Szweda LI. Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 305: 242-245 (2004). *
Buning C, Genschel J, Buhner S, Kruger S, Kling K, Dignass A, Baier P, Bochow B, Ockenga J, Schmidt HH, Lochs H. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment. Pharmacol. Ther. 19: 1073-1078 (2004). *
Buning C, Halangk J, Dignass A, Ockenga J, Deindl P, Nickel R, Genschel J, Landt O, Lochs H, Schmidt H, Witt H. Keratin 8 Y54H and G62C mutations are not associated with inflammatory bowel disease. Dig. Liver Dis. 36: 388-391 (2004).
Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am. J. Gastroenterol. 99: 523-526 (2004). *
Burakoff R. Indeterminate colitis: clinical spectrum of disease. J. Clin. Gastroenterol. 38: S41-S43 (2004).
Bureau C, Peron JM, Sirach E, Selves J, Otal P, Vinel JP. Liver nodules ressembling focal nodular hyperplasia after portal vein thrombosis. J. Hepatol. 41: 499-500 (2004). *
Burgmann T, Rawsthorne P, Bernstein CN. Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use? Am. J. Gastroenterol. 99: 889-893 (2004). *
Burim RV, Canalle R, Martinelli Ad A, Takahashi CS. Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. Mutagenesis 19: 291-298 (2004). *
Burk O, Koch I, Raucy J, Hustert E, Eichelbaum M, Brockmoller J, Zanger UM, Wojnowski L. The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR). J. Biol. Chem. 279: 38379-38385 (2004). *
Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am. J. Transplant. 4: 686-693 (2004). *
Burmeister T, Ebert AD, Pritze W, Loddenkemper C, Schwartz S, Thiel E. Insertional polymorphisms of endogenous HERV-K113 and HERV-K115 retroviruses in breast cancer patients and age-matched controls. AIDS Res. Hum. Retroviruses 20: 1223-1229 (2004).
Burnett R, Ravel G, Descotes J. Clinical and histopathological progression of lesions in lupus-prone (NZB x NZW) F1 mice. Exp. Toxicol. Pathol. 56: 37-44 (2004).
Burnham JM, Shults J, Semeao E, Foster B, Zemel BS, Stallings VA, Leonard MB. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J. Bone Miner. Res. 19: 1961-1968 (2004).
Burns KA, Martinon F. Inflammatory diseases: is ubiquitinated NEMO at the hub? Curr. Biol. 14: R1040-R1042 (2004). *
Burra P, Samuel D, Wendon J, Pietrangelo A, Gupta S. Strategies for liver support: from stem cells to xenotransplantation. J. Hepatol. 41: 1050-1059 (2004). *
Burra P, Senzolo M, Pizzolato G, Ermani M, Chierichetti F, Bassanello M, Naccarato R, Dam M. Does liver-disease aetiology have a role in cerebral blood-flow alterations in liver cirrhosis? Eur. J. Gastroenterol. Hepatol. 16: 885-890 (2004).
Burstein E, Ganesh L, Dick RD, Van De Sluis B, Wilkinson JC, Klomp LW, Wijmenga C, Brewer GJ, Nabel GJ, Duckett CS. A novel role for XIAP in copper homeostasis through regulation of MURR1. EMBO J. 23: 244-254 (2004). *
Burt AD. Spectrum of liver pathology in immune mediated liver diseases. J. Gastroenterol. Hepatol. 19: S353-S355 (2004). *
Burt RK, Verda L, Oyama Y, Statkute L, Slavin S. Non-myeloablative stem cell transplantation for autoimmune diseases. Springer Semin. Immunopathol. 26: 57-69 (2004). *
Burt RK, Verda L, Statkute L, Quigley K, Yaung K, Brush M, Oyama Y. Stem cell transplantation for autoimmune diseases. Clin. Adv. Hematol. Oncol. 2: 313-319 (2004).
Burt RW, Leppert MF, Slattery ML, Samowitz WS, Spirio LN, Kerber RA, Kuwada SK, Neklason DW, Disario JA, Lyon E, Hughes JP, Chey WY, White RL. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 127: 444-451 (2004). *
Burton JR Jr, Sonnenberg A, Rosen HR. Retransplantation for recurrent hepatitis C in the MELD era: maximizing utility. Liver Transpl. 10: S59-S64 (2004). *
Burzyn D, Rassa JC, Kim D, Nepomnaschy I, Ross SR, Piazzon I. Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J. Virol. 78: 576-584 (2004). *
Bush DA, Hillebrand DJ, Slater JM, Slater JD. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology 127 (5 Suppl. 2): S189-S193 (2004). *
Bush M, Patel S, Lapinski R, Stone J. Perinatal outcomes in inflammatory bowel disease. J. Matern. Fetal. Neonatal. Med. 15: 237-241 (2004).
Bush NE, Bowen DJ, Wooldridge J, Ludwig A, Meischke H, Robbins R. What do we mean by Internet access? A framework for health researchers. Prev. Chronic Dis. 1: A15 (2004).
Buss H, Dorrie A, Schmitz ML, Frank R, Livingstone M, Resch K, Kracht M. Phosphorylation of serine 468 by GSK-3b negatively regulates basal p65 NF-kB activity. J. Biol. Chem. 279: 49571-49574 (2004). *
Busse W, Banks-Schlegel S, Noel P, Ortega H, Taggart V, Elias J; NHLBI Working Group. Future research directions in asthma: an NHLBI Working Group report. Am. J. Respir. Crit. Care Med. 170: 683-690 (2004). *
Busuttil RW, Lake JR. Role of tacrolimus in the evolution of liver transplantation. Transplantation 77: S44-S51 (2004).
Butterfield LH. Immunotherapeutic strategies for hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S232-S241 (2004). *
Buyse F, Vandenbranden M, Ruysschaert JM. Mistargeted MRPdeltaF728 mutant is rescued by intracellular GSH. FEBS Lett. 578: 145-151 (2004). *
Buyse IM, McCarthy SE, Lurix P, Pace RP, Vo D, Bartlett GA, Schmitt ES, Ward PA, Oermann C, Eng CM, Roa BB. Use of MALDI-TOF mass spectrometry in a 51-mutation test for cystic fibrosis: evidence that 3199del6 is a disease-causing mutation. Genet. Med. 6: 426-430 (2004).
Buzzetti R, Petrone A, Ribaudo MC, Alemanno I, Zavarella S, Mein CA, Maiani F, Tiberti C, Baroni MG, Vecci E, Arca M, Leonetti F, Mario UD. The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity. Eur. J. Hum. Genet. 12: 1050-1054 (2004). *
Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 23: 77-99 (2004). *
Byrnes V, Cardenas A, Afdhal N, Hanto D. Symptomatic focal nodular hyperplasia during pregnancy: a case report. Ann. Hepatol. 3: 35-37 (2004). *
Bzowska M, Jura N, Lassak A, Black RA, Bereta J. Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells. Eur. J. Biochem. 271: 2808-2820 (2004). *
Cabezas Gelabert R. Effect of ursodeoxycholic acid combined with statins in hypercholesterolemia treatment: a prospective clinical trial. Rev. Clin. Esp. 204: 632-635 (2004).
Cabrera-Abreu JC, Davies P, Matek Z, Murphy MS. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch. Dis. Child. 89: 69-71 (2004). *
Caenepeel S, Charydczak G, Sudarsanam S, Hunter T, Manning G. The mouse kinome: discovery and comparative genomics of all mouse protein kinases. Proc. Natl. Acad. Sci. U.S.A. 101: 11707-11712 (2004). *
Cahill BA, Braccia D. Current treatment for hepatocellular carcinoma. Clin. J. Oncol. Nurs. 8: 393-399 (2004).
Cai Z, Scott-Ward TS, Li H, Schmidt A, Sheppard DN. Strategies to investigate the mechanism of action of CFTR modulators. J. Cyst. Fibros. 3 Suppl. 2: 141-147 (2004).
Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. (Lond.) 107: 1-11 (2004). *
Calder PC. n-3 Fatty acids, inflammation, and immunity - relevance to postsurgical and critically ill patients. Lipids 39: 1147-1161 (2004).
Caldwell SH, Chang CY, Nakamoto RK, Krugner-Higby L. Mitochondria in nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 595-617, x (2004).
Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM. Obesity and hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S97-S103 (2004). *
Calista D, Morri M. Lichen planus induced by hepatitis B vaccination: a new case and review of the literature. Int. J. Dermatol. 43: 562-564 (2004).
Callan MF. Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients. Curr. Opin. Rheumatol. 16: 399-405 (2004).
Calmus Y. Graft-versus-host disease following living donor liver transplantation: high risk when the donor is HLA-homozygous. J. Hepatol. 41: 505-507 (2004). *
Cals-Grierson MM, Ormerod AD. Nitric oxide function in the skin. Nitric Oxide 10: 179-193 (2004). *
Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, Palozza P. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 25: 2303-2310 (2004). *
Calvisi DF, Ladu S, Hironaka K, Factor VM, Thorgeirsson SS. Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer. J. Hepatol. 41: 815-822 (2004). *
Calzolari A, Deaglio S, Sposi NM, Petrucci E, Morsilli O, Gabbianelli M, Malavasi F, Peschle C, Testa U. Transferrin receptor 2 protein is not expressed in normal erythroid cells. Biochem. J. 381: 629-634 (2004). *
Camargo JF, Correa PA, Castiblanco J, Anaya JM. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun. 5: 609-614 (2004). *
Cameron ER, Neil JC. The Runx genes: lineage-specific oncogenes and tumor suppressors. Oncogene 23: 4308-4314 (2004). *
Camilleri M. Is there a SERT-ain association with IBS? Gut 53: 1396-1399 (2004). *
Camilleri M. GIH clinical research 2003-2004: the year in review. Clin. Gastroenterol. Hepatol. 2: 1043-1047 (2004). *
Campatelli A, Di Candio G, Morelli L, Coletti L, De Giovanni M, Urbani L, Catalano G, Filipponi F, Mosca F. Interventional ultrasound: experience in 426 orthotopic liver transplantations. Transplant. Proc. 36: 550-551 (2004). *
Campbell JD, Deol SS, Ashcroft FM, Kerr ID, Sansom MS. Nucleotide-dependent conformational changes in HisP: molecular dynamics simulation of an ABC transporter nucleotide binding domain. Biophys. J. 87: 3703-3715 (2004). *
Campbell MS, Lichtenstein GR, Rhim AD, Faust TW. Osteopenia and osteoporosis in patients with primary sclerosing cholangitis cannot be predicted by severity of liver disease. Gastroenterology 126: A715-A716 (2004).
Campbell S, Michaelson J, Burkly L, Putterman C. The role of TWEAK/Fn14 IN the pathogenesis of inflammation and systemic autoimmunity. Front. Biosci. 9: 2273-2284 (2004).
Campeotto F, Butel MJ, Kalach N, Derrieux S, Aubert-Jacquin C, Barbot L, Francoual C, Dupont C, Kapel N. High faecal calprotectin concentrations in newborn infants. Arch. Dis. Child. Fetal Neonatal Ed. 89: F353-F355 (2004).
Canani RB, Romano MT, Greco L, Terrin G, Sferlazzas C, Barabino A, Fontana M, Roggero P, Guariso G, De Angelis G, Fecarotta S, Polito G, Cucchiara S. Effects of disease activity on anti-Saccharomyces cerevisiae antibodies - Implications for diagnosis and follow-up of children with Crohn's disease. Inflamm. Bowel Dis. 10: 234-239 (2004). *
Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J. Pharmacol. Exp. Ther. 308: 1191-1196 (2004). *
Candore G, Balistreri CR, Colonna-Romano G, Lio D, Caruso C. Major histocompatibility complex and sporadic Alzheimer's disease: a critical reappraisal. Exp. Gerontol. 39: 645-652 (2004). *
Cantarovich M, Barkun J, Giannetti N, Cecere R, Besner JG, Tchervenkov J. History of C(2) monitoring in heart and liver transplant patients treated with cyclosporine microemulsion. Transplant. Proc. 36: S442-S447 (2004). *
Cantin AM. Potential for antioxidant therapy of cystic fibrosis. Curr. Opin. Pulm. Med. 10: 531-536 (2004).
Cantor RM, Yuan J, Napier S, Kono N, Grossman JM, Hahn BH, Tsao BP. Systemic lupus erythematosus genome scan: support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23. Arthritis Rheum. 50: 3203-3210 (2004). *
Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. (Maywood) 229: 1136-1142 (2004). *
Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am. J. Clin. Nutr. 80: 1717S-1720S (2004). *
Cantz T, Sharma AD, Jochheim-Richter A, Arseniev L, Klein C, Manns MP, Ott M. Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration. Cell Transplant. 13: 659-666 (2004).
Cao CM, Chen JZ, Xia Q, Zhang SZ, Lin GH, Wong TM. Interleukin-2 confers cardioprotection by inhibiting mitochondrial permeability transition pore. Conf. Proc. IEEE Eng. Med. Biol. Soc. 5: 3618-3621 (2004).
Cao G, Liang Y, Jiang XC, Eacho PI. Liver X receptors as potential therapeutic targets for multiple diseases. Drug News Perspect. 17: 35-41 (2004).
Cao W, Vrees M, Potenti FM, Harnett KM, Fiocchi C, Pricolo VE. Interleukin 1beta-induced production of H2O2 contributes to reduced sigmoid colonic circular smooth muscle contractility in ulcerative colitis. J. Pharmacol. Exp. Ther. 311: 60-70 (2004). *
Cao W, Vrees MD, Kirber MT, Fiocchi C, Pricolo VE. Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G833-G843 (2004). *
Cao WM, Murao K, Imachi H, Yu X, Dobashi H, Yoshida K, Muraoka T, Kotsuna N, Nagao S, Wong NC, Ishida T. Insulin like growth factor-I regulation of hepatic scavenger receptor class BI. Endocrinology 145: 5540-5547 (2004). *
Cao X, Liu W, Lin F, Li H, Kolluri SK, Lin B, Han YH, Dawson MI, Zhang XK. Retinoid X receptor regulates Nur77/TR3-dependent apoptosis by modulating its nuclear export and mitochondrial targeting. Mol. Cell. Biol. 24: 9705-9725 (2004). *
Capling RK, Bastani B. The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis. Ren. Fail. 26: 563-568 (2004).
Capon F, Allen MH, Ameen M, Burden AD, Tillman D, Barker JN, Trembath RC. A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Hum. Mol. Genet. 13: 2361-2368 (2004). *
Capon F, Helms C, Veal CD, Tillman D, Burden AD, Barker JN, Bowcock AM, Trembath RC. Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasis. J. Med. Genet. 41: 459-460 (2004). *
Capon F, Trembath RC, Barker JN. An update on the genetics of psoriasis. Dermatol. Clin. 22: 339-347, vii (2004).
Caprilli R, Angelucci E, Cocco A, Viscido A, Zippi M. Efficacy of conventional immunosuppressive drugs in IBD. Dig. Liver Dis. 36: 766-780 (2004).
Capron A, Dombrowicz D, Capron M. Helminth infections and allergic diseases: from the Th2 paradigm to regulatory networks. Clin. Rev. Allergy Immunol. 26: 25-34 (2004). *
Caproni M, Volpi W, Giomi B, Cardinali C, Antiga E, Melani L, Dagata A, Fabbri P. Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm. Venereol. 84: 288-290 (2004).
Capuano G, Pomponi D, Iaccarino V, Budillon G. An unusual case of ascites. Dig. Liver Dis. 36: 628-631 (2004).
Caputo I, D'Amato A, Troncone R, Auricchio S, Esposito C. Transglutaminase 2 in celiac disease: minireview article. Amino Acids 26: 381-386 (2004). *
Carbone J, Sarmiento E, Rodriguez-Molina J, Fernandez-Cruz E. Atypical presentation of common variable immunodeficiency without infections. Allergol. Immunopathol. (Madr.) 32: 218-222 (2004).
Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40: 652-659 (2004). *
Carbonnel F. Why and how should we look for deep ulcerations in severe attacks of ulcerative colitis? Gastroenterol. Clin. Biol. 28: 215-217 (2004).
Card T, Logan RF, Rodrigues LC, Wheeler JG. Antibiotic use and the development of Crohn's disease. Gut 53: 246-250 (2004). *
Card T, West J, Hubbard R, Logan RF. Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 53: 251-255 (2004). *
Cardarelli F, Pascual M, Chung RT, Tolkoff-Rubin N, Wong W, Cosimi AB, Saidman SL. Interferon-alpha therapy in liver transplant recipients: lack of association with increased production of anti-HLA antibodies. Am. J. Transplant. 4: 1352-1356 (2004).
Cardenas A. Gastric varix: radiological-endoscopic correlation. Ann. Hepatol. 3: 74 (2004). *
Carey EJ, Douglas DD, Balan V, Vargas HE, Byrne TJ, Moss AA, Mulligan DC. Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: a single-center experience. Liver Transpl. 10: 529-533 (2004). *
Caricato M, Ausania F, Borzomati D, Valeri S, Coppola R, Verzi A, Tonini G. Large abdominal mass in Crohn's disease. Gut 53: 1493 (2004). *
Carini R, De Cesaris MG, Splendore R, Baldanzi G, Nitti MP, Alchera E, Filigheddu N, Domenicotti C, Pronzato MA, Graziani A, Albano E. Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning. Gastroenterology 127: 914-923 (2004). *
Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127: 224-238 (2004). *
Carlsen H, Alexander G, Austenaa LM, Ebihara K, Blomhoff R. Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response. Mutat. Res. 551: 199-211 (2004).
Carlsen HS, Baekkevold ES, Morton HC, Haraldsen G, Brandtzaeg P. Monocyte-like and mature macrophages produce CXCL13 (B-cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood 104: 3021-3027 (2004). *
Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 429: 446-452 (2004). *
Carlson MD, Al-Mateen M, Brewer GJ. Atypical childhood Wilson's disease. Pediatr. Neurol. 30: 57-60 (2004).
Carlton VE, Pawlikowska L, Bull LN. Molecular basis of intrahepatic cholestasis. Ann. Med. 36: 606-617 (2004).
Carmena R, Betteridge DJ. Statins and diabetes. Semin. Vasc. Med. 4: 321-332 (2004).
Carneiro LA, Travassos LH, Philpott DJ. Innate immune recognition of microbes through Nod1 and Nod2: implications for disease. Microbes Infect. 6: 609-616 (2004). *
Carney G, Wei S, Rizzo WB. Sjogren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2. Hum. Mutat. 24: 186 (2004). *
Caro AA, Cederbaum AI. Antioxidant properties of S-adenosyl-L-methionine in Fe(2+)-initiated oxidations. Free Radic. Biol. Med. 36: 1303-1316 (2004).
Carod Artal FJ, Vargas AP, Marinho PB, Fernandes Silva TV, Portugal D. Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome). Rev. Neurol. 38: 327-331 (2004).
Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Jarvinen H, Haglund C. Estimating the probability of cancer with several tumor markers in patients with colorectal disease. Oncology 66: 296-302 (2004).
Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Jarvinen H, Haglund C. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer. Tumour Biol. 25: 228-234 (2004).
Carpenter E, Jackson MA, Friesen CA, Scarbrough M, Roberts CC. Crohn's-associated chronic recurrent multifocal osteomyelitis responsive to infliximab. J. Pediatr. 144: 541-544 (2004). *
Carpo M, Scarlato M, Bardella M, Terrani C, Peracchi M, Allaria S, Nobile-Orazio E, Bresolin N. Painful sensory neuropathy and dysimmunity: is there a relation? J. Peripher. Nerv. Syst. 9: 121 (2004).
Carr BI. Hepatocellular carcinoma: current management and future trends. Gastroenterology 127 (5 Suppl. 2): S218-S224 (2004). *
Carr C, Desai J. OPCAB surgery in a cirrhotic hepatocellular carcinoma patient awaiting liver transplant. Ann. Thorac. Surg. 78: 1460-1462 (2004).
Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J. Am. Acad. Dermatol. 51: 212-216 (2004).
Carroll MC. A protective role for innate immunity in systemic lupus erythematosus. Nat. Rev. Immunol. 4: 825-831 (2004). *
Carter JD, Chen M, Ellett JD, Smith KM, Nadler JL, Yang Z. Impact of donor immune cells in pancreatic islet transplantation. Transplant. Proc. 36: 2866-2868 (2004). *
Carter JD, Valeriano J, Vasey FB. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to Chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J. Rheumatol. 31: 1973-1980 (2004).
Carter MJ, Jones S, Camp NJ, Cox A, Mee J, Warren B, Duff GW, Lobo AJ, Di Giovine FS. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun. 5: 8-15 (2004). *
Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 53 Suppl. 5: V1-V16 (2004). *
Caruso C, Aquino A, Candore G, Scola L, Colonna-Romano G, Lio D. Looking for immunological risk genotypes. Ann. N. Y. Acad. Sci. 1019: 141-146 (2004). *
Carvalho AA, Lima UW, Valiente RA. Statin and fibrate associated myopathy: study of eight patients. Arq. Neuropsiquiatr. 62: 257-261 (2004). *
Carvalho B, Mirikitani EJ, Lyell D, Evans DA, Druzin M, Riley ET. Neonatal chest wall rigidity following the use of remifentanil for cesarean delivery in a patient with autoimmune hepatitis and thrombocytopenia. Int. J. Obstet. Anesth. 13: 53-56 (2004). *
Casals T, Aparisi L, Martinez-Costa C, Gimenez J, Ramos MD, Mora J, Diaz J, Boadas J, Estivill X, Farre A. Different CFTR mutational spectrum in alcoholic and idiopathic chronic pancreatitis? Pancreas 28: 374-379 (2004).
Casanas R, Scharfetter H, Altes A, Remacha A, Sarda P, Sierra J, Merwa R, Hollaus K, Rosell J. Measurement of liver iron overload by magnetic induction using a planar gradiometer: preliminary human results. Physiol. Meas. 25: 315-323 (2004). *
Casanelli JM, Keli E, N'Dri J, Bohoussou PE, Blegole C, Moussa B, N'guessan HA. Crohn's disease: first report in Cote-d'Ivoire. Med. Trop. (Mars.) 64: 384-386 (2004).
Casanova JL, Abel L. Human mannose-binding lectin in immunity: friend, foe, or both? J. Exp. Med. 199: 1295-1299 (2004). *
Casanova JL, Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 4: 55-66 (2004). *
Casas-Melley AT, Falkenstein KP, Flynn LM, Ziegler VL, Dunn SP. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus. Pediatr. Transplant. 8: 362-366 (2004).
Casellas F, Alcala MJ, Prieto L, Miro JR, Malagelada JR. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. Am. J. Gastroenterol. 99: 457-461 (2004). *
Casellas F, Antoln M, Varela E, Garca-Lafuente A, Guarner F, Borruel N, Armengol Miro JR, Malagelada JR. Fecal excretion of human deoxyribonucleic acid as an index of inflammatory activity in ulcerative colitis. Clin. Gastroenterol. Hepatol. 2: 683-689 (2004). *
Casellas F, Fontanet G, Borruel N, Malagelada J. The opinion of patients with inflammatory bowel disease on healthcare received. Rev. Esp. Enferm. Dig. 96: 174-184 (2004). *
Casellas Jorda F. TNF-alpha inhibitors in inflamatory bowel disease. Med. Clin. (Barc.) 123: 627-634 (2004).
Casellas Jorda F, Lopez Vivancos J. Evaluation of quality of life in digestive diseases. Gastroenterol. Hepatol. 27: 58-68 (2004).
Caserta TM, Knisley AA, Tan FK, Arnett FC, Brown TL. Genotypic analysis of the TGF beta-509 allele in patients with systemic lupus erythematosus and Sjogren's syndrome. Ann. Genet. 47: 359-363 (2004).
Casillas S, Delaney CP, Senagore AJ, Brady K, Fazio VW. Does conversion of a laparoscopic colectomy adversely affect patient outcome? Dis. Colon Rectum 47: 1680-1685 (2004).
Casper RC. Nutrients, neurodevelopment, and mood. Curr. Psychiatry Rep. 6: 425-429 (2004).
Cassano P, Fava M. Tolerability issues during long-term treatment with antidepressants. Ann. Clin. Psychiatry 16: 15-25 (2004).
Castano G, Viudez P, Sookoian S. Losartan in preascitic cirrhosis. Am. J. Gastroenterol. 99: 2282-2283 (2004). *
Castellaneta SP, Afzal NA, Greenberg M, Deere H, Davies S, Murch SH, Walker-Smith JA, Thomson M. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 39: 257-261 (2004). *
Castelli M, Reiners JJ, Kessel D. A mechanism for the proapoptotic activity of ursodeoxycholic acid: effects on Bcl-2 conformation. Cell Death Differ. 11: 906-914 (2004). *
Castellvi JM, Xiol X, Guardiola J, Sabate I I, Roca M, Lama C, Figueras J, Jaurrieta E, Casais L. Pretransplantation risk factors for graft loss after liver transplantation in cirrhotic patients; effect of cytomegalovirus serologic status. Transpl. Int. 17: 131-137 (2004).
Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, Mizoguchi E, Geha RS. Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 101: 3903-3908 (2004). *
Castiglione F, De Sio I, Cozzolino A, Rispo A, Manguso F, Del Vecchio Blanco G, Di Girolamo E, Castellano L, Ciacci C, Mazzacca G. Bowel wall thickness at abdominal ultrasound and the one-year-risk of surgery in patients with Crohn's disease. Am. J. Gastroenterol. 99: 1977-1983 (2004). *
Castrillo A, Tontonoz P. PPARs in atherosclerosis: the clot thickens. J. Clin. Invest. 114: 1538-1540 (2004). *
Castro B, Crespo J, Garcia-Suarez C, Fabrega E, Casafont F, Pons-Romero F. Triple immunosuppressive therapy in the treatment of severe ulcerative colitis. Gastroenterol. Hepatol. 27: 1-5 (2004).
Castro RE, Sola S, Ramalho RM, Steer CJ, Rodrigues CM. The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of Bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons. J. Pharmacol. Exp. Ther. 311: 845-852 (2004). *
Castro-Chavez F. Microarrays, antiobesity and the liver. Ann. Hepatol. 3: 137-145 (2004). *
Catania VA, Sanchez Pozzi EJ, Luquita MG, Ruiz ML, Villanueva SS, Jones B, Mottino AD. Co-regulation of expression of phase II metabolizing enzymes and multidrug resistance-associated protein 2. Ann. Hepatol. 3: 11-17 (2004). *
Cater MA, Forbes J, La Fontaine S, Cox D, Mercer JF. Intracellular trafficking of the human Wilson protein: the role of the six N-terminal metal binding sites. Biochem. J. 380: 805-813 (2004). *
Caturelli E, Solmi L, Anti M, Fusilli S, Roselli P, Andriulli A, Fornari F, Del Vecchio Blanco C, De Sio I. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 53: 1356-1362 (2004). *
Cavasotto CN, Liu G, James SY, Hobbs PD, Peterson VJ, Bhattacharya AA, Kolluri SK, Zhang XK, Leid M, Abagyan R, Liddington RC, Dawson MI. Determinants of retinoid X receptor transcriptional antagonism. J. Med. Chem. 47: 4360-4372 (2004). *
Cavill D, Waterman SA, Gordon TP. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjogren's syndrome. Scand. J. Immunol. 59: 261-266 (2004). *
Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, Bluteau O, Blanche H, Franco D, Monges G, Belghiti J, Sa Cunha A, Laurent-Puig P, Degott C, Zucman-Rossi J. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J. Hepatol. 41: 292-298 (2004). *
Celec P. Nuclear factor kappa B - molecular biomedicine: the next generation. Biomed. Pharmacother. 58: 365-371 (2004).
Celinska-Lowenhoff M, Undas A. Nonlipid effects of fibrates. Przegl. Lek. 61: 99-101 (2004).
Celius T, Garberg P, Lundgren B. Stable suppression of MDR1 gene expression and function by RNAi in Caco-2 cells. Biochem. Biophys. Res. Commun. 324: 365-371 (2004). *
Centers for Disease Control and Prevention (CDC). Investigation of rabies infections in organ donor and transplant recipients - Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb. Mortal. Wkly. Rep. 53: 586-589 (2004).
Centers for Disease Control and Prevention (CDC). Tuberculosis associated with blocking agents against tumor necrosis factor-alpha - California, 2002-2003. MMWR Morb. Mortal. Wkly. Rep. 53: 683-686 (2004).
Centers for Disease Control and Prevention (CDC). Update: investigation of rabies infections in organ donor and transplant recipients - Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb. Mortal. Wkly. Rep. 53: 615-616 (2004).
Centrella M, Christakos S, McCarthy TL. Skeletal hormones and the C/EBP and Runx transcription factors: interactions that integrate and redefine gene expression. Gene 342: 13-24 (2004). *
Ceriati E, Deganello F, De Peppo F, Ciprandi G, Silveri M, Marchetti P, Rava L, Rivosecchi M. Surgery for ulcerative colitis in pediatric patients: functional results of 10-year follow-up with straight endorectal pull-through. Pediatr. Surg. Int. 20: 573-578 (2004).
Cerrone GE, Caputo M, Lopez AP, Gonzalez C, Massa C, Cedola N, Targovnik HM, Frechtel GD. Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adults. Mol. Diagn. 8: 43-49 (2004).
Cervera R, Asherson RA, Acevedo ML, Gomez-Puerta JA, Espinosa G, De La Red G, Gil V, Ramos-Casals M, Garcia-Carrasco M, Ingelmo M, Font J. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann. Rheum. Dis. 63: 1312-1317 (2004). *
Cesaratto L, Vascotto C, Calligaris S, Tell G. The importance of redox state in liver damage. Ann. Hepatol. 3: 86-92 (2004). *
Cevik R, Nas K, Gur A, Ayyildiz O, Arica M. Small joint monoarthritis and pyoderma gangrenosum in newly diagnosed ulcerative colitis: an unusual presentation. J. Clin. Rheumatol. 10: 360-362 (2004).
Cha S, Brayer J, Gao J, Brown V, Killedar S, Yasunari U, Peck AB. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand. J. Immunol. 60: 552-565 (2004). *
Chacon O, Bermudez LE, Barletta RG. Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu. Rev. Microbiol. 58: 329-363 (2004). *
Chae SC, Lee YC, Park YR, Shin JS, Song JH, Oh GJ, Hong ST, Pae HO, Choi BM, Chung HT. Analysis of the polymorphisms in eotaxin gene family and their association with asthma, IgE, and eosinophil. Biochem. Biophys. Res. Commun. 320: 131-137 (2004). *
Chae SC, Park YR, Lee YC, Lee JH, Chung HT. The association of TIM-3 gene polymorphism with atopic disease in Korean population. Hum. Immunol. 65: 1427-1431 (2004).
Chae SC, Park YR, Shim SC, Yoon KS, Chung HT. The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. Immunol. Lett. 95: 91-95 (2004).
Chak A, Faulx A, Kinnard M, Brock W, Willis J, Wiesner GL, Parrado AR, Goddard KA. Identification of Barrett's esophagus in relatives by endoscopic screening. Am. J. Gastroenterol. 99: 2107-2114 (2004). *
Chalasani N, Aljadhey H, Kesterson J, Murray MD, Hall SD. Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity. Gastroenterology 126: 1287-1292 (2004). *
Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 99: 1497-1502 (2004). *
Challis S, Surgenor S. Helping patients with Crohn's disease to stop smoking. Prof. Nurse 19: 386-389 (2004).
Chamaillard M, Inohara N, Nunez G. Battling enteroinvasive bacteria: Nod1 comes to the rescue. Trends Microbiol. 12: 529-532 (2004). *
Chamberlain AJ, Hollowood K, Turner RJ, Byren I. Tumid lupus erythematosus occurring following highly active antiretroviral therapy for HIV infection: a manifestation of immune restoration. J. Am. Acad. Dermatol. 51 (5 Suppl.): S161-S165 (2004).
Chambers MS. Sjogren's syndrome. ORL Head Neck Nurs. 22: 22-30 (2004).
Champault A, Benoist S, Alves A, Panis Y. Surgical therapy for Crohn's disease of the colon and rectum. Gastroenterol. Clin. Biol. 28: 882-892 (2004).
Chan AT, Giovannucci EL, Schernhammer ES, Colditz GA, Hunter DJ, Willett WC, Fuchs CS. A prospective study of aspirin use and the risk for colorectal adenoma. Ann. Intern. Med. 140: 157-166 (2004). *
Chan C, Berthiaume F, Nath BD, Tilles AW, Toner M, Yarmush ML. Hepatic tissue engineering for adjunct and temporary liver support: critical technologies. Liver Transpl. 10: 1331-1342 (2004). *
Chan CC, Reed GF, Kim Y, Agron E, Buggage RR. A correlation of pregnancy term, disease activity, serum female hormones, and cytokines in uveitis. Br. J. Ophthalmol. 88: 1506-1509 (2004). *
Chan CW, Carpenter JR, Rigamonti C, Gunsar F, Burroughs AK. Survival following the development of ascites and/or oedema in primary biliary cirrhosis: a stage prognostic model. Gut 53: A84 (2004).
Chan CW, Gunsar F, Feudjo M, Rigamonti C, Vlachogiannakos Y, Carpenter JR, Burroughs AK. Long term ursodeoxycholic acid treatment for primary biliary cirrhosis: a 12 year follow up. Gut 53: A84 (2004).
Chan DC, Watts GF, Barrett PH, Whitfield AJ, Van Bockxmeer FM. ATP-binding cassette transporter G8 gene as a determinant of apolipoprotein B-100 kinetics in overweight men. Arterioscler. Thromb. Vasc. Biol. 24: 2188-2191 (2004). *
Chan FK, Hung LC, Suen BY, Wong VW, Hui AJ, Wu JC, Leung WK, Lee YT, To KF, Chung SC, Sung JJ. Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial. Gastroenterology 127: 1038-1043 (2004). *
Chan J, Flynn J. The immunological aspects of latency in tuberculosis. Clin. Immunol. 110: 2-12 (2004).
Chan JL, Davis-Reed L, Kimball AB. Counter-regulatory balance: atopic dermatitis in patients undergoing infliximab infusion therapy. J. Drugs Dermatol. 3: 315-318 (2004).
Chan PC, Chen HL, Ni YH, Hsu HY, Chang LY, Lee PI, Chang MH. Outcome predictors of fulminant hepatic failure in children. J. Formos. Med. Assoc. 103: 432-436 (2004).
Chan SC, Liu CL, Lo CM, Fan ST. Applicability of histidine-tryptophan-ketoglutarate solution in right lobe adult-to-adult live donor liver transplantation. Liver Transpl. 10: 1415-1421 (2004). *
Chandak GR, Idris MM, Reddy DN, Mani KR, Bhaskar S, Rao GV, Singh L. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis. Gut 53: 723-728 (2004). *
Chande N, McDonald J, MacDonald J. Interventions for treating collagenous colitis. Cochrane Database Syst. Rev. 1: CD003575 (2004). *
Chande N, McDonald JW, Macdonald JK. Interventions for treating collagenous colitis: a Cochrane inflammatory bowel disease group systematic review of randomized trials. Am. J. Gastroenterol. 99: 2459-2465 (2004). *
Chandra P, Brouwer KL. The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm. Res. 21: 719-735 (2004). *
Chandra RK. Micronutrients, probiotics and the liver. J. Gastroenterol. Hepatol. 19: S398-S400 (2004). *
Chang CI, Pili-Floury S Se, Herve M, Parquet C, Chelliah Y, Lemaitre B, Mengin-Lecreulx D, Deisenhofer J. A Drosophila pattern recognition receptor contains a peptidoglycan docking groove and unusual L,D-carboxypeptidase activity. PLoS Biol. 2: E277 (2004). *
Chang JC, Cohen RD. Medical management of severe ulcerative colitis. Gastroenterol. Clin. North Am. 33: 235-250 (2004).
Chang M, Schroy PC 3rd. Endoscopic colorectal cancer screening-can supply meet demand? Gastroenterology 126: 1482-1485 (2004). *
Chang PY, Lu SC, Su TC, Chou SF, Huang WH, Morrisett JD, Chen CH, Liau CS, Lee YT. Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. J. Lipid Res. 45: 2116-2122 (2004). *
Chang YT, Shiao YM, Chin PJ, Liu YL, Chou FC, Wu S, Lin YF, Li LH, Lin MW, Liu HN, Tsai SF. Genetic polymorphisms of the HCR gene and a genomic segment in close proximity to HLA-C are associated with patients with psoriasis in Taiwan. Br. J. Dermatol. 150: 1104-1111 (2004). *
Chapat L, Chemin K, Dubois B, Bourdet-Sicard R, Kaiserlian D. Lactobacillus casei reduces CD8(+) T cell-mediated skin inflammation. Eur. J. Immunol. 34: 2520-2528 (2004). *
Chapelon-Abric C. Epidemiology of sarcoidosis and its genetic and environmental risk factors. Rev. Med. Interne. 25: 494-500 (2004).
Chapman NH, Igo RP, Thomson JB, Matsushita M, Brkanac Z, Holzman T, Berninger VW, Wijsman EM, Raskind WH. Linkage analyses of four regions previously implicated in dyslexia: confirmation of a locus on chromosome 15q. Am. J. Med. Genet. 131B: 67-75 (2004). *
Chapman RW. Novel approaches to the treatment of primary sclerosing cholangitis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 72-73 (2004). *
Chapman RW. High dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 75. June 18-19 (2004). *
Charagundla SR, Levine MS, Torigian DA, Campbell MS, Furth EE, Rombeau J. Diffuse intestinal ganglioneuromatosis mimicking Crohn's disease. AJR Am. J. Roentgenol. 182: 1166-1168 (2004). *
Charakida A, Mouser PE, Chu AC. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin. Drug Saf. 3: 119-129 (2004). *
Charizopoulou N, Jansen S, Dorsch M, Stanke F, Dorin JR, Hedrich HJ, Tummler B. Instability of the insertional mutation in CftrTgH(neoim)Hgu cystic fibrosis mouse model. BMC Genet. 5: 6 (2004). *
Charrow J. Ashkenazi Jewish genetic disorders. Fam. Cancer 3: 201-206 (2004). *
Chassaing N, Martin L, Mazereeuw J, Barrie L, Nizard S, Bonafe JL, Calvas P, Hovnanian A. Novel ABCC6 mutations in pseudoxanthoma elasticum. J. Invest. Dermatol. 122: 608-613 (2004). *
Chatauret N, Butterworth RF. Effects of liver failure on inter-organ trafficking of ammonia: implications for the treatment of hepatic encephalopathy J. Gastroenterol. Hepatol. 19: S219-S223 (2004). *
Chatzicostas C, Drygiannakis D, Koutroubakis I, Niniraki M, Petinaki E, Koulentaki M, Dimoulios P, Kouroumalis E. Increased prevalence of IgM anticardiolipin antibodies in patients with primary biliary cirrhosis. Gut 53: A83-A84 (2004).
Chaudhuri A, Behan PO. Multiple sclerosis is not an autoimmune disease. Arch. Neurol. 61: 1610-1612 (2004). *
Chaudhuri J, Alt FW. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 4: 541-552 (2004). *
Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 127: 1356-1371 (2004). *
Chavanas S, Mechin MC, Takahara H, Kawada A, Nachat R, Serre G, Simon M. Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. Gene 330: 19-27 (2004). *
Chazouilleres O. Primary sclerosing cholangitis and biliary malignancy: a glimmer of hope? J. Hepatol. 40: 857-859 (2004). *
Che T, You Y, Wang D, Tanner MJ, Dixit VM, Lin X. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation. J. Biol. Chem. 279: 15870-15876 (2004). *
Chebli JM, Gaburri PD, Meirelles De Souza AF, Pereira Da Silva CE, Pinto JR, Felga GE. Benign intracranial hypertension during corticosteroid therapy for idiopathic ulcerative colitis: another indication for cyclosporine? J. Clin. Gastroenterol. 38: 827-828 (2004).
Cheema SR, Arif F, Charney D, Meisels IS, Cheema SS. IgA-dominant glomerulonephritis associated with hepatitis A. Clin. Nephrol. 62: 138-143 (2004).
Cheetham GM. Novel protein kinases and molecular mechanisms of autoinhibition. Curr. Opin. Struct. Biol. 14: 700-705 (2004). *
Cheifetz A, Itzkowitz S. The diagnosis and treatment of pouchitis in inflammatory bowel disease. J. Clin. Gastroenterol. 38: S44-S50 (2004).
Cheifetz AS. You say goodbye and I say aloe. Inflamm. Bowel Dis. 10: 693-695 (2004). *
Chemmanur AT, Bonkovsky HL. Hepatic porphyrias: diagnosis and management. Clin. Liver Dis. 8: 807-838, viii (2004).
Chen C, Zhang J, Li J, Huang J, Yang C, Huang G, Shi J. Hydrodynamic-based in vivo transfection of retinoic X receptor-alpha gene can enhance vitamin A-induced attenuation of liver fibrosis in mice. Liver Int. 24: 679-686 (2004). *
Chen CH, Ho MC, Lee PH, Chang MH, Jeng YM, Ni YH. A child with primary sclerosing cholangitis successfully treated by liver transplantation. Acta Paediatr. Taiwan 45: 239-241 (2004).
Chen CJ, Ho TY, Lu JJ, Sheu LF, Lee SY, Tien CH, Cheng SN. Identical twin brothers concordant for Langerhans' cell histiocytosis and discordant for Epstein-Barr virus-associated haemophagocytic syndrome. Eur. J. Pediatr. 163: 536-569 (2004). *
Chen CM, Gong Y, Zhang M, Chen JJ. Reciprocal cross talk between Nod2 and TAK1 signaling pathways. J. Biol. Chem. 279: 25876-25882 (2004). *
Chen CS, Roberton D, Hammerton ME. Juvenile arthritis-associated uveitis: visual outcomes and prognosis. Can. J. Ophthalmol. 39: 614-620 (2004).
Chen CY, Tsao PN, Chen HL, Chou HC, Hsieh WS, Chang MH. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. J. Pediatr. 145: 317-321 (2004). *
Chen EY, Bartlett MC, Loo TW, Clarke DM. The DeltaF508 mutation disrupts packing of the transmembrane segments of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 279: 39620-39627 (2004). *
Chen F. Endogenous inhibitors of nuclear factor-kappaB, an opportunity for cancer control. Cancer Res. 64: 8135-8138 (2004). *
Chen F, Ananthanarayanan M, Emre S, Neimark E, Bull LN, Knisely As A, Strautnieks SS, Thompson RJ, Magid MS, Gordon R, Balasubramanian N, Suchy FJ, Shneider BL. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 126: 756-764 (2004). *
Chen F, Wollmer MA, Hoerndli F, Munch G, Kuhla B, Rogaev EI, Tsolaki M, Papassotiropoulos A, Gotz J. Role for glyoxalase I in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101: 7687-7692 (2004). *
Chen G, Li J, Ochani M, Rendon-Mitchell B, Qiang X, Susarla S, Ulloa L, Yang H, Fan S, Goyert SM, Wang P, Tracey KJ, Sama AE, Wang H. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J. Leukoc. Biol. 76: 994-1001 (2004). *
Chen G, Liang G, Ou J, Goldstein JL, Brown MS. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. U.S.A. 101: 11245-11250 (2004). *
Chen G, Ward MF, Sama AE, Wang H. Extracellular HMGB1 as a proinflammatory cytokine. J. Interferon Cytokine Res. 24: 329-333 (2004).
Chen GH, Yang Y, Lu MQ, Cai CJ, He XS, Zhu XF, Xu C, Li H, Huang JF. Liver transplantation for hepatocellular carcinoma: a report of 60 cases. Zhonghua Wai Ke Za Zhi 42: 413-416 (2004).
Chen H, Liu LL, Ye LL, McGuckin C, Tamowski S, Scowen P, Tian H, Murray K, Hatton WJ, Duan D. Targeted inactivation of cystic fibrosis transmembrane conductance regulator chloride channel gene prevents ischemic preconditioning in isolated mouse heart. Circulation 110: 700-704 (2004). *
Chen HW, Zhen ZJ, Su SY, Xu ZM, Fei L, Ji Y. Clinical experience with 13 cases of orthotopic liver transplantation. Di Yi Jun Yi Da Xue Xue Bao 24: 445-447 (2004).
Chen J, Kyte C, Valcin M, Chan W, Wetmur JG, Selhub J, Hunter DJ, Ma J. Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int. J. Cancer 110: 617-620 (2004). *
Chen J, Liu C. Methotrexate for ankylosing spondylitis. Cochrane Database Syst. Rev. 3: CD004524 (2004).
Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4: 336-347 (2004). *
Chen L, Zeng Y, Yang H, Lee TD, French SW, Corrales FJ, Garcia-Trevijano ER, Avila MA, Mato JM, Lu SC. Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A. FASEB J. 18: 914-916 (2004). *
Chen M, Abele R, Tampe R. Functional non-equivalence of ABC signature motifs in the transporter associated with antigen processing (TAP). J. Biol. Chem. 279: 46073-46081 (2004). *
Chen M, Aosai F, Norose K, Mun HS, Ishikura H, Hirose S, Piao LX, Fang H, Yano A. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice. Int. Immunol. 16: 937-946 (2004). *
Chen M, Crowson AN, Woofter M, Luca MB, Magro CM. Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases. J. Rheumatol. 31: 818-820 (2004).
Chen QB, Fan LY, Zhong RQ, Tu XQ, Yuan Y, Zhu Y, Ye WM, Lu HQ, Han HX. A study on the relationship between interleukin-10 promoter polymorphism and autoimmune liver disease. Zhonghua Gan Zang Bing Za Zhi 12: 356-358 (2004).
Chen RH, Chen WC, Chen CC, Tsai CH, Tsai FJ. Association between the TAP1 gene codon 637 polymorphism and Graves' disease. Endocrine 25: 137-140 (2004).
Chen S, Ho C, Feng D, Chi Z. Tracer kinetic modeling of 11C-acetate applied in the liver with positron emission tomography. IEEE Trans. Med. Imaging 23: 426-432 (2004).
Chen SY, Lin JR, Darbha R, Lin P, Liu TY, Chen YM. Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway. Cancer Res. 64: 3617-3623 (2004). *
Chen VK, Arguedas MR, Kilgore ML, Eloubeidi MA. A cost-minimization analysis of alternative strategies in diagnosing pancreatic cancer. Am. J. Gastroenterol. 99: 2223-2234 (2004). *
Chen VK, Eloubeidi MA. Endoscopic ultrasound-guided fine needle aspiration is superior to lymph node echofeatures: a prospective evaluation of mediastinal and peri-intestinal lymphadenopathy. Am. J. Gastroenterol. 99: 628-633 (2004). *
Chen W, Gluud C. Bile acids for liver transplanted patients. Cochrane Database Syst. Rev. 2: CD004384 (2004). *
Chen WD, Gluud C. Glucocorticosteroids for primary sclerosing cholangitis. Cochrane Database Syst. Rev. 3: CD004036 (2004). *
Chen X, Jensen PE. The expression of HLA-DO (H2-O) in B lymphocytes. Immunol. Res. 29: 19-28 (2004). *
Chen X, Krakauer T, Oppenheim JJ, Howard OM. Yin zi huang, an injectable multicomponent Chinese herbal medicine, is a potent inhibitor of T-cell activation. J. Altern. Complement. Med. 10: 519-526 (2004).
Chen X, Liang H, Van Remmen H, Vijg J, Richardson A. Catalase transgenic mice: characterization and sensitivity to oxidative stress. Arch. Biochem. Biophys. 422: 197-210 (2004). *
Chen X, Oppenheim JJ, Howard OM. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components. Cell. Mol. Immunol. 1: 336-342 (2004). *
Chen X, Wolin SL. The Ro 60 kDa autoantigen: insights into cellular function and role in autoimmunity. J. Mol. Med. 82: 232-239 (2004).
Chen Y, Altenberg GA, Reuss L. Mechanism of activation of Xenopus CFTR by stimulation of PKC. Am. J. Physiol. Cell Physiol. 287: C1256-C1263 (2004). *
Chen Y, Button B, Altenberg GA, Reuss L. Potentiation of the effect of PKA stimulation of Xenopus CFTR by activation of PKC: role of NBD2. Am. J. Physiol. Cell Physiol. 287: C1436-C1444 (2004). *
Chen Y, Chong MM, Darwiche R, Thomas HE, Kay TW. Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency. Am. J. Pathol. 165: 913-921 (2004). *
Chen Y, Ferguson SS, Negishi M, Goldstein JA. Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor. J. Pharmacol. Exp. Ther. 308: 495-501 (2004). *
Chen Y, Gan H, Ouyang Q, Xu D, Pan Y. The effects of anti-inflammatory on activation of nuclear factor-kappaB and expression of cell adhesion molecules in patients with ulcerative colitis. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 21: 732-736 (2004).
Chen Y, Hu X, Wei LN. Molecular interaction of retinoic acid receptors with coregulators PCAF and RIP140. Mol. Cell. Endocrinol. 226: 43-50 (2004).
Chen ZQ, Annilo T, Shulenin S, Dean M. Three ATP-binding cassette transporter genes, Abca14, Abca15, and Abca16, form a cluster on mouse chromosome 7F3. Mamm. Genome 15: 335-343 (2004). *
Cheng G, An F, Zou MJ, Sun J, Hao XH, He YX. Time- and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid. World J. Gastroenterol. 10: 1769-1774 (2004). *
Cheng J, Zhang Y, Li Q. Real-time PCR genotyping using displacing probes. Nucleic Acids Res. 32: e61 (2004). *
Cheng JB, Motola DL, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Identification and characterization of CYP2R1, a microsomal vitamin D 25-hydroxylase. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 21. June 18-19 (2004). *
Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. U.S.A. 101: 7711-7715 (2004). *
Cheng L, Enomoto T, Hirota T, Shimizu M, Takahashi N, Akahoshi M, Matsuda A, Dake Y, Doi S, Enomoto K, Yamasaki A, Fukuda S, Mao XQ, Hopkin JM, Tamari M, Shirakawa T. Polymorphisms in ADAM33 are associated with allergic rhinitis due to Japanese cedar pollen. Clin. Exp. Allergy 34: 1192-1201 (2004). *
Cheng Y, Ohlsson L, Duan RD. Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice. Br. J. Nutr. 91: 715-723 (2004). *
Cheng YF, Chen CL, Huang TL, Chen TY, Chen YS, Takatsuki M, Wang CC, Chiu KW, Tsang LL, Sun PL, Jawan B. Risk factors for intraoperative portal vein thrombosis in pediatric living donor liver transplantation. Clin. Transplant. 18: 390-394 (2004).
Cheng YF, Chen CL, Huang TL, Chen TY, Chen YS, Wang CC, Tsang LL, Chiu KW, Jawan B, Eng HL. 3DCT angiography for detection of vascular complications in pediatric liver transplantation. Liver Transpl. 10: 248-252 (2004). *
Cherian S, Singh P. Is routine ileoscopy useful? An observational study of procedure times, diagnostic yield, and learning curve. Am. J. Gastroenterol. 99: 2324-2329 (2004). *
Chermesh I, Eliakim R. Mesalazine-induced reversible infertility in a young male. Dig. Liver Dis. 36: 551-552 (2004).
Chernajovsky Y, Gould DJ, Podhajcer OL. Gene therapy for autoimmune diseases: quo vadis? Nat. Rev. Immunol. 4: 800-811 (2004). *
Chernavsky AC, Paladino N, Rubio AE, De Biasio MB, Periolo N, Cuarterolo M, Goni J, Galoppo C, Canero-Velasco MC, Munoz AE, Fainboim H, Fainboim L. Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children. Hum. Immunol. 65: 683-691 (2004).
Cheroutre H. Starting at the beginning: new perspectives on the biology of mucosal T cells. Annu. Rev. Immunol. 22: 217-246 (2004). *
Cheroutre H, Madakamutil L. Acquired and natural memory T cells join forces at the mucosal front line. Nat. Rev. Immunol. 4: 290-300 (2004). *
Cherrington NJ, Slitt AL, Li N, Klaassen CD. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab. Dispos. 32: 734-741 (2004). *
Cheung C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C, Gonzalez FJ. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha. Cancer Res. 64: 3849-3854 (2004). *
Cheung J, Scudamore CH, Yoshida EM. Management of polycystic liver disease. Can. J. Gastroenterol. 18: 666-670 (2004).
Chevalier E, Petoux F, Chovet M, Langlois A. Beneficial effect of trimebutine and N-monodesmethyl trimebutine on trinitrobenzene sulfonic acid-induced colitis in rats. Life Sci. 76: 319-329 (2004). *
Chey WD, Chey WY, Heath AT, Dukes GE, Carter EG, Northcutt A, Ameen VZ. Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome. Am. J. Gastroenterol. 99: 2195-2203 (2004). *
Chez MG, Chin K, Hung PC. Immunizations, immunology, and autism. Semin. Pediatr. Neurol. 11: 214-217 (2004).
Chi T. A BAF-centred view of the immune system. Nat. Rev. Immunol. 4: 965-977 (2004). *
Chiang JY. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J. Hepatol. 40: 539-551 (2004). *
Chiang JYL, Li T, Jahan A. Mechanisms of bile acid inhibition of genes in bile acid synthesis. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 23. June 18-19 (2004). *
Chiang N, Bermudez EA, Ridker PM, Hurwitz S, Serhan CN. Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc. Natl. Acad. Sci. U.S.A. 101: 15178-15183 (2004). *
Chiba T, Goto S, Yokosuka O, Imazeki F, Tanaka M, Fukai K, Takahashi Y, Tsujimura H, Saisho H. Fatal chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis. Eur. J. Gastroenterol. Hepatol. 16: 225-228 (2004).
Chiba T, Yokosuka O, Arai M, Tada M, Fukai K, Imazeki F, Kato M, Seki N, Saisho H. Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. J. Hepatol. 41: 436-445 (2004). *
Chicharro JL, Hoyos J, Gomez-Gallego F, Villa JG, Bandres F, Celaya P, Jimenez F, Alonso JM, Cordova A, Lucia A. Mutations in the hereditary haemochromatosis gene HFE in professional endurance athletes. Br. J. Sports Med. 38: 418-421 (2004). *
Chignard N, Beretta L. Proteomics for hepatocellular carcinoma marker discovery. Gastroenterology 127 (5 Suppl. 2): S120-S125 (2004). *
Chin J. Intestinal microflora: negotiating health outcomes with the warring community within us. Asia Pac. J. Clin. Nutr. 13: S24-S25 (2004).
Chinen J, Shearer WT. Advances in asthma, allergy and immunology series 2004: basic and clinical immunology. J. Allergy Clin. Immunol. 114: 398-405 (2004). *
Chinetti G, Zawadski C, Fruchart JC, Staels B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem. Biophys. Res. Commun. 314: 151-158 (2004). *
Chistiakov DA, Savost'anov KV, Shestakova MV, Chugunova LA, Samkhalova MSh, Dedov II, Nosikov VV. Confirmation of a susceptibility locus for diabetic nephropathy on chromosome 3q23-q24 by association study in Russian type 1 diabetic patients. Diabetes Res. Clin. Pract. 66: 79-86 (2004).
Chistiakov DA, Savost'anov KV, Turakulov RI. Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study. Mol. Genet. Metab. 83: 264-270 (2004). *
Chistiakov DA, Savost'anov KV, Turakulov RI, Titovich EV, Zilberman LI, Kuraeva TL, Dedov II, Nosikov VV. A new type 1 diabetes susceptibility locus containing the catalase gene (chromosome 11p13) in a Russian population. Diabetes Metab. Res. Rev. 20: 219-224 (2004).
Chistiakov DA, Seryogin Y, Savost'anov KV, Zilberman LI, Titovich EV, Kuraeva TL, Dedov II, Nosikov VV. Evidence for a type 1 diabetes susceptibility locus (IDDM10) on chromosome 10p11-q11 in a Russian population. Scand. J. Immunol. 60: 316-323 (2004). *
Chitkara DK, Bredenoord AJ, Cremonini F, Delgado-Aros S, Smoot RL, El-Youssef M, Freese D, Camilleri M. The role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipation. Am. J. Gastroenterol. 99: 1579-1584 (2004). *
Chloupkova M, Reaves SK, LeBard LM, Koeller DM. The mitochondrial ABC transporter Atm1p functions as a homodimer. FEBS Lett. 569: 65-69 (2004). *
Chlumska A, Benes Z, Mukensnabl P. Ulcerative colitis - contemporary morphological criteria. Cesk. Patol. 40: 154-158 (2004).
Cho JH. Advances in the genetics of inflammatory bowel disease. Curr. Gastroenterol. Rep. 6: 467-473 (2004).
Cho JJ, Joseph B, Sappal BS, Giri RK, Wang R, Ludlow JW, Furth ME, Susick R, Gupta S. Analysis of the functional integrity of cryopreserved human liver cells including xenografting in immunodeficient mice to address suitability for clinical applications. Liver Int. 24: 361-370 (2004). *
Cho ML, Yoon CH, Hwang SY, Park MK, Min SY, Lee SH, Park SH, Kim HY. Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts. Arthritis Rheum. 50: 776-784 (2004). *
Cho SM, Kim J, Ryu HJ, Kim JJ, Kim HH, Park JH, Kim HT, Kim KH, Cho HY, Oh B, Park C, Kimm K, Jo I, Lee JE, Shin HD, Lee JK. Identification of single nucleotide polymorphisms in the tumor necrosis factor (TNF) and TNF receptor superfamily in the Korean population. Hum. Immunol. 65: 710-718 (2004).
Cho WK, Siegrist VJ, Zinzow W. Impaired regulatory volume decrease in freshly isolated cholangiocytes from cystic fibrosis mice: implications for cystic fibrosis transmembrane conductance regulator effect on potassium conductance. J. Biol. Chem. 279: 14610-14618 (2004). *
Cho WS, Chae C. Expression of cyclooxygenase-2 and nitric oxide synthase 2 in swine ulcerative colitis caused by Salmonella typhimurium. Vet. Pathol. 41: 419-423 (2004). *
Cho Y, Lew BL, Seong K, Kim NI. An inverse relationship between ceramide synthesis and clinical severity in patients with psoriasis. J. Korean Med. Sci. 19: 859-863 (2004). *
Choda Y, Morimoto Y, Miyaso H, Shinoura S, Saito S, Yagi T, Iwagaki H, Tanaka N. Failure of the gut barrier system enhances liver injury in rats: protection of hepatocytes by gut-derived hepatocyte growth factor. Eur. J. Gastroenterol. Hepatol. 16: 1017-1025 (2004).
Choi J, Enis DR, Koh KP, Shiao SL, Pober JS. T lymphocyte-endothelial cell interactions. Annu. Rev. Immunol. 22: 683-709 (2004). *
Cholongitas E, Mavrogiannaki A, Papaioannou C, Karagiannis S, Papatheodoridis GV. Pericarditis and possible antiphospholipid syndrome on primary biliary cirrhosis. Ann. Hepatol. 3: 167-168 (2004). *
Chong AJ, Shimamoto A, Hampton CR, Takayama H, Spring DJ, Rothnie CL, Yada M, Pohlman TH, Verrier ED. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J. Thorac. Cardiovasc. Surg. 128: 170-179 (2004). *
Chong L, McDonald H, Strauss AE. Deconstructing aging. Science 305: 1419 (2004). *
Chong WP, Ip WK, Wong WH, Lau CS, Chan TM, Lau YL. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun. 5: 484-492 (2004). *
Choquet A, Yamamoto-Furusho JK, Reyes E, Takahashi-Monroy T, Vargas-Vorackova F, Uscanga L. Predictors of colectomy in patients with ulcerative colitis. A cohort analysis of 184 cases. Rev. Invest. Clin. 56: 11-15 (2004).
Choudari CP, Imperiale TF, Sherman S, Fogel E, Lehman GA. Risk of pancreatitis with mutation of the cystic fibrosis gene. Am. J. Gastroenterol. 99: 1358-1363 (2004). *
Choudhury J, Sanyal AJ. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 575-594, ix (2004).
Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin. Liver Dis. 24: 349-362 (2004).
Chowers Y, Odes S, Bujanover Y, Eliakim R, Bar Meir S, Avidan B. The month of birth is linked to the risk of Crohn's disease in the Israeli population. Am. J. Gastroenterol. 99: 1974-1976 (2004). *
Christen U, von Herrath MG. Factors that determine enhancement versus abrogation of autoimmunity by viral infections. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 20 (2004). *
Christen U, Edelmann KH, McGavern DB, Wolfe T, Coon B, Teague MK, Miller SD, Oldstone MB, von Herrath MG. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J. Clin. Invest. 114: 1290-1298 (2004). *
Christen U, von Herrath MG. Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol. Immunol. 40: 1113-1120 (2004). *
Christen U, von Herrath MG. Initiation of autoimmunity. Curr. Opin. Immunol. 16: 759-767 (2004). *
Christensen E. Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC): which treatments are of value? [http://www.easl.ch/PGC/Erik%20Christensen.pdf] (2004). *
Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores - where are we and where should we go? J. Hepatol. 41: 344-350 (2004). *
Christians U. Transport proteins and intestinal metabolism: P-glycoprotein and cytochrome P4503A. Ther. Drug Monit. 26: 104-106 (2004).
Christman AK, Fermo JD, Markowitz JS. Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder. Pharmacotherapy 24: 1020-1036 (2004).
Chu R, Lim H, Brumfield L, Liu H, Herring C, Ulintz P, Reddy JK, Davison M. Protein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activation. Mol. Cell. Biol. 24: 6288-6297 (2004). *
Chu ZT, Tsuchiya N, Kyogoku C, Ohashi J, Qian YP, Xu SB, Mao CZ, Chu JY, Tokunaga K. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens 63: 21-27 (2004). *
Chua AC, Olynyk JK, Leedman PL, Trinder D. Nontransferrin-bound iron uptake by hepatocytes is increased in the Hfe knockout mouse model of hereditary hemochromatosis. Blood 104: 1519-1525 (2004). *
Chuang FR, Lin CC, Wang PH, Cheng YF, Hsu KT, Chen YS, Lee CH, Chen CL. Acute renal failure after cadaveric related liver transplantation. Transplant. Proc. 36: 2328-2330 (2004). *
Chuang JH, Wang PW, Tai MH. An adipocentric view of liver fibrosis and cirrhosis. Chang Gung Med. J. 27: 855-868 (2004).
Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, Amad M, White JA, Petkovich M, Jones G, Korczak B. CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids. J. Biol. Chem. 279: 6305-6314 (2004). *
Chuma M, Sakamoto M, Yasuda J, Fujii G, Nakanishi K, Tsuchiya A, Ohta T, Asaka M, Hirohashi S. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J. Hepatol. 41: 629-636 (2004). *
Chun KS, Surh YJ. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 68: 1089-1100 (2004). *
Chung TW, Moon SK, Chang YC, Ko JH, Lee YC, Cho G, Kim SH, Kim JG, Kim CH. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 18: 1670-1681 (2004). *
Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428: 486 (2004). *
Churchill GA, Airey DC, Allayee H, Angel JM, Attie AD, Beatty J, Beavis WD, Belknap JK, Bennett B, Berrettini W, Bleich A, Bogue M, Broman KW, Buck KJ, Buckler E, Burmeister M, Chesler EJ, Cheverud JM, Clapcote S, Cook MN, Cox RD, et al. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat. Genet. 36: 1133-1137 (2004). *
Chutkan R. Video capsule endoscopy in IBD. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 54. May 7-8 (2004). *
Ciarimboli G, Struwe K, Arndt P, Gorboulev V, Koepsell H, Schlatter E, Hirsch JR. Regulation of the human organic cation transporter hOCT1. J. Cell. Physiol. 201: 420-428 (2004). *
Cicchillo RM, Iwig DF, Jones AD, Nesbitt NM, Baleanu-Gogonea C, Souder MG, Tu L, Booker SJ. Lipoyl synthase requires two equivalents of S-adenosyl-L-methionine to synthesize one equivalent of lipoic acid. Biochemistry 43: 6378-6386 (2004). *
Cicchillo RM, Lee KH, Baleanu-Gogonea C, Nesbitt NM, Krebs C, Booker SJ. Escherichia coli lipoyl synthase binds two distinct [4Fe-4S] clusters per polypeptide. Biochemistry 43: 11770-11781 (2004). *
Cihakova D, Sharma RB, Fairweather D, Afanasyeva M, Rose NR. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol. Med. 102: 175-194 (2004).
Cima RR, Pemberton JH. Surgical indications and procedures in ulcerative colitis. Curr. Treat. Options Gastroenterol. 7: 181-190 (2004).
Cima RR, Pemberton JH. Early surgical intervention in ulcerative colitis. Gut 53: 306-307 (2004). *
Cimaz R. Any increased risk of autoimmune disease? Lupus 13: 736-739 (2004).
Cinek O, Drevinek P, Sumnik Z, Bendlova B, Vavrinec J. Association of insulin gene variants with type 1 diabetes mellitus in Czech population. Cas. Lek. Cesk. 143: 318-322 (2004).
Cinek O, Vavrincova P, Striz I, Drevinek P, Sedlakova P, Vavrinec J, Slavcev A. Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J. Rheumatol. 31: 1206-1210 (2004).
Cioffi M, Riegler G, Vietri MT, Pilla P, Caserta L, Carratu R, Sica V, Molinari AM. Serum p53 antibodies in patients affected with ulcerative colitis. Inflamm. Bowel Dis. 10: 606-611 (2004). *
Cisse A, Morel Y, Coulibaly M, Souare IS, Cisse AF, Nabe A, Camara LM, Cisse B, Camara S, Bangoura SA, Sylla A, Dia H, Da Silva L. Wilson's disease: study of 6 neurologic forms observed at the University Hospital in Conakry. Med. Trop. (Mars.) 64: 53-57 (2004).
Ciulla A, Tomasello G, Urso G, Sanzo A, Maiorana A, Castronovo G, Damiani S. Abrikossoff's tumour: report of a rare case in anal perianal region. Ann. Ital. Chir. 75: 87-89 (2004).
Clark BS, Chang IF, Karpen SJ, Herrera L, Scott JD, Bristow LJ, Quiros-Tejeira RE, Goss JA. Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients. Transplantation 77: 1480 (2004).
Clark D. Human herpesvirus type 6 and multiple sclerosis. Herpes 11 Suppl. 2: 112A-119A (2004). *
Clark VJ, Dean M. Haplotype structure and linkage disequilibrium in chemokine and chemokine receptor genes. Hum. Genomics 1: 255-273 (2004).
Clark VJ, Dean M. Characterisation of SNP haplotype structure in chemokine and chemokine receptor genes using CEPH pedigrees and statistical estimation. Hum. Genomics 1: 195-207 (2004).
Clarke D, Currie E, Madhavan K, Parks R, Garden O. Hepatic resection for benign non-cystic liver lesions. HPB (Oxford) 6: 115-119 (2004). *
Clarke GA, Bouchard G, Paigen B, Carey MC. Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse. Gut 53: 136-142 (2004). *
Clarke LL, Gawenis LR, Bradford EM, Judd LM, Boyle KT, Simpson JE, Shull GE, Tanabe H, Ouellette AJ, Franklin CL, Walker NM. Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G1050-G1058 (2004). *
Clarke N, Germain P, Altucci L, Gronemeyer H. Retinoids: potential in cancer prevention and therapy. Expert Rev. Mol. Med. 6: 1-23 (2004).
Clarke P. Urticaria. Aust. Fam. Physician 33: 501-503 (2004).
Clarke SD. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr. Opin. Lipidol. 15: 13-18 (2004).
Claudel T, Sturm E, Kuipers F, Staels B. The farnesoid X receptor: a novel drug target? Expert Opin. Investig. Drugs 13: 1135-1148 (2004).
Claustres M, Altieri JP, Guittard C, Templin C, Chevalier-Porst F, Des Georges M. Are p.I148T, p.R74W and p.D1270N cystic fibrosis causing mutations? BMC Med. Genet. 5: 19 (2004). *
Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab. Invest. 84: 282-291 (2004). *
Cleland LG, James MJ, Proudman SM. Food inflammation and the anti-inflammatory aspects of food. Asia Pac. J. Clin. Nutr. 13: S26 (2004).
Clemente MG, Musu MP, Troncone R, Volta U, Congia M, Ciacci C, Neri E, Not T, Maggiore G, Strisciuglio P, Corazza GR, Gasbarrini G, Cicotto L, Sole G, Fasano A, De Virgiliis S. Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study. Am. J. Gastroenterol. 99: 1551-1556 (2004). *
Clevers H. At the crossroads of inflammation and cancer. Cell 118: 671-674 (2004). *
Cline AM, Radic MZ. Apoptosis, subcellular particles, and autoimmunity. Clin. Immunol. 112: 175-182 (2004). *
Clough JD. Fish oil is no snake oil. Cleve. Clin. J. Med. 71: 174 (2004).
Clough JD. Fantastic voyage: the peeping pill. Cleve. Clin. J. Med. 71: 366 (2004). *
Coady-Fariborzian L, Angel LP, Procaccino JA. Perforated colon secondary to virtual colonoscopy: report of a case. Dis. Colon Rectum 47: 1247-1249 (2004). *
Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, Mose PL. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126: 1657-1664 (2004). *
Coates SW Jr, Hogenauer C, Santa Ana CA, Rosenblatt RL, Emmett M, Fordtran JS. Inhibition of neutral sodium absorption by a prostaglandin analogue in patients with cystic fibrosis. Gastroenterology 127: 65-72 (2004). *
Coatmeur O, Rassiat E, Bonniaud P, Jouve JL, Minello A, Bedenne L, Faivre J, Hillon P. Acute pseudo-angiocholitis due to colonic adenocarcinoma in a man with primary sclerosis cholangitis and ulcerative colitis. Ann. Med. Interne. (Paris) 154: 547-548 (2004).
Coccia EM, Severa M, Giacomini E, Monneron D, Remoli ME, Julkunen I, Cella M, Lande R, Uze G. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34: 796-805 (2004). *
Cocco E, Murru MR, Melis C, Schirru L, Solla E, Lai M, Rolesu M, Marrosu MG. PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients. J. Neurol. 251: 1085-1088 (2004). *
Cock TA, Houten SM, Auwerx J. Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm. EMBO Rep. 5: 142-147 (2004). *
Cocq P, Yazdanpannah Y, Mesnard B, Colombel JF. Anti-TNF therapeutic agents in inflammatory bowel disease: indications, side effects and management. Gastroenterol. Clin. Biol. 28: S61-S69 (2004).
Coffer PJ, Burgering BM. Forkhead-box transcription factors and their role in the immune system. Nat. Rev. Immunol. 4: 889-899 (2004). *
Coffey MJ, Ross L. Human subject protections in genetic research. Genet. Test. 8: 209-213 (2004).
Cogger VC, Muller M, Fraser R, McLean AJ, Khan J, Le Couteur DG. The effects of oxidative stress on the liver sieve. J. Hepatol. 41: 370-376 (2004). *
Cohen IR. Functional immunomics and immune homeostasis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 21 (2004). *
Cohen IR, Quintana FJ, Mimran A. Tregs in T cell vaccination: exploring the regulation of regulation. J. Clin. Invest. 114: 1227-1232 (2004). *
Cohen J. Medicine. Microbicide shuts the door on HIV. Science 306: 387 (2004). *
Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305: 869-872 (2004). *
Cohen JC, Lundblad LK, Bates JH, Levitzky M, Larson JE. The "Goldilocks effect" in cystic fibrosis: identification of a lung phenotype in the cftr knockout and heterozygous mouse. BMC Genet. 5: 21 (2004). *
Cohen JD, Zaltni S, Kaiser MJ, Bozonnat MC, Jorgensen C, Daures JP, Sany J. Secondary addition of methotrexate to partial responders to etanercept alone is effective in severe rheumatoid arthritis. Ann. Rheum. Dis. 63: 209-210 (2004). *
Cohen LB. Re: Disappearance of Crohn's ulcers in the terminal ileum after thalidomide therapy. Can J Gastroenterol 2004; 18(2): 101-104. Can. J. Gastroenterol. 18: 419 (2004).
Cohen RD. Mesalamine in IBD: multiple hats? Gastroenterology 127: 1001-1002 (2004). *
Cohen RD. Sperm, sex, and 6-MP: the perception on conception. Gastroenterology 127: 1263-1264 (2004). *
Cohen SL, Moore AM, Ward WE. Interleukin-10 knockout mouse: a model for studying bone metabolism during intestinal inflammation. Inflamm. Bowel Dis. 10: 557-563 (2004). *
Cohen SM, O'Connor AM, Hart J, Merel NH, Te HS. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause 11: 575-577 (2004).
Cohet C, Cheng S, MacDonald C, Baker M, Foliaki S, Huntington N, Douwes J, Pearce N. Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood. J. Epidemiol. Community Health 58: 852-857 (2004). *
Cohn JA, Mitchell RM, Jowell PS. The role of cystic fibrosis gene mutations in determining susceptibility to chronic pancreatitis. Gastroenterol. Clin. North Am. 33: 817-837, vii (2004).
Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22: 789-815 (2004). *
Cole CR, Bucuvalas JC, Hornung RW, Krug S, Ryckman FC, Atherton H, Alonso MP, Balistreri WF, Kotagal U. Impact of liver transplantation on HRQOL in children less than 5 years old. Pediatr. Transplant. 8: 222-227 (2004).
Cole DK, Gao GF. CD8: adhesion molecule, co-receptor and immuno-modulator. Cell. Mol. Immunol. 1: 81-88 (2004). *
Cole E, Deshpande R. The impact of cyclosporine on the development of immunosuppressive therapy: perspective from a transplant nephrologist involved with the development of C(2). Transplant. Proc. 36: S408-S413 (2004). *
Collantes R, Ong JP, Younossi ZM. Nonalcoholic fatty liver disease and the epidemic of obesity. Cleve. Clin. J. Med. 71: 657-664 (2004). *
Colle I, De Vriese AS, Van Vlierberghe H, Lameire NH, DeVos M. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients. Liver Int. 24: 63-68 (2004). *
Collett A, Tanianis-Hughes J, Warhurst G. Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions? Biochem. Pharmacol. 68: 783-790 (2004). *
Collin P, Maki M, Kaukinen K. It is the compliance, not milligrams of gluten, that is essential in the treatment of celiac disease. Nutr. Rev. 62: 490 (2004).
Collins FS. What we do and don't know about 'race', 'ethnicity', genetics and health at the dawn of the genome era. Nat. Genet. 36 (11 Suppl.): S13-S15 (2004). *
Collins JE, Heward JM, Howson JM, Foxall H, Carr-Smith J, Franklyn JA, Gough SC. Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United kingdom. J. Clin. Endocrinol. Metab. 89: 6336-6339 (2004). *
Collins JE, Heward JM, Nithiyananthan R, Nejentsev S, Todd JA, Franklyn JA, Gough SC. Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians. Clin. Endocrinol. (Oxf.) 60: 618-624 (2004). *
Collins JL. Therapeutic opportunities for liver X receptor modulators. Curr. Opin. Drug Discov. Devel. 7: 692-702 (2004).
Collins LV, Hajizadeh S, Holme E, Jonsson IM, Tarkowski A. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J. Leukoc. Biol. 75: 995-1000 (2004). *
Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin. Microbiol. Rev. 17: 348-369 (2004). *
Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A, Giovannini M, Perret C. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc. Natl. Acad. Sci. U.S.A. 101: 17216-17221 (2004). *
Colombel JF, Loftus EV Jr, Tremaine WJ, Egan LJ, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 126: 19-31 (2004). *
Colombel JF, Loftus EV Jr, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am. J. Gastroenterol. 99: 878-883 (2004). *
Colombel JF, Sandborn WJ. Development of fistulae in ileo-anal pouch does not necessarily indicate Crohn's disease: response. Am. J. Gastroenterol. 99: 2067 (2004). *
Colombo C, Battezzati PM. Liver involvement in cystic fibrosis: primary organ damage or innocent bystander? J. Hepatol. 41: 1041-1044 (2004). *
Colon AL, Madrigal JL, Menchen LA, Moro MA, Lizasoain I, Lorenzo P, Leza JC. Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats. Dig. Dis. Sci. 49: 1713-1721 (2004). *
Colquhoun P, Chen HC, Kim JI, Efron J, Weiss EG, Nogueras JJ, Vernava AM, Wexner SD. High compliance rates observed for follow up colonoscopy post polypectomy are achievable outside of clinical trials: efficacy of polypectomy is not reduced by low compliance for follow up. Colorectal Dis. 6: 158-161 (2004).
Comabella M, Altet L, Peris F, Villoslada P, Sanchez A, Montalban X. Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients. Mult. Scler. 10: 618-620 (2004). *
Combarros O, Infante J, Llorca J, Pena N, Fernandez-Viadero C, Berciano J. The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease. Neurosci. Lett. 366: 312-314 (2004). *
Combes B, Luketic VA, Peters MG, Zetterman RK, Garcia-Tsao G, Munoz SJ, Lin D, Flye N, Carithers RL Jr. Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. Am. J. Gastroenterol. 99: 264-268 (2004). *
Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics 113: 1573-1581 (2004). *
Comerford LW, Bickston SJ. Treatment of luminal and fistulizing Crohn's disease with infliximab. Gastroenterol. Clin. North Am. 33: 387-406 (2004).
Cominelli F. Cytokine-based therapies for Crohn's disease - new paradigms. N. Engl. J. Med. 351: 2045-2048 (2004). *
Conant SB, Swanborg RH. Autoreactive T cells persist in rats protected against experimental autoimmune encephalomyelitis and can be activated through stimulation of innate immunity. J. Immunol. 172: 5322-5328 (2004). *
Conde I, Paniagua R, Fraile B, Ruiz A, Arenas MI. Expression of vitamin D3 receptor and retinoid receptors in human breast cancer: identification of potential heterodimeric receptors. Int. J. Oncol. 25: 1183-1191 (2004).
Cong Y, Liu C, Weaver CT, Elson CO. Early upregulation of T cell IL-10 production plays an important role in oral tolerance induction. Ann. N. Y. Acad. Sci. 1029: 319-320 (2004). *
Connell W. Pro: endoscopic surveillance minimizes the risk of cancer. Am. J. Gastroenterol. 99: 1631-1633 (2004). *
Conney AH. Tailoring cancer chemoprevention regimens to the individual. J. Cell. Biochem. 91: 277-286 (2004). *
Connor SJ, Paraskevopoulos N, Newman R, Cuan N, Hampartzoumian T, Lloyd AR, Grimm MC. CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease. Gut 53: 1287-1294 (2004). *
Constantin A, Dieude P, Lauwers-Cances V, Jamard B, Mazieres B, Cambon-Thomsen A, Cornelis F, Cantagrel A. Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis. Arthritis Rheum. 50: 742-747 (2004). *
Conti F, Dousset B, Cherruau B, Guerin C, Soubrane O, Houssin D, Calmus Y. Use of lidocaine metabolism to test liver function during the long-term follow-up of liver transplant recipients. Clin. Transplant. 18: 235-241 (2004).
Contos MJ, Choudhury J, Mills AS, Sanyal AJ. The histologic spectrum of nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 481-500 (2004).
Contreas G, Valletta E, Ulmi D, Cantoni S, Pinelli L. Screening of coeliac disease in north Italian children with type 1 diabetes: limited usefulness of HLA-DQ typing. Acta Paediatr. 93: 628-632 (2004).
Contu L, Orru S, Carcassi C, Giuressi E, Mulargia M, Cappai L, Valentini D, Lai S, Boero R, Masala MV, Aste N, Biggio P, Cottoni F, Cerimele D. A psoriasis vulgaris protective gene maps close to the HLA-C locus on the EH18.2-extended haplotype. Tissue Antigens 64: 43-57 (2004). *
Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5: 975-979 (2004). *
Cook MC. B cell biology, apoptosis, and autoantibodies to phospholipids. Thromb. Res. 114: 307-319 (2004). *
Cook S. Update on multiple sclerosis research. Rev. Neurol. Dis. 1: 37-40 (2004).
Cook SD. Multiple sclerosis. Rev. Neurol. Dis. 1: 51-52 (2004).
Cook SD. Does Epstein-Barr virus cause multiple sclerosis? Rev. Neurol. Dis. 1: 115-123 (2004).
Cook-Mills JM, Johnson JD, Deem TL, Ochi A, Wang L, Zheng Y. Calcium mobilization and RAC1 activation are required for VCAM-1-stimulated NADPH oxidase activity. Biochem. J. 378: 539-547 (2004). *
Cooke A, Zaccone P, Raine T, Phillips JM, Dunne DW. Infection and autoimmunity: are we winning the war, only to lose the peace? Trends Parasitol. 20: 316-321 (2004). *
Cooksey RC, Jouihan HA, Ajioka RS, Hazel MW, Jones DL, Kushner JP, McClain DA. Oxidative stress, beta cell apoptosis and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 145: 5305-5312 (2004). *
Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat. Rev. Immunol. 4: 978-988 (2004). *
Cooper GS, Koroukian SM. Geographic variation among medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am. J. Gastroenterol. 99: 1544-1550 (2004). *
Cooper GS, Parks CG. Occupational and environmental exposures as risk factors for systemic lupus erythematosus. Curr. Rheumatol. Rep. 6: 367-374 (2004).
Cooper ZN, Nelson RM, Ross LF. Certificates of confidentiality in research: rationale and usage. Genet. Test. 8: 214-220 (2004).
Cooray HC, Janvilisri T, van Veen HW, Hladky SB, Barrand MA. Interaction of the breast cancer resistance protein with plant polyphenols. Biochem. Biophys. Res. Commun. 317: 269-275 (2004). *
Cope AP, Feldmann M. Emerging approaches for the therapy of autoimmune and chronic inflammatory disease. Curr. Opin. Immunol. 16: 780-786 (2004).
Copeland BH, Aramide O, Wehbe S, Fitzgerald SM, Krishnaswamy G. Eosinophilia in a patient with cyclical vomiting: a case report. Clin. Mol. Allergy 2: 7 (2004). *
Coplan PM, Mitchnick M, Rosenberg ZF. Public health. Regulatory challenges in microbicide development. Science 304: 1911-1912 (2004). *
Coppin H, Ribouchon MT, Fontaine B, Edan G, Clanet M, Roth MP; French Multiple Sclerosis Genetics Group. A vulnerability locus to multiple sclerosis maps to 7p15 in a region syntenic to an EAE locus in the rat. Genes Immun. 5: 72-75 (2004). *
Copreni E, Penzo M, Carrabino S, Conese M. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis. Gene Ther. 11 Suppl. 1: S67-S75 (2004).
Coran AG, Rivosecchi M. Surgery for ulcerative colitis in children. Pediatr. Surg. Int. 20: 565-566 (2004). *
Corazza N, Brunner T, Buri C, Rihs S, Imboden MA, Seibold I, Mueller C. Transmembrane tumor necrosis factor is a potent inducer of colitis even in the absence of its secreted form. Gastroenterology 127: 816-825 (2004). *
Corbett K, Kelleher S, Rowland M, Daly L, Drumm B, Canny G, Greally P, Hayes R, Bourke B. Cystic fibrosis-associated liver disease: a population-based study. J. Pediatr. 145: 327-332 (2004). *
Cordoba J, Lopez-Hellin J, Planas M, Sabin P, Sanpedro F, Castro F, Esteban R, Guardia J. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J. Hepatol. 41: 38-43 (2004). *
Cordonnier-Pratt MM, Liang C, Wang H, Kolychev DS, Sun F, Freeman R, Sullivan R, Pratt LH. MAGIC database and interfaces: an integrated package for gene discovery and expression. Comp. Funct. Genomics 5: 268-275 (2004). *
Cormet-Boyaka E, Jablonsky M, Naren AP, Jackson PL, Muccio DD, Kirk KL. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation. Proc. Natl. Acad. Sci. U.S.A. 101: 8221-8226 (2004). *
Cornwell PD, De Souza AT, Ulrich RG. Profiling of hepatic gene expression in rats treated with fibric acid analogs. Mutat. Res. 549: 131-145 (2004).
Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chretien Y, Poupon RE, Poupon R. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. Liver Int. 24: 187-193 (2004). *
Correa PA, Gomez LM, Anaya JM. Polymorphism of TNF-alpha in autoimmunity and tuberculosis. Biomedica 24 Supp. 1: 43-51 (2004).
Correa PA, Tobon GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, Maldonado-Cocco JA, Anaya JM. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1. Biomedica 24: 140-152 (2004).
Corrieri-Baizeau C, Borel I, Cottin V, Vukusic S, Scoazec JY, Audigier JC, Boillot O, Dumortier J. Autoimmune hepatitis associated with multiple sclerosis. Gastroenterol. Clin. Biol. 28: 1186 (2004).
Cortes LM, Baltazar LM, Lopez-Cardona MG, Olivares N, Ramos C, Salazar M, Sandoval L, Lorenz MG, Chakraborty R, Paterson AD, Rivas F. HLA class II haplotypes in Mexican systemic lupus erythematosus patients. Hum. Immunol. 65: 1469-1476 (2004).
Cortes-Hernandez J, Fossati-Jimack L, Petry F, Loos M, Izui S, Walport MJ, Cook HT, Botto M. Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in mice. Eur. J. Immunol. 34: 3713-3722 (2004). *
Cortez-Pinto H, Ermelinda Camilo M. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Best Pract. Res. Clin. Gastroenterol. 18: 1089-1104 (2004).
Cortright DN, Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1. Eur. J. Biochem. 271: 1814-1819 (2004). *
Cosnes J. Understanding the opposite effects of smoking in IBD. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 48. May 7-8 (2004). *
Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract. Res. Clin. Gastroenterol. 18: 481-496 (2004).
Cosnes J, Nion-Larmurier I, Afchain P, Beaugerie L, Gendre JP. Gender differences in the response of colitis to smoking. Clin. Gastroenterol. Hepatol. 2: 41-48 (2004). *
Costa-Carvalho BT, Viana MA, Brunialti MK, Kallas EG, Salomao R. An imbalance of naive and memory/effector subsets and altered expression of CD38 on T lymphocytes in two girls with hyper-IgM syndrome. Clin. Exp. Immunol. 136: 291-296 (2004). *
Costello DJ, Walsh SL, Harrington HJ, Walsh CH. Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series. J. Neurol. Neurosurg. Psychiatry 75: 631-633 (2004). *
Cotler SJ, Kanji K, Keshavarzian A, Jensen DM, Jakate S. Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis. J. Clin. Gastroenterol. 38: 801-804 (2004).
Coulombe M, Gill RG. The immunobiology of pancreatic islet transplantation. Adv. Exp. Med. Biol. 552: 154-169 (2004).
Coulouarn C, Lefebvre G, Derambure C, Lequerre T, Scotte M, Francois A, Cellier D, Daveau M, Salier JP. Altered gene expression in acute systemic inflammation detected by complete coverage of the human liver transcriptome. Hepatology 39: 353-364 (2004). *
Couriel DR, Saliba R, Hicks K, Ippoliti C, De Lima MJ, Hosing C, Khouri I, Andersson B, Donato M, Gajewski J, Anderlini P, Kontoyiannis DP, Cohen A, Martin T, Giralt S, Champlin R. Tumor necrosis factor alpha blockade for the treatment of steroid-refractory acute GVHD. Blood 104: 649-654 (2004). *
Courselaud B, Troadec MB, Fruchon S, Ilyin G, Borot N, Leroyer P, Coppin H, Brissot P, Roth MP, Loreal O. Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice. Blood Cells Mol. Dis. 32: 283-289 (2004).
Courtney ED, Melville DM, Leicester RJ. Review article: chemoprevention of colorectal cancer. Aliment. Pharmacol. Ther. 19: 1-24 (2004). *
Courtney JM, Ennis M, Elborn JS. Cytokines and inflammatory mediators in cystic fibrosis. J. Cyst. Fibros. 3: 223-231 (2004).
Courtois G, Israel A. Human pathologies associated with NF-kappaB defects. J. Soc. Biol. 198: 93-96 (2004).
Coutinho J. RUNX1: transcription factor scores a hat-trick of autoimmune diseases. Clin. Genet. 65: 180-182 (2004).
Couzin J. Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors. Science 306: 384-385 (2004). *
Couzin J. Long-sought enzyme found, revealing new gene switch on histones. Science 306: 2171a (2004). *
Couzin J. Genetics. Two new asthma genes uncovered. Science 304: 185-187 (2004). *
Couzin J. Genomics. Consensus emerges on HapMap strategy. Science 304: 671-673 (2004). *
Couzin J. Basic and clinical immunology meeting. Genes crisscross disease lines. Science 305: 773 (2004). *
Couzin J. Basic and clinical immunology meeting. And action! Dendritic cells go live. Science 305: 772-773 (2004). *
Couzin J. Basic and clinical immunology meeting. An old favorite is resurrected: regulatory T cells take the stage. Science 305: 772 (2004). *
Couzin J. Putting tolerance to the test. Science 305: 194-196 (2004). *
Couzin J, Vogel G. Cell therapy. Renovating the heart. Science 304: 192-194 (2004). *
Covic A, Mutica C, Ignat A, Boaru I, Veisa G, Gusbeth-Tatomir P, Enea M, Covic M. Retrospective study of 97 ANCA-positive patients: epidemiological and clinical spectrum. Rev. Med. Chir. Soc. Med. Nat. Iasi. 108: 305-310 (2004).
Covington MB. Omega-3 fatty acids. Am. Fam. Physician 70: 133-140 (2004). *
Cowie SE, Yoshida EM, Ryan AG, Chung SW, Buczkowski AK, Ho SG, Erb SR, Steinbrecher UP, Scudamore CH. Hepatic abscesses after liver transplantation secondary to traumatic intrahepatic bile duct injuries in a cadaveric allograft donor. Transpl. Int. 17: 379-383 (2004).
Cox NJ. Human genetics: an expression of interest. Nature 430: 733-734 (2004). *
Coyle AJ, Gutierrez-Ramos JC. The role of ICOS and other costimulatory molecules in allergy and asthma. Springer Semin. Immunopathol. 25: 349-359 (2004). *
Cozar-Castellano I, Del Valle Machargo M, Trujillo E, Arteaga MF, Gonzalez T, Martin-Vasallo P, Avila J. hIscA: a protein implicated in the biogenesis of iron-sulfur clusters. Biochim. Biophys. Acta 1700: 179-188 (2004). *
Crabb DW. Alcohol deranges hepatic lipid metabolism via altered transcriptional regulation. Trans. Am. Clin. Climatol. Assoc. 115: 273-287 (2004). *
Crabb DW, Galli A, Fischer M, You M. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol 34: 35-38 (2004). *
Crabb DW, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc. Nutr. Soc. 63: 49-63 (2004). *
Crabtree MD, Fletcher C, Churchman M, Hodgson SV, Neale K, Phillips RK, Tomlinson IP. Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases. Gut 53: 271-276 (2004). *
Cracowski JL. Isoprostanes: an emerging role in vascular physiology and disease? Chem. Phys. Lipids 128: 75-83 (2004). *
Cracowski JL. Isoprostanes: a putative key role in vascular diseases. Rev. Med. Interne. 25: 459-463 (2004).
Craig CE, Quaglia A, Selden C, Lowdell M, Hodgson H, Dhillon AP. The histopathology of regeneration in massive hepatic necrosis. Semin. Liver Dis. 24: 49-64 (2004).
Craig SA. Betaine in human nutrition. Am. J. Clin. Nutr. 80: 539-549 (2004). *
Cramer T, Schuppan D, Bauer M, Pfander D, Neuhaus P, Herbst H. Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis. Liver Int. 24: 335-344 (2004). *
Crane C, Martin M. Social learning, affective state and passive coping in irritable bowel syndrome and inflammatory bowel disease. Gen. Hosp. Psychiatry 26: 50-58 (2004).
Craven M, Simpson JW, Ridyard AE, Chandler ML. Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002). J. Small Anim. Pract. 45: 336-342 (2004).
Crawford CL. Does thalidomide have a role in leprosy? Lancet 363: 1911 (2004). *
Crawford DH, Fletcher LM, Hubscher SG, Stuart KA, Gane E, Angus PW, Jeffrey GP, McCaughan GW, Kerlin P, Powell LW, Elias EE. Patient and graft survival after liver transplantation for hereditary hemochromatosis: implications for pathogenesis. Hepatology 39: 1655-1662 (2004). *
Crawford JH, Yang S, Zhou M, Simms HH, Wang P. Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Crit. Care Med. 32: 502-508 (2004).
Creange A. The diagnosis of acquired sensory neuropathies. Rev. Neurol. (Paris) 160: 363-370 (2004).
Cresswell P. Cell biology. Cutting and pasting antigenic peptides. Science 304: 525-527 (2004). *
Crestani M, De Fabiani E, Caruso D, Mitro N, Gilardi F, Vigil Chacon AB, Patelli R, Godio C, Galli G. LXR (liver X receptor) and HNF-4 (hepatocyte nuclear factor-4): key regulators in reverse cholesterol transport. Biochem. Soc. Trans. 32: 92-96 (2004). *
Creusot RJ, Fathman CG. Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunity. J. Clin. Invest. 114: 892-894 (2004). *
Creuzot-Garcher C, Lafontaine PO, Brignole F, Pisella PJ, d'Athis P, Bron A, Lapierre V, Baudouin C. Treating severe dry eye syndromes with autologous serum. J. Fr. Ophtalmol. 27: 346-351 (2004).
Criado PR, de Oliveira Ramos R, Vasconcellos C, Jardim Criado RF, Valente NY. Two case reports of cutaneous adverse reactions following hepatitis B vaccine: lichen planus and granuloma annulare. J. Eur. Acad. Dermatol. Venereol. 18: 603-606 (2004).
Criscuoli V, Casa A, Orlando A, Pecoraro G, Oliva L, Traina M, Rizzo A, Cottone M. Severe acute colitis associated with CMV: a prevalence study. Dig. Liver Dis. 36: 818-820 (2004).
Crispin JC, Vargas MI, Alcocer-Varela J. Immunoregulatory T cells in autoimmunity. Autoimmun. Rev. 3: 45-51 (2004).
Criswell LA. Familial clustering of disease features: implications for the etiology and investigation of systemic autoimmune disease. Arthritis Rheum. 50: 1707-1708 (2004). *
Criswell LA, Lum RF, Turner KN, Woehl B, Zhu Y, Wang J, Tiwari HK, Edberg JC, Kimberly RP, Moreland LW, Seldin MF, Bridges SL Jr. The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept. Arthritis Rheum. 50: 2750-2756 (2004). *
Crocenzi FA, Mottino AD, Roma MG. Regulation of synthesis and trafficking of canalicular transporters and its alteration in acquired hepatocellular cholestasis. Experimental therapeutic strategies for its prevention. Curr. Med. Chem. 11: 501-524 (2004).
Croft NM. The spice of life for cystic fibrosis. Gastroenterology 127: 1639-1640 (2004). *
Croitoru K, Zhou P. T-cell-induced mucosal damage in the intestine. Curr. Opin. Gastroenterol. 20: 581-586 (2004).
Crone CC, Gabriel GM. Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations. Clin. Pharmacokinet. 43: 361-394 (2004).
Crone J, Gold BD. Helicobacter pylori infection in pediatrics. Helicobacter 9 Suppl. 1: 49-56 (2004).
Cronin DC 2nd, Millis JM. Split-liver transplantation: coming of age. Liver Transpl. 10: 1326-1328 (2004). *
Crowe DL, Chandraratna RA. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands. Breast Cancer Res. 6: R546-R555 (2004). *
Cruickshank SM, McVay LD, Baumgart DC, Felsburg PJ, Carding SR. Colonic epithelial cell mediated suppression of CD4 T cell activation. Gut 53: 678-684 (2004). *
Cruz E, Vieira J, Goncalves R, Alves H, Almeida S, Rodrigues P, Lacerda R, Porto G. Involvement of the major histocompatibility complex region in the genetic regulation of circulating CD8 T-cell numbers in humans. Tissue Antigens 64: 25-34 (2004). *
Cserepes J, Szentpetery Z, Seres L, Ozvegy-Laczka C, Langmann T, Schmitz G, Glavinas H, Klein I, Homolya L, Varadi A, Sarkadi B, Elkind NB. Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization. Biochem. Biophys. Res. Commun. 320: 860-867 (2004). *
Csiszar A, Ungvari Z. Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease. Med. Hypotheses 63: 696-698 (2004).
Cubelic S, Misak Z, Gasparov S, Kolacek S. Nonalcoholic steatohepatitis in children. Lijec. Vjesn. 126: 197-200 (2004).
Cuchacovich M, Ferreira L, Aliste M, Soto L, Cuenca J, Cruzat A, Gatica H, Schiattino I, Perez C, Aguirre A, Salazar-Onfray F, Aguillon J. Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis. Scand. J. Rheumatol. 33: 228-232 (2004). *
Cuenca F, Garcia Paredes J, Mendoza J, Cruz D, Herrero A, Diaz-Rubio M. Experience with granulocytapheresis in Crohn's disease. Rev. Esp. Enferm. Dig. 96: 501-506 (2004).
Cuffari C, Dassopoulos T, Turnbough L, Thompson RE, Bayless TM. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 2: 410-417 (2004). *
Cuffari C, Li DY, Mahoney J, Barnes Y, Bayless TM. Peripheral blood mononuclear cell DNA 6-thioguanine metabolite levels correlate with decreased interferon-gamma production in patients with Crohn's disease on AZA therapy. Dig. Dis. Sci. 49: 133-137 (2004). *
Cui FL, Fan J, Li W, Fan YC, Hu ZD. Fluorescence spectroscopy studies on 5-aminosalicylic acid and zinc 5-aminosalylicylate interaction with human serum albumin. J. Pharm. Biomed. Anal. 34: 189-197 (2004).
Cui HH, Chen CL, Wang JD, Yang YJ, Cun Y, Wu JB, Liu YH, Dan HL, Jian YT, Chen XQ. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J. Gastroenterol. 10: 1521-1525 (2004). *
Cui J, Lew J-L, Zhao A, Huang L, Wright SD. The farnesoid X receptor controls gene expression in a ligand and promoter-selective fashion. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 32. June 18-19 (2004). *
Cukovic-Cavka S. Diffuse jejunoileitis in an adolescent. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 69. May 7-8 (2004). *
Culliford A, Markowitz D, Rotterdam H, Green PHR. Scalloping of duodenal mucosa in Crohn's disease. Inflamm. Bowel Dis. 10: 270-273 (2004). *
Cullum JL, Wojciechowski AE, Pelletier G, Simpson JS. Bupropion sustained release treatment reduces fatigue in cancer patients. Can. J. Psychiatry 49: 139-144 (2004). *
Culver DA, Thomassen MJ, Kavuru MS. Pulmonary sarcoidosis: new genetic clues and ongoing treatment controversies. Cleve. Clin. J. Med. 71: 88, 90, 92 (2004). *
Cummings JH, Antoine JM, Azpiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder PC, Gibson GR, Guarner F, Isolauri E, Pannemans D, Shortt C, Tuijtelaars S, Watzl B. PASSCLAIM - gut health and immunity. Eur. J. Nutr. 43 Suppl. 2: II118-II173 (2004).
Cummings JH, Kong SC. Probiotics, prebiotics and antibiotics in inflammatory bowel disease. Novartis Found. Symp. 263: 99-111 (2004).
Cunliffe RN, Mahida YR. Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J. Leukoc. Biol. 75: 49-58 (2004). *
Cunnick GH, Richardson NG, Ratcliffe N, Donaldson DR. Acute ulcerative colitis in a Meckel's diverticulum. Int. J. Clin. Pract. 58: 422-423 (2004).
Cuppens H, Cassiman JJ. CFTR mutations and polymorphisms in male infertility. Int. J. Androl. 27: 251-256 (2004). *
Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, Scaife C, Raut C, Wolff R, Choi H, Loyer E, Vallone P, Fiore F, Scordino F, De Rosa V, Orlando R, Pignata S, Daniele B, Izzo F. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann. Surg. 239: 450-458 (2004). *
Curotto de Lafaille MA, Lino AC, Kutchukhidze N, Lafaille JJ. CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J. Immunol. 173: 7259-7268 (2004). *
Currid A, Ortega B, Valverde MA. Chloride secretion in a morphologically differentiated human colonic cell line that expresses the epithelial Na+ channel. J. Physiol. 555: 241-250 (2004). *
Curry AJ, Chikwe J, Smith XG, Cai M, Schwarz H, Bradley JA, Bolton EM. OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival. Transplantation 78: 807-814 (2004).
Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev. 13: 285-292 (2004). *
Cuthbert AP, Fisher SA, Lewis CM, Mathew CG, Sanderson J, Forbes A. Genetic association between EPHX1 and Crohn's disease: population stratification, genotyping error, or random chance? Gut 53: 1386 (2004). *
Cuthbert GL, Daujat S, Snowden AW, Erdjument-Bromage H, Hagiwara T, Yamada M, Schneider R, Gregory PD, Tempst P, Bannister AJ, Kouzarides T. Histone deimination antagonizes arginine methylation. Cell 118: 545-553 (2004). *
Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, Straub RH. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 13: 635-638 (2004).
Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Caputi AP. WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock. Shock 22: 340-346 (2004). *
Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Centorrino T, Caputi AP. Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice. Lab. Invest. 84: 1643-1654 (2004). *
Cuzzocrea S, Mazzon E, Di Paola R, Genovese T, Patel NS, Muia C, Threadgill MD, De Sarro A, Thiemermann C. 5-Aminoisoquinolinone reduces colon injury by experimental colitis. Naunyn. Schmiedebergs Arch. Pharmacol. 370: 464-473 (2004). *
Cuzzocrea S, Mazzon E, Di Paola R, Patel NS, Genovese T, Muia C, De Sarro A, Thiemermann C. Erythropoietin reduces the development of experimental, inflammatory bowel disease. J. Pharmacol. Exp. Ther. 311: 1272-1280 (2004). *
Czaja AJ. Round table: classification of autoimmune liver diseases and diagnostic criteria. Subgroups of autoimmune hepatitis are irrelevant. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 58-59 (2004). *
Czaja AJ. Autoimmune hepatitis: clinical and laboratory diagnosis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 52-54 (2004). *
Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 20: 231-240 (2004).
Czaja AJ, Carpenter HA. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J. Hepatol. 40: 646-652 (2004). *
Czaja AJ, Carpenter HA. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology 39: 1631-1638 (2004). *
Czaja AJ, Muratori P, Muratori L, Carpenter HA, Bianchi FB. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int. 24: 322-329 (2004). *
Czaja AJ, Shums Z, Donaldson PT, Norman GL. Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis. Dig. Dis. Sci. 49: 611-618 (2004). *
Czaja AJ, Shums Z, Norman GL. Nonstandard antibodies as prognostic markers in autoimmune hepatitis. Autoimmunity 37: 195-201 (2004).
Czako L, Takacs T, Morvay Z, Csernay L, Lonovics J. Diagnostic role of secretin-enhanced MRCP in patients with unsuccessful ERCP. World J. Gastroenterol. 10: 3034-3038 (2004). *
Czako L, Takacs T, Morvay Z, Csernay L, Lonovics J. Diagnostic value of secretin-enhanced magnetic resonance cholangiopancreatography (S-MRCP) after unsuccessful endoscopic retrograde cholangiopancreatography (ERCP). Orv. Hetil. 145: 529-534 (2004).
Czito BG, Hong TJ, Cohen DP, Tyler DS, Lee CG, Anscher MS, Ludwig KA, Seigler HF, Mantyh C, Morse MA, Lockhart AC, Petros WP, Honeycutt W, Spector NL, Ertel PJ, Mangum SG, Hurwitz HI. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon. Int. J. Radiat. Oncol. Biol. Phys. 58: 779-785 (2004).
Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-Lopez AJ. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up. J. Clin. Oncol. 22: 4659-4664 (2004). *
D'Apice MR, Gambardella S, Russo S, Lucidi V, Nardone AM, Pietropolli A, Novelli G. Segregation analysis in cystic fibrosis at-risk family demonstrates that the M348K CFTR mutation is a rare innocuous polymorphism. Prenat. Diagn. 24: 981-983 (2004). *
D'Archivio M, Silano M, Fagnani C, Scazzocchio B, Nistico L, Giovannini C, Vari' R, D'Ippolito C, Cotichini R, Stazi MA, De Vincenzi M. Clinical evolution of celiac disease in Italy 1982-2002. J. Clin. Gastroenterol. 38: 877-879 (2004).
D'Argenio G, Farrace MG, Cosenza V, De Ritis F, Della Valle N, Manguso F, Piacentini M. Expression of apoptosis-related proteins in rat with induced colitis. Int. J. Colorectal Dis. 19: 451-460 (2004). *
D'Auria F, Rovere-Querini P, Giazzon M, Ajello P, Baldissera E, Manfredi AA, Sabbadini MG. Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-alpha antibodies. J. Intern. Med. 255: 409-418 (2004). *
D'Cruz D, Ablamunits V. Why do we need a new journal in autoimmunity? J. Autoimmune Dis. 1: 1 (2004). *
D'Elios MM, Appelmelk BJ, Amedei A, Bergman MP, Prete GD. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol. Med. 10: 316-323 (2004). *
D'Haens G. Optimizing the use of current drugs in IBD. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 65. May 7-8 (2004). *
D'Haens G. Mucosal healing in pediatric Crohn's disease: the goal of medical treatment. Inflamm. Bowel Dis. 10: 479-480 (2004). *
D'Haens G, Hlavaty T. Advances in medical therapy for Crohn's disease. Curr. Gastroenterol. Rep. 6: 496-505 (2004).
D'Haens G, van Bodegraven AA. Mesalazine is safe for the treatment of IBD. Gut 53: 155 (2004). *
D'Inca R, Cardin R, Benazzato L, Angriman I, Martines D, Sturniolo GC. Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia. Inflamm. Bowel Dis. 10: 23-27 (2004). *
D'Ovidio V, Aratari A, Viscido A, Pimpo MT, Caprilli R, Torchio P. Infliximab and quality of life in steroid-dependent Crohn's disease. Dig. Liver Dis. 36: 557-558 (2004).
Da Costa CU, Wantia N, Kirschning CJ, Busch DH, Rodriguez N, Wagner H, Miethke T. Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur. J. Immunol. 34: 2874 (2004). *
Daberkow U, Dorffel Y, Schmidt H, Scholze J. Multifocal nodular fatty infiltration of the liver associated with porphyria and haemochromatosis. Dtsch. Med. Wochenschr. 129: 617-620 (2004).
Dabos KJ, Newsome PN, Parkinson JA, Mohammed HH, Sadler IH, Plevris JN, Hayes PC. Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure. Transplantation 77: 200-205 (2004).
Daftarian P, Song GY, Ali S, Faynsod M, Longmate J, Diamond DJ, Ellenhorn JD. Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors. Cancer Res. 64: 5407-5414 (2004). *
Dager WE, White RH. Low-molecular-weight heparin-induced thrombocytopenia in a child. Ann. Pharmacother. 38: 247-250 (2004).
Daghfous R, El Aidli S, Ben Mami N, Amrani R, Loueslati MH, Lakhal M, Belkahia C. Cholestasis soon after administration of amoxicillin-clavulanic acid. Therapie 59: 658-660 (2004).
Dahl M, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J. Exp. Med. 199: 1391-1399 (2004). *
Dahl SG, Ravna AW, Sylte I. Structures and models of transporter proteins. J. Pharmacol. Exp. Ther. 309: 853-860 (2004). *
Dahlke MH, Popp FC, Larsen S, Schlitt HJ, Rasko JE. Stem cell therapy of the liver - fusion or fiction? Liver Transpl. 10: 471-479 (2004). *
Dai S, Hirayama T, Abbas S, Abu-Amer Y. The IKK inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J. Biol. Chem. 279: 37219-37222 (2004). *
Dai SM, Matsuno H, Nakamura H, Nishioka K, Yudoh K. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum. 50: 432-443 (2004). *
Dai X, Yamasaki K, Shirakata Y, Sayama K, Hashimoto K. All-trans-retinoic acid induces interleukin-8 via the nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways in normal human keratinocytes. J. Invest. Dermatol. 123: 1078-1085 (2004). *
Dai YS, Liang MG, Gellis SE, Bonilla FA, Schneider LC, Geha RS, Orange JS. Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia. J. Am. Acad. Dermatol. 51: 718-722 (2004).
Dairkee SH, Ji Y, Ben Y, Moore DH, Meng Z, Jeffrey SS. A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue. BMC Genomics 5: 47 (2004). *
Dajotoy T, Andersson P, Bjartell A, Lofdahl CG, Tapper H, Egesten A. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma. J. Leukoc. Biol. 76: 685-691 (2004). *
Dal Pra C, Chen S, Betterle C, Zanchetta R, McGrath V, Furmaniak J, Rees Smith B. Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase. Eur. J. Endocrinol. 150: 313-321 (2004). *
Dalbeth N, Yeoman S, Dockerty JL, Highton J, Robinson E, Tan PL, Herman D, McQueen FM. A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis. Ann. Rheum. Dis. 63: 718-722 (2004). *
Daly MJ, Rioux JD. New approaches to gene hunting in IBD. Inflamm. Bowel Dis. 10: 312-317 (2004). *
Dam-Larsen S, Franzmann M, Andersen IB, Christoffersen P, Jensen LB, Sorensen TI, Becker U, Bendtsen F. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 53: 750-755 (2004). *
Damiano JS, Newman RM, Reed JC. Multiple roles of CLAN (caspase-associated recruitment domain, leucine-rich repeat, and NAIP CIIA HET-E, and TP1-containing protein) in the mammalian innate immune response. J. Immunol. 173: 6338-6345 (2004). *
Damiano JS, Oliveira V, Welsh K, Reed JC. Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses. Biochem. J. 381: 213-219 (2004). *
Danese S, Motte Cd Cde L, Fiocchi C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am. J. Gastroenterol. 99: 938-945 (2004). *
Danese S, Sans M, Fiocchi C. The CD40/CD40L costimulatory pathway in inflammatory bowel disease. Gut 53: 1035-1043 (2004). *
Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev. 3: 394-400 (2004).
Danese S, Scaldaferri F, Papa A, Pola R, Sans M, Gasbarrini G, Pola P, Gasbarrini A. Platelets: new players in the mucosal scenario of inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci. 8: 193-198 (2004).
Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. 350: 1387-1397 (2004). *
Daniel F, Seksik P, Cacheux W, Jian R, Marteau P. Tolerance of 4-aminosalicylic acid enemas in patients with inflammatory bowel disease and 5-aminosalicylic-induced acute pancreatitis. Inflamm. Bowel Dis. 10: 258-260 (2004). *
Daniele B, Bencivenga A, Megna AS, Tinessa V. alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S108-S112 (2004). *
Dann AT, Kenyon AP, Seed PT, Poston L, Shennan AH, Tribe RM. Glutathione S-transferase and liver function in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology 40: 1406-1414 (2004). *
Daperno M, D'haens G, Van Assche G, Baert F, Bulois P, Maunoury V, Sostegni R, Rocca R, Pera A, Gevers A, Mary JY, Colombel JF, Rutgeerts P. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest. Endosc. 60: 505-512 (2004). *
Daperno M, Sostegni R, Lavagna A, Crocella L, Ercole E, Rigazio C, Rocca R, Pera A. The role of endoscopy in inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci. 8: 209-214 (2004).
Daperno M, Sostegni R, Scaglione N, Ercole E, Rigazio C, Rocca R, Pera A. Outcome of a conservative approach in severe ulcerative colitis. Dig. Liver Dis. 36: 21-28 (2004). *
Darabi K, Karulin AY, Boehm BO, Hofstetter HH, Fabry Z, LaManna JC, Chavez JC, Tary-Lehmann M, Lehmann PV. The third signal in T cell-mediated autoimmune disease? J. Immunol. 173: 92-99 (2004). *
Darbari A, Sena L, Argani P, Oliva-Hemker JM, Thompson R, Cuffari C. Gadolinium-enhanced magnetic resonance imaging: a useful radiological tool in diagnosing pediatric IBD. Inflamm. Bowel Dis. 10: 67-72 (2004). *
Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421 (2004). *
Darling RL, Romero JJ, Dial EJ, Akunda JK, Langenbach R, Lichtenberger LM. The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice. Gastroenterology 127: 94-104 (2004). *
Darlow JM, Farrell AM, Stott DI. Non-functional immunoglobulin G transcripts in a case of hyper-immunoglobulin M syndrome similar to type 4. Immunology 111: 212-222 (2004). *
Darlow SJ, Mandal A, Pick B, Thomas T, Mayberry JF, Robinson RJ. The short-term effects of Eudragit-L-coated prednisolone metasulphobenzoate (Predocol) on bone formation and bone mineral density in acute ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 16: 1173-1176 (2004).
Dartt DA. Dysfunctional neural regulation of lacrimal gland secretion and its role in the pathogenesis of dry eye syndromes. Ocul. Surf. 2: 76-91 (2004).
Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, Howald WN, Way SS, Hajjar AM. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both Toll-like receptors 2 and 4. Infect. Immun. 72: 5041-5051 (2004). *
Darwish AA, Sokal E, Stephenne X, Najimi M, De Goyet Jd J, Reding R. Permanent access to the portal system for cellular transplantation using an implantable port device. Liver Transpl. 10: 1213-1215 (2004). *
Das A, Saxena RK. Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell cultures. Immunol. Lett. 94: 209-214 (2004).
Das D. Cancer and hereditary haemochromatosis. QJM 97: 698-699 (2004). *
Das KM. "Is foe your friend?" Inflamm. Bowel Dis. 10: 693 (2004). *
Das KM. Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen. J. Gastroenterol. Hepatol. 19: S290-S294 (2004). *
Das SK, Chu W, Zhang Z, Hasstedt SJ, Elbein SC. Calsquestrin 1 (CASQ1) gene polymorphisms under chromosome 1q21 linkage peak are associated with type 2 diabetes in Northern European Caucasians. Diabetes 53: 3300-3306 (2004). *
Das UN. Perinatal supplementation of long-chain polyunsaturated fatty acids, immune response and adult diseases. Med. Sci. Monit. 10: HY19-HY25 (2004). *
Date RS, Panesar KJ, Neilly P. Infliximab as a therapy for non-Crohn's enterocutaneous fistulae. Int. J. Colorectal Dis. 19: 603-606 (2004). *
Davalos M, Roman R, Bustios C, Zumaeta E, Yabar A. Autoimmune hepatitis: clinical forms and related factors to their response to treatment. Rev. Gastroenterol. Peru 24: 305-313 (2004).
Davenport M, De Ville de Goyet J, Stringer MD, Mieli-Vergani G, Kelly DA, McClean P, Spitz L. Seamless management of biliary atresia in England and Wales (1999-2002). Lancet 363: 1354-1357 (2004). *
Davern TJ 2nd. Acetaminophen hepatotoxicity. Hepatology 40: 1021-1022 (2004). *
Davezac N, Tondelier D, Lipecka J, Fanen P, Demaugre F, Debski J, Dadlez M, Schrattenholz A, Cahill MA, Edelman A. Global proteomic approach unmasks involvement of keratins 8 and 18 in the delivery of cystic fibrosis transmembrane conductance regulator (CFTR)/DeltaF508-CFTR to the plasma membrane. Proteomics 4: 3833-3844 (2004). *
David CS, Taneja V. Role of major histocompatibility complex genes in murine collagen-induced arthritis: a model for human rheumatoid arthritis. Am. J. Med. Sci. 327: 180-187 (2004).
Davidson AJ, Castanon-Cervantes O, Stephan FK. Daily oscillations in liver function: diurnal vs circadian rhythmicity. Liver Int. 24: 179-186 (2004). *
Davidson DJ, Gray MA, Kilanowski FM, Tarran R, Randell SH, Sheppard DN, Argent BE, Dorin JR. Murine epithelial cells: isolation and culture. J. Cyst. Fibros. 3 Suppl. 2: 59-62 (2004).
Davidson LA, Nguyen DV, Hokanson RM, Callaway ES, Isett RB, Turner ND, Dougherty ER, Wang N, Lupton JR, Carroll RJ, Chapkin RS. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res. 64: 6797-6804 (2004). *
Davies DR, O'Hara AJ, Irwin PJ, Guilford WG. Successful management of histiocytic ulcerative colitis with enrofloxacin in two Boxer dogs. Aust. Vet. J. 82: 58-61 (2004).
Davies E, Tsang CW, Ghazali AR, Harris RM, Waring RH. Effects of culture with TNF-alpha, TGF-beta and insulin on sulphotransferase (SULT 1A1 and 1A3) activity in human colon and neuronal cell lines. Toxicol. In Vitro 18: 749-754 (2004).
Davies JC, Turner MW, Klein N. Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles. Eur. Respir. J. 24: 798-804 (2004). *
Davies PS, Enns CA. Expression of the hereditary hemochromatosis protein HFE increases ferritin levels by inhibiting iron export in HT29 cells. J. Biol. Chem. 279: 25085-25092 (2004). *
Davies RJ, Scott IS, Morris LS, Rushbrook SM, Bird K, Vowler SL, Arends M, Miller R, Coleman N. Increased expression of minichromosome maintenance protein 2 in active inflammatory bowel disease. Colorectal Dis. 6: 103-110 (2004).
Davies SJ, Lim KC, Blank RB, Kim JH, Lucas KD, Hernandez DC, Sedgwick JD, McKerrow JH. Involvement of TNF in limiting liver pathology and promoting parasite survival during schistosome infection. Int. J. Parasitol. 34: 27-36 (2004). *
Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127: 1372-1380 (2004). *
Davis J Jr, Webb A, Lund S, Sack K. Results from an open-label extension study of etanercept in ankylosing spondylitis. Arthritis Rheum. 51: 302-304 (2004). *
Davis PB, Drumm ML. Some like it hot: curcumin and CFTR. Trends Mol. Med. 10: 473-475 (2004). *
Davis SR, Stacpoole PW, Williamson J, Kick LS, Quinlivan EP, Coats BS, Shane B, Bailey LB, Gregory JF 3rd. Tracer-derived total and folate-dependent homocysteine remethylation and synthesis rates in humans indicate that serine is the main one-carbon donor. Am. J. Physiol. Endocrinol. Metab. 286: E272-E279 (2004). *
Davis W Jr, Boyd JT, Ile KE, Tew KD. Human ATP-binding cassette transporter-2 (ABCA2) positively regulates low-density lipoprotein receptor expression and negatively regulates cholesterol esterification in Chinese hamster ovary cells. Biochim. Biophys. Acta 1683: 89-100 (2004). *
Dawson LJ, Allison HE, Stanbury J, Fitzgerald D, Smith PM. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches. Rheumatology (Oxford) 43: 1488-1495 (2004). *
Dawson MI. Synthetic retinoids and their nuclear receptors. Curr. Med. Chem. Anticancer Agents 4: 199-230 (2004).
Dawson PA. Molecular pathways for intestinal bile acid transport. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 53. June 18-19 (2004). *
Day A, Whitten K, Bohane T. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease. J. Paediatr. Child. Health 40: 681-684 (2004).
Day CP. The potential role of genes in nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 673-691, xi (2004).
Dayan M, Sthoeger Z, Neiman A, Abarbanel J, Sela M, Mozes E. Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis. Hum. Immunol. 65: 571-577 (2004).
de Bruijn MF, Speck NA. Core-binding factors in hematopoiesis and immune function. Oncogene 23: 4238-4248 (2004). *
De Carolis S, Botta A, Fatigante G, Garofalo S, Ferrazzani S, Gasbarrini A,. Celiac disease and inflammatory bowel disease in pregnancy. Lupus 13: 653-658 (2004).
De Fabiani E, Mitro N, Godio C, Gilardi F, Caruso D, Crestani M. Bile acid signaling to the nucleus: finding new connections in the transcriptional regulation of metabolic pathways. Biochimie 86: 771-778 (2004).
de Franchis R, Dell'Era A, Iannuzzi F. Diagnosis and treatment of portal hypertension. Dig. Liver Dis. 36: 787-798 (2004).
De Gobbi M, D'Antico S, Castagno F, Testa D, Merlini R, Bondi A, Camaschella C. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience. Haematologica 89: 1161-1167 (2004). *
De Gottardi A, Touri F, Maurer CA, Perez A, Maurhofer O, Ventre G, Bentzen CL, Niesor EJ, Dufour JF. The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer. Dig. Dis. Sci. 49: 982-989 (2004). *
de Groot CJ, Jansen MW, Bertina RM, Schonkeren JJ, Helmerhorst FM, Huizinga TW. Interleukin 10-2849AA genotype protects against pre-eclampsia. Genes Immun. 5: 313-314 (2004). *
de Groot PG, Derksen RH. Pathophysiology of antiphospholipid antibodies. Neth. J. Med. 62: 267-272 (2004). *
De Hertogh G, Geboes K. Crohn's disease and infections: a complex relationship. MedGenMed. 6: 14 (2004). *
de Hoyos A, Loredo ML, Martinez MA, Gil MR. Use of a stiff guidewire in transjugular liver biopsy in patients with a pronounced angle of the suprahepatic veins. Ann. Hepatol. 3: 72-73 (2004). *
De Jesus LE, Marques AM, Rocha MS, Brom BR, Siqueira RR. Left colon stenosis caused by tuberculosis. J. Pediatr. Surg. 39: e5-e7 (2004).
De Jesus-Monge WE, Torres EA, Baez VM, De Jesus O, Rivera L, Gonzalez-Keelan C. Crohn's disease associated to chordoma: a case report. P. R. Health Sci. J. 23: 233-236 (2004).
de Jong DJ, Drenth JP. Absence of an association of the IBD2 locus gene keratin 8 and inflammatory bowel disease in a large genetic association study. Dig. Liver Dis. 36: 380-383 (2004).
De Jong DJ, Goullet M, Naber TH. Side effects of azathioprine in patients with Crohn's disease. Eur. J. Gastroenterol. Hepatol. 16: 207-212 (2004).
De Jong YP, Rietdijk ST, Faubion WA, Abadia-Molina AC, Clarke K, Mizoguchi E, Tian J, Delaney T, Manning S, Gutierrez-Ramos JC, Bhan AK, Coyle AJ, Terhorst C. Blocking inducible co-stimulator in the absence of CD28 impairs T(h)1 and CD25(+) regulatory T cells in murine colitis. Int. Immunol. 16: 205-213 (2004). *
De Keyser F, Baeten D, Van den Bosch F, Kruithof E, Verbruggen G, Mielants H, Veys E. Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis. Drugs 64: 2793-2811 (2004).
de la Rosa M, Rutz S, Dorninger H, Scheffold A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34: 2480-2488 (2004). *
De Lange T, Larsen S, Aabakken L. Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis. BMC Gastroenterol. 4: 9 (2004). *
de Leeuw RJ, Davies JJ, Rosenwald A, Bebb G, Gascoyne RD, Dyer MJ, Staudt LM, Martinez-Climent JA, Lam WL. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum. Mol. Genet. 13: 1827-1837 (2004). *
de Lujan Alvarez M, Ronco MT, Ochoa JE, Monti JA, Carnovale CE, Pisani GB, Lugano MC, Carrillo MC. Interferon alpha-induced apoptosis on rat preneoplastic liver is mediated by hepatocytic transforming growth factor beta(1). Hepatology 40: 394-402 (2004). *
De Marco F, Liguori R, Giardina MG, D'Armiento M, Angelucci E, Lucariello A, Morante R, Cimino L, Galeota-Lanza A, Tarantino G, Ascione A, Budillon G, Vecchione R, Martinelli R, Matarazzo M, De Simone V. High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy. Clin. Chem. Lab. Med. 42: 17-24 (2004).
De Meyts P, Palsgaard J, Sajid W, Theede AM, Aladdin H. Structural biology of insulin and IGF-1 receptors. Novartis Found. Symp. 262: 160-171 (2004).
de Moreno de Leblanc A, Perdigon G. Yogurt feeding inhibits promotion and progression of experimental colorectal cancer. Med. Sci. Monit. 10: BR96-BR104 (2004). *
De Palma GD, Rega M, Puzziello A, Aprea G, Ciacci C, Castiglione F, Ciamarra P, Persico M, Patrone F, Mastantuono L, Persico G. Capsule endoscopy is safe and effective after small-bowel resection. Gastrointest. Endosc. 60: 135-138 (2004). *
De Ponti F. Pharmacology of serotonin: what a clinician should know. Gut 53: 1520-1535 (2004). *
De Quatrebarbes J, Cordel N, Bravard P, Lenormand B, Joly P. Miescher's cheilitis and lymphocytic clonal expansion: 2 cases. Ann. Dermatol. Venereol. 131: 55-57 (2004).
De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, Lebeer K, Wyns B, Vincent C, Mielants H, Boullart L, Serre G, Veys EM, De Keyser F. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann. Rheum. Dis. 63: 1587-1593 (2004). *
De Sanctis LB, Mandreoli M, Poggi C, Pileri S, Casanova S, Santoro A. Acute renal failure in a young woman with Fisher-Evans' syndrome. J. Nephrol. 17: 739-743 (2004).
de Saussure P, Lavergne-Slove A, Mazeron MC, Alain S, Matuchansky C, Bouhnik Y. A prospective assessment of cytomegalovirus infection in active inflammatory bowel disease. Aliment. Pharmacol. Ther. 20: 1323-1327 (2004). *
De Seze J, Dubucquoi S, Fauchais AL, Hachulla E, Matthias T, Lefranc D, Hatron PY, Vermersch P, Witte T. Autoantibodies against alpha-fodrin in Sjogren's syndrome with neurological manifestations. J. Rheumatol. 31: 500-503 (2004).
de Silva E, Stumpf MP. HIV and the CCR5-Delta32 resistance allele. FEMS Microbiol. Lett. 241: 1-12 (2004). *
De Simone M, Cioffi U, Contessini-Avesani E, Oreggia B, Paliotti R, Pierini A, Bolla G, Oggiano E, Ferrero S, Magrini F, Ciulla MM. Elevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgery. BMC Gastroenterol. 4: 29 (2004). *
De Tena JG, Manzano L, Leal JC, Antonio ES, Sualdea V, Alvarez-Mon M. Active Crohn's disease patients show a distinctive expansion of circulating memory CD4(+)CD45RO(+)CD28(null) T cells. J. Clin. Immunol. 24: 185-196 (2004). *
de Vijlder HC, Westerhof W, Schreuder GM, de Lange P, Claas FH. Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res. 17: 270-274 (2004). *
De Vos M. Joint involvement in inflammatory bowel disease. Aliment. Pharmacol. Ther. 20 Suppl. 4: 36-42 (2004). *
De Vos Tot Nederveen Cappel WH, Meulenbeld HJ, Kleibeuker JH, Nagengast FM, Menko FH, Griffioen G, Cats A, Morreau H, Gelderblom H, Vasen HF. Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer. Int. J. Cancer 109: 468-471 (2004). *
De Vries J, Michielsen H, Van Heck GL, Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br. J. Health Psychol. 9: 279-291 (2004).
Decaens T, Maitre S, Marfaing A, Naveau S, Chaput JC, Mathurin P. Inflammatory bowel disease and latent thrombocythemia: a novel cause of hepatic vein thrombosis. Gastroenterol. Clin. Biol. 28: 394-397 (2004).
Decaestecker K, Decaestecker E, Castellani C, Jaspers M, Cuppens H, De Boeck K. Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients. Eur. Respir. J. 23: 679-684 (2004). *
Deenadayalu VP, Chadalawada V, Rex DK. 170 degrees wide-angle colonoscope: effect on efficiency and miss rates. Am. J. Gastroenterol. 99: 2138-2142 (2004). *
DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int. J. Clin. Pract. Suppl. 143: 9-21 (2004).
Degner D, Grohmann R, Kropp S, Ruther E, Bender S, Engel RR, Schmidt LG. Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 37 Suppl. 1: S39-S45 (2004).
Degre D, Bourgeois N, Boon N, Le Moine O, Louis H, Donckier V, El Nakadi I, Closset J, Lingier P, Vereerstraeten P, Gelin M, Adler M. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transpl. Int. 17: 31-38 (2004).
Deguti MM, Genschel J, Cancado EL, Barbosa ER, Bochow B, Mucenic M, Porta G, Lochs H, Carrilho FJ, Schmidt HH. Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients. Hum. Mutat. 23: 398 (2004). *
Deitch HR, Huppert J, Adams Hillard PJ. Unusual vulvar ulcerations in young adolescent females. J. Pediatr. Adolesc. Gynecol. 17: 13-16 (2004).
Dekker E, Fockens P. New endoscopic tools for the IBD physician. Inflamm. Bowel Dis. 10 Suppl. 1: S7-S10 (2004). *
Dekker L, Armbrust W, Rademaker CM, Prakken B, Kuis W, Wulffraat NM. Safety of anti-TNFalpha therapy in children with juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 22: 252-258 (2004).
Del Barrio M, Lacunza MM, Armendariz AC, Margall MA, Asiain MC. Liver transplant patients: their experience in the intensive care unit. A phenomenological study. J. Clin. Nurs. 13: 967-976 (2004).
del Castillo-Olivares A, Campos JA, Pandak WM, Gil G. The role of alpha1-fetoprotein transcription factor/LRH-1 in bile acid biosynthesis: a known nuclear receptor activator that can act as a suppressor of bile acid biosynthesis. J. Biol. Chem. 279: 16813-16821 (2004). *
Del Compare ME, D'Agostino D, Ferraris JR, Boldrini G, Waisman G, Krmar RT. Twenty-four-hour ambulatory blood pressure profiles in liver transplant recipients. Pediatr. Transplant. 8: 496-501 (2004). *
Del Giudice G, Michetti P. Inflammation, immunity and vaccines for Helicobacter pylori. Helicobacter 9 Suppl. 1: 23-28 (2004).
Delarue J, LeFoll C, Corporeau C, Lucas D. n-3 Long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod. Nutr. Dev. 44: 289-299 (2004).
Delatycki M, Allen K, Gow P, MacFarlane J, Radomski C, Thompson J, Hayden M, Goldberg Y, Samuels M. A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant juvenile hemochromatosis. Clin. Genet. 65: 378-383 (2004). *
Delatycki MB, Powell LW, Allen KJ. Hereditary hemochromatosis genetic testing of at-risk children: what is the appropriate age? Genet. Test. 8: 98-103 (2004).
Delerive P, Galardi CM, Bisi JE, Nicodeme E, Goodwin B. Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein AI gene transcription. Mol. Endocrinol. 18: 2378-2387 (2004). *
Delgado J, Delgado B, Fich A, Odes S. Microscopic colitis. Isr. Med. Assoc. J. 6: 482-484 (2004). *
Delgado-Aros S, Camilleri M, Cremonini F, Ferber I, Stephens D, Burton DD. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 127: 1685-1694 (2004). *
Delhalle S, Blasius R, Dicato M, Diederich M. A beginner's guide to NF-kappaB signaling pathways. Ann. N. Y. Acad. Sci. 1030: 1-13 (2004). *
Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, et al. The DNA sequence and comparative analysis of human chromosome 10. Nature 429: 375-381 (2004). *
Demetriou AA, Brown RS Jr, Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS 2nd, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, de Hemptinne B, Broelsch CE, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 239: 660-667 (2004). *
Demidova TN, Hamblin MR. Macrophage-targeted photodynamic therapy. Int. J. Immunopathol. Pharmacol. 17: 117-126 (2004).
Deng M, Rutherford MS, Abrahamsen MS. Host intestinal epithelial response to Cryptosporidium parvum. Adv. Drug Deliv. Rev. 56: 869-884 (2004).
Denicourt C, Dowdy SF. Medicine. Targeting apoptotic pathways in cancer cells. Science 305: 1411-1413 (2004). *
Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R. Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc. Natl. Acad. Sci. U.S.A. 101: 12634-12639 (2004). *
Denk GU, Soroka CJ, Mennone A, Koepsell H, Beuers U, Boyer JL. Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis. Hepatology 39: 1382-1389 (2004). *
Denk GU, Soroka CJ, Takeyama Y, Chen WS, Schuetz JD, Boyer JL. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J. Hepatol. 40: 585-591 (2004). *
Denk H. Pathology of portal hypertension. J. Gastroenterol. Hepatol. 19: S346-S348 (2004). *
Denk H, Stumptner C, Fuchsbichler A, Zatloukal K. Mallory bodies and liver diseases. J. Gastroenterol. Hepatol. 19: S349-S352 (2004). *
Denkers EY, Butcher BA, Del Rio L, Kim L. Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signaling cascades during intracellular Toxoplasma gondii infection. Immunol. Rev. 201: 191-205 (2004). *
Denkinger CM, Metz C, Fingerle-Rowson G, Denkinger MD, Forsthuber T. Macrophage migration inhibitory factor and its role in autoimmune diseases. Arch. Immunol. Ther. Exp. (Warsz.) 52: 389-400 (2004).
Denman AM, Rager-Zisman B. Viruses and autoimmune diseases-adapting Koch's postulates. Autoimmun. Rev. 3: 355-361 (2004).
Dennis CL. Preventing postpartum depression part I: a review of biological interventions. Can. J. Psychiatry 49: 467-475 (2004).
Derichs N, Mekus F, Bronsveld I, Bijman J, Veeze HJ, von der Hardt H, Tummler B, Ballmann M. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients. Pediatr. Res. 55: 69-75 (2004). *
Derijks LJ, Gilissen LP, Engels LG, Bos LP, Bus PJ, Lohman JJ, Curvers WL, Van Deventer SJ, Hommes DW, Hooymans PM. Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy. Ther. Drug Monit. 26: 311-318 (2004).
Derk CT, Vivino FB. A primary care approach to Sjogren's syndrome. Helping patients cope with sicca symptoms, extraglandular manifestations. Postgrad. Med. 116: 49-54, 59, 65 (2004).
Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. Clin. Ther. 26: 1599-1607 (2004). *
des Georges M, Guittard C, Altieri JP, Templin C, Sarles J, Sarda P, Claustres M. High heterogeneity of CFTR mutations and unexpected low incidence of cystic fibrosis in the Mediterranean France. J. Cyst. Fibros. 3: 265-272 (2004).
Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, Velidedeoglu E, Chapman WC, Markmann JF. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 77: 99-106 (2004).
Desir B, Amre DK, Lu SE, Ohman-Strickland P, Dubinsky M, Fisher R, Seidman EG. Utility of serum antibodies in determining clinical course in pediatric Crohn's disease. Clin. Gastroenterol. Hepatol. 2: 139-146 (2004). *
Desmet VJ. Pathogenesis of ductal plate malformation. J. Gastroenterol. Hepatol. 19: S356-S360 (2004). *
Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J. Hepatol. 40: 860-867 (2004). *
Desmond CP, Roberts SK. Exercise-related abdominal pain as a manifestation of the median arcuate ligament syndrome. Scand. J. Gastroenterol. 39: 1310-1313 (2004). *
Desreumaux P, Romano O. 5-Aminosalicylates and colorectal cancer: preventive role in chronic inflammatory bowel disease? Gastroenterol. Clin. Biol. 28: 509 (2004).
Deters M, Kirchner G, Koal T, Resch K, Kaever V. Everolimus/cyclosporine interactions on bile flow and biliary excretion of bile salts and cholesterol in rats. Dig. Dis. Sci. 49: 30-37 (2004). *
Dethloff T, Hansen BA, Larsen FS. Tacrolimus ameliorates cerebral vasodilatation and intracranial hypertension in the rat with portacaval anastomosis and hyperammonemia. Liver Transpl. 10: 922-927 (2004). *
Detry O, De Roover A, Coimbra C, Delwaide J, Szapiro D, Kaba A, Joris J, Damas P, Meurisse M, Honore P. Autoimmune cirrhosis treated by liver transplantation using the right hepatic lobe from a living related donor. Rev. Med. Liege. 59: 69-74 (2004).
Detry O, De Roover A, Delwaide J, Coimbra C, Kaba A, Joris J, Damas P, Meurisse M, Honore P. Living related liver transplantation in adults: first year experience at the University of Liege. Acta Chir. Belg. 104: 166-171 (2004).
Deugnier Y. Hemochromatosis. Rev. Prat. 54: 669-673 (2004).
Deugnier Y, Le Gall JY. Should we support large-scale screening for genetic haemochromatosis in France? Bull. Acad. Natl. Med. 188: 265-272 (2004).
Devany M, Kotharu NP, Matsuo H. Solution NMR structure of the C-terminal domain of the human protein DEK. Protein Sci. 13: 2252-2259 (2004). *
Devauchelle V, Marion S, Cagnard N, Mistou S, Falgarone G, Breban M, Letourneur F, Pitaval A, Alibert O, Lucchesi C, Anract P, Hamadouche M, Ayral X, Dougados M, Gidrol X, Fournier C, Chiocchia G. DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. Genes Immun. 5: 597-608 (2004). *
Devaux J, Beeton C, Beraud E, Crest M. Ion channels and demyelination: basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers. Rev. Neurol. (Paris) 160: 16-27 (2004).
Devchand PR, Ziouzenkova O, Plutzky J. Oxidative stress and peroxisome proliferator-activated receptors: reversing the curse? Circ. Res. 95: 1137-1139 (2004). *
Devendra D, Galloway TS, Horton SJ, Wilkin TJ. Exploring the idiotypes of insulin antibodies as markers for remission in type 1 diabetes. Diabet. Med. 21: 1316-1324 (2004). *
Devenny A, Wassall H, Ninan T, Omran M, Khan SD, Russell G. Respiratory symptoms and atopy in children in Aberdeen: questionnaire studies of a defined school population repeated over 35 years. BMJ 329: 489-490 (2004). *
Devitt A, Parker KG, Ogden CA, Oldreive C, Clay MF, Melville LA, Bellamy CO, Lacy-Hulbert A, Gangloff SC, Goyert SM, Gregory CD. Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice. J. Cell Biol. 167: 1161-1170 (2004). *
Devlin SM, Swain MG, Urbanski SJ, Burak KW. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy. Can. J. Gastroenterol. 18: 321-326 (2004).
Dewar D, Pereira SP, Ciclitira PJ. The pathogenesis of coeliac disease. Int. J. Biochem. Cell. Biol. 36: 17-24 (2004). *
Dhawan A. Acute liver failure in childhood. J. Gastroenterol. Hepatol. 19: S382-S385 (2004). *
Dhawan A, Cheeseman P, Mieli-Vergani G. Approaches to acute liver failure in children. Pediatr. Transplant. 8: 584-588 (2004).
Dhawan A, Mitry RR, Hughes RD, Lehec S, Terry C, Bansal S, Arya R, Wade JJ, Verma A, Heaton ND, Rela M, Mieli-Vergani G. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 78: 1812-1814 (2004).
Dhiman RK, Chawla YK. Minimal hepatic encephalopathy: should we start treating it? Gastroenterology 127: 1855-1857 (2004). *
Di Bisceglie AM. Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S104-S107 (2004). *
Di Bisceglie AM. Screening for hepatocellular carcinoma: being old is not all bad. Am. J. Gastroenterol. 99: 1477-1478 (2004). *
Di Bisceglie AM, Loyet M, Peters M. Long term follow up of bone mineral density in patients with primary biliary cirrhosis. Minerva Med. 95: 529-534 (2004).
Di Fiore F, Lecleire S, Herve S, Savoye G, Lerebours E. Life-threatening bleeding revealing gastric involvement in a Crohn's disease patient. J. Clin. Gastroenterol. 38: 833-834 (2004).
Di Mola FF, Di Sebastiano P, Gardini A, Innocenti P, Zimmermann A, Buchler MW, Friess H. Differential expression of connective tissue growth factor in inflammatory bowel disease. Digestion 69: 245-253 (2004).
Di Rocco P, Manco M, Rosa G, Greco AV, Mingrone G. Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab. Obes. Res. 12: 734-739 (2004). *
Di Sabatino A, Armellini E, Corazza GR. Doppler sonography in the diagnosis of inflammatory bowel disease. Dig. Dis. 22: 63-66 (2004).
Di Sabatino A, Carsetti R, Rosado MM, Ciccocioppo R, Cazzola P, Morera R, Tinozzi FP, Tinozzi S, Corazza GR. Immunoglobulin M memory B cell decrease in inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci. 8: 199-203 (2004).
Di Sabatino A, Ciccocioppo R, Armellini E, Morera R, Ricevuti L, Cazzola P, Fulle I, Corazza GR. Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn's disease. Inflamm. Bowel Dis. 10: 573-577 (2004). *
Di Sabatino A, Ciccocioppo R, Benazzato L, Sturniolo GC, Corazza GR. Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients. Aliment. Pharmacol. Ther. 19: 1019-1024 (2004). *
Di Sabatino A, Ciccocioppo R, Cinque B, Millimaggi D, Morera R, Ricevuti L, Cifone MG, Corazza GR. Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease. Gut 53: 70-77 (2004). *
Di Sario A, Bendia E, Macarri G, Candelaresi C, Taffetani S, Marzioni M, Omenetti A, De Minicis S, Trozzi L, Benedetti A. The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen alpha1(I), TIMP-1 and MMP-2. Dig. Liver Dis. 36: 744-751 (2004).
Di Stefano G, Derenzini M, Kratz F, Lanza M, Fiume L. Liver-targeted doxorubicin: effects on rat regenerating hepatocytes. Liver Int. 24: 246-252 (2004). *
Di Tola M, Sabbatella L, Anania MC, Viscido A, Caprilli R, Pica R, Paoluzi P, Picarelli A. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin. Chem. Lab. Med. 42: 1092-1097 (2004).
Di-Poi N, Michalik L, Desvergne B, Wahli W. Functions of peroxisome proliferator-activated receptors (PPAR) in skin homeostasis. Lipids 39: 1093-1099 (2004).
Dia D, Ba-Fall K, Bouldouyre M, Chevalier B, Debonne JM. DRESS syndrome to allopurinol: a case in Dakar. Dakar Med. 49: 114-115 (2004).
Diab A, Hussain RZ, Lovett-Racke AE, Chavis JA, Drew PD, Racke MK. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. J. Neuroimmunol. 148: 116-126 (2004).
Diaco M, Ancarini F, Montalto M, Verrechia E, Evoli A, Servidei S, Gasbarrini G, Manna R. Association of myasthenia gravis and antisynthetase syndrome: a case report. Int. J. Immunopathol. Pharmacol. 17: 395-400 (2004).
Diamanti A, Papadatou B, Knafelz D, Gambarara M, Ferretti F, Castro M. Clinical outcome and safety of periodic infliximab therapy in children and adolescents with Crohn's disease. J. Pediatr. Gastroenterol. Nutr. 39: 302-303 (2004). *
Diamantis I, Boumpas DT. Autoimmune hepatitis: evolving concepts. Autoimmun. Rev. 3: 207-214 (2004).
Diaz FJ, Davalos MM, Roman VR, Bustios SC, Zumaeta VE. Hepatotoxicity and pancreatitis associated with gold salts: case report. Rev. Gastroenterol. Peru 24: 353-356 (2004).
Diaz Rodriguez C, Gonzalez Rivero C, Trinidad San Jose JC, Del Rio Romero D, Moreno Fernandez A, Granja Romero E. Osteal complications as first manifestation in a patient with primary Sjogren's syndrome and with associated distal tubular acidosis (type 1) and chronic renal insufficiency. Therap. Apher. Dial. 8: 160-163 (2004).
Diaz Rodriguez C, Granja E, Vazquez Martul E, Sacristan F, Moreno Fernandez A, Gonzalez Rivero C, del Rio Romero D, Trinidad JC. Association between membranous glomerulonephritis and Crohn's disease. Nefrologia 24: 368-371 (2004).
Diaz VM, Hurtado M, Thomson TM, Reventos J, Paciucci R. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 53: 993-1000 (2004). *
Diaz-Lopez C, Geli C, Corominas H, Malat N, Diaz-Torner C, Llobet JM, De La Serna AR, Laiz A, Moreno M, Vazquez G. Are there clinical or serological differences between male and female patients with primary Sjogren's syndrome? J. Rheumatol. 31: 1352-1355 (2004). *
Diaz-Valle D, Benitez del Castillo JM, Fernandez Acenero MJ, Pascual Allen D, Moriche Carretero M. Bilateral lid margin ulcers as the initial manifestation of Crohn disease. Am. J. Ophthalmol. 138: 292-294 (2004). *
DiBaise JK, Young RJ, Vanderhoof JA. Intestinal rehabilitation and the short bowel syndrome: part 2. Am. J. Gastroenterol. 99: 1823-1832 (2004). *
Dice JP. Physical urticaria. Immunol. Allergy Clin. North Am. 24: 225-246, vi (2004).
Dickey W, Hughes DF. Histology of the terminal ileum in coeliac disease. Scand. J. Gastroenterol. 39: 665-667 (2004). *
Dickins M. Induction of cytochromes P450. Curr. Top. Med. Chem. 4: 1745-1766 (2004).
Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E; Eurobank members. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br. J. Haematol. 127: 479-490 (2004). *
Diczfalusy U. Analysis of cholesterol oxidation products in biological samples. J. AOAC Int. 87: 467-473 (2004).
Diebold MD, Samalin E, Merle C, Bouche O, Higuero T, Jolly D, Ramaholimihaso F, Renard P, Yaziji N, Thiefin G, Cadiot G. Colonic flat neoplasia: frequency and concordance between endoscopic appearance and histological diagnosis in a French prospective series. Am. J. Gastroenterol. 99: 1795-1800 (2004). *
Diebold SS, Kaisho T, Hemmi H, Akira S, Reis E Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531 (2004). *
Diedegraefe B. Giving the NOD to a new understanding of Crohn's disease: mother nature has finally started to show her CARDs. Inflamm. Bowel Dis. 10: 171-172 (2004). *
Diehl AM. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 619-638, x (2004).
Diehl AM. Fatty liver, hypertension, and the metabolic syndrome. Gut 53: 923-924 (2004). *
Diehl GE, Yue HH, Hsieh K, Kuang AA, Ho M, Morici LA, Lenz LL, Cado D, Riley LW, Winoto A. TRAIL-R as a negative regulator of innate immune cell responses. Immunity 21: 877-889 (2004). *
Dieleman LA, Hoentjen F, Qian BF, Sprengers D, Tjwa E, Torres MF, Torrice CD, Sartor RB, Tonkonogy SL. Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats. Clin. Exp. Immunol. 136: 30-39 (2004). *
Dienes HP. Liver histology in autoimmune hepatitis - diagnostic implications. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 51 (2004). *
Dierkes J, Westphal S, Luley C. The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels. Expert Opin. Drug Saf. 3: 101-111 (2004).
Dieter MZ, Maher JM, Cheng X, Klaassen CD. Expression and regulation of the sterol half-transporter genes ABCG5 and ABCG8 in rats. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 139: 209-218 (2004). *
Dietrich CF, Ignee A, Trojan J, Fellbaum C, Schuessler G. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 53: 401-405 (2004). *
Dietrich CG, Gartung C, Lorenzen J, Geier A, Wasmuth HE, Matern S, Lammert F. Enlarged cervical lymph nodes and elevated liver chemistry tests: a therapeutic dilemma. Ann. Hepatol. 3: 118-120 (2004). *
Dietrich CG, Geier A, Salein N, Lammert F, Roeb E, Oude Elferink RP, Matern S, Gartung C. Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2. Gastroenterology 126: 1044-1053 (2004). *
Dietrich CG, Geier A, Wasmuth HE, Matern S, Gartung C, de Waart DR, Elferink RP. Influence of biliary cirrhosis on the detoxification and elimination of a food derived carcinogen. Gut 53: 1850-1855 (2004). *
Dieude P, Osorio J, Petit-Teixeira E, Moreno S, Garnier S, Cailleau-Moindrault S, Stalens C, Lasbleiz S, Bardin T, Prum B, Cornelis F. A TNFR1 genotype with a protective role in familial rheumatoid arthritis. Arthritis Rheum. 50: 413-419 (2004). *
Dif F, Marty C, Baudoin C, De Vernejoul MC, Levi G. Severe osteopenia in CFTR-null mice. Bone 35: 595-603 (2004).
Dignass AU, Baumgart DC, Sturm A. The aetiopathogenesis of inflammatory bowel disease - immunology and repair mechanisms. Aliment. Pharmacol. Ther. 20 Suppl. 4: 9-17 (2004). *
Dijkmans BA, Jansen G. Antimetabolites in the treatment of arthritis: current status of the use of antimetabolites. Nucleosides Nucleotides Nucleic Acids 23: 1083-1088 (2004).
Dijkstra G, Blokzijl H, Bok L, Homan M, van Goor H, Nico Faber K, Jansen PL, Moshage H. Opposite effect of oxidative stress on inducible nitric oxide synthase and haem oxygenase-1 expression in intestinal inflammation: anti-inflammatory effect of carbon monoxide. J. Pathol. 204: 296-303 (2004). *
Dijkstra G, van Goor H, Jansen PL, Moshage H. Targeting nitric oxide in the gastrointestinal tract. Curr. Opin. Investig. Drugs 5: 529-536 (2004).
Dikopoulos N, Wegenka U, Kroger A, Hauser H, Schirmbeck R, Reimann J. Recently primed CD8+ T cells entering the liver induce hepatocytes to interact with naive CD8+ T cells in the mouse. Hepatology 39: 1256-1266 (2004). *
Dikow R, Degenhard M, Kraus T, Sauer P, Schemmer P, Uhl W, Buchler M, Zeier M. Blood pressure profile and treatment quality in liver allograft recipients-benefit of tacrolimus versus cyclosporine. Transplant. Proc. 36: 1512-1515 (2004). *
Diks SH, Kok K, O'Toole T, Hommes DW, Van Dijken P, Joore J, Peppelenbosch MP. Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells. J. Biol. Chem. 279: 49206-49213 (2004). *
Dilger K, Schwab M, Fromm MF. Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein. Inflamm. Bowel Dis. 10: 578-583 (2004). *
Dillon FX. Anesthesia issues in the perioperative management of myasthenia gravis. Semin. Neurol. 24: 83-94 (2004).
Dimagno MJ, Dimagno EP. Chronic pancreatitis. Curr. Opin. Gastroenterol. 20: 444-451 (2004).
Dimakou K, Papaioannides D, Latsi P, Katsimboula S, Korantzopoulos P, Orphanidou D. Disseminated tuberculosis complicating anti-TNF-alpha treatment. Int. J. Clin. Pract. 58: 1052-1055 (2004). *
Dimasi N, Moretta L, Biassoni R. Structure of the Ly49 family of natural killer (NK) cell receptors and their interaction with MHC class I molecules. Immunol. Res. 30: 95-104 (2004). *
Dimoulios F, Kolios G, Notas G, Xidakis C, Tsagarakis N, Kouroumalis A, Kouroumalis E. Increased circulating endothelin-2 may be a fundamental abnormality in primary biliary cirrhosis. J. Hepatol. 40 Suppl. 1: 160 (2004).
Dinarello CA. Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr. Opin. Pharmacol. 4: 378-385 (2004).
Ding JW, Wang K, Brems JJ, Gamelli RL. Protection against concanavalin A-induced hepatocyte apoptosis by molsidomine is time-dependent. J. Am. Coll. Surg. 198: 67-77 (2004). *
Ding LA, Li JS, Li YS, Zhu NT, Liu FN, Tan L. Intestinal barrier damage caused by trauma and lipopolysaccharide. World J. Gastroenterol. 10: 2373-2378 (2004). *
Ding SZ, O'hara AM, Denning TL, Dirden-Kramer B, Mifflin RC, Reyes VE, Ryan KA, Elliott SN, Izumi T, Boldogh I, Mitra S, Ernst PB, Crowe SE. Helicobacter pylori and H2O2 increase AP endonuclease-1/redox factor-1 expression in human gastric epithelial cells. Gastroenterology 127: 845-858 (2004). *
Ding WX, Ni HM, DiFrancesca D, Stolz DB, Yin XM. Bid-dependent generation of oxygen radicals promotes death receptor activation-induced apoptosis in murine hepatocytes. Hepatology 40: 403-413 (2004). *
Ding WX, Yin XM. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J. Cell. Mol. Med. 8: 445-454 (2004). *
Diosdado B, Wapenaar MC, Franke L, Duran KJ, Goerres MJ, Hadithi M, Crusius JB, Meijer JW, Duggan DJ, Mulder CJ, Holstege FC, Wijmenga C. A microarray screen for novel candidate genes in coeliac disease pathogenesis. Gut 53: 944-951 (2004). *
Disario JA, Freeman ML, Bjorkman DJ, Macmathuna P, Petersen BT, Jaffe PE, Morales TG, Hixson LJ, Sherman S, Lehman GA, Jamal MM, Al-Kawas FH, Khandelwal M, Moore JP, Derfus GA, Jamidar PA, Ramirez FC, Ryan ME, Woods KL, Carr-Locke DL, Alder SC. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology 127: 1291-1299 (2004). *
Dissemond J. Oral lichen planus: an overview. J. Dermatolog. Treat. 15: 136-140 (2004).
Distante S, Robson KJ, Graham-Campbell J, Arnaiz-Villena A, Brissot P, Worwood M. The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum. Genet. 115: 269-279 (2004). *
Ditsworth D, Zong WX. NF-kappaB: key mediator of inflammation-associated cancer. Cancer Biol. Ther. 3: 1214-1216 (2004). *
Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest. 114: 57-66 (2004). *
Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss Hepatology 39: 1647-1654 (2004). *
Djilali-Saiah I, Renous R, Caillat-Zucman S, Debray D, Alvarez F. Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. J. Hepatol. 40: 904-909 (2004).
Doboseru R, Drug VL, Azoicai D, Mitrica D, Mihai C, Tarasi I, Popa I, Cijevschi-Prelipcean C, Stanciu C. The changing spectrum of lower gastrointestinal haemorrhages. Rev. Med. Chir. Soc. Med. Nat. Iasi. 108: 90-93 (2004).
Dodgson JB, Romanov MN. Use of chicken models for the analysis of human disease. Curr. Protoc. Hum. Genet. Chapter 15: Unit 15.5 (2004).
Dodig S, Cepelak I. The facts and controversies about selenium. Acta Pharm. 54: 261-276 (2004).
Dodon MD, Li Z, Hamaia S, Gazzolo L. Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells. J. Gen. Virol. 85: 1921-1932 (2004). *
Doering J, Begue B, Lentze MJ, Rieux-Laucat F, Goulet O, Schmitz J, Cerf-Bensussan N, Ruemmele FM. Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn�s disease. Gut 53: 1632-1638 (2004). *
Doganci T, Bozkurt S. Celiac disease with various presentations. Pediatr. Int. 46: 693-696 (2004).
Doganci T, Sayli T, Gulderen F, Erden E, Sencer H. Case of disseminated Langerhans' cell histiocytosis presenting with sclerosing cholangitis. Int. J. Dermatol. 43: 673-675 (2004). *
Dogru M, Tsubota K. New insights into the diagnosis and treatment of dry eye. Ocul. Surf. 2: 59-75 (2004).
Doherty MJ, Healy M, Richardson SG, Fisher NC. Total body iron overload in welder's siderosis. Occup. Environ. Med. 61: 82-85 (2004). *
Doherty TM, Fitzpatrick LA, Shaheen A, Rajavashisth TB, Detrano RC. Genetic determinants of arterial calcification associated with atherosclerosis. Mayo Clin. Proc. 79: 197-210 (2004). *
Dohi T, Fujihashi K, Koga T, Etani Y, Yoshino N, Kawamura YI, McGhee JR. CD4+CD45RBHi interleukin-4 defective T cells elicit antral gastritis and duodenitis. Am. J. Pathol. 165: 1257-1268 (2004). *
Dohmen K, Mizuta T, Nakamuta M, Shimohashi N, Ishibashi H, Yamamoto K. Fenofibrate for patients with asymptomatic primary biliary cirrhosis. World J. Gastroenterol. 10: 894-898 (2004). *
Dolegowska B, Chlubek D. Isoprostanes - new possibility of the oxidative stress estimation. Przegl. Lek. 61: 1410-1414 (2004).
Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G. Hepatitis C core and nonstructural 3 proteins trigger Toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127: 1513-1524 (2004). *
Dolinsek J, Urlep D, Karell K, Partanen J, Micetic-Turk D. The prevalence of celiac disease among family members of celiac disease patients. Wien. Klin. Wochenschr. 116 Suppl. 2: 8-12 (2004).
Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment. Pharmacol. Ther. 20: 615-621 (2004). *
Domagk D, Wessling J, Reimer P, Hertel L, Poremba C, Senninger N, Heinecke A, Domschke W, Menzel J. Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation. Am. J. Gastroenterol. 99: 1684-1689 (2004). *
Domenech E, Hinojosa J, Esteve-Comas M, Gomollon F, Herrera JM, Bastida G, Obrador A, Ruiz R, Saro C, Gassull MA; for the Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Aliment. Pharmacol. Ther. 20: 1347-1352 (2004). *
Domenech E, Scala L, Bernal I, Garcia-Planella E, Casalots A, Pinol M, Esteve-Comas M, Cabre E, Boix J, Gassull MA. Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study. Gastroenterol. Hepatol. 27: 563-567 (2004).
Domenech Morral E. Serologic disease markers in inflammatory bowel disease. Med. Clin. (Barc.) 122: 138-139 (2004).
Doms RW. Unwelcome guests with master keys: how HIV enters cells and how it can be stopped. Top. HIV Med. 12: 100-103 (2004). *
Donadieu J, Rolon MA, Pion I, Thomas C, Doz F, Barkaoui M, Robert A, Deville A, Mazingue F, David M, Brauner R, Cabrol S, Garel C, Polak M; French LCH Study Group. Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. J. Clin. Endocrinol. Metab. 89: 604-609 (2004). *
Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr. J. 3: 19 (2004). *
Donaldson PT. The role of genetics in immunopathogenesis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 47-48 (2004). *
Donaldson PT. Genetics of liver disease: immunogenetics and disease pathogenesis. Gut 53: 599-608 (2004). *
Donaldson PT. Genetics of autoimmune and viral liver diseases; understanding the issues. J. Hepatol. 41: 327-332 (2004). *
Donate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP. Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities. Cancer Res. 64: 5812-5817 (2004). *
Donate F, McCrae K, Shaw DE, Mazar AP. Extracellular tropomyosin: a novel common pathway target for anti-angiogenic therapy. Curr. Cancer Drug Targets 4: 543-553 (2004).
Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L, Bolondi L. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 53: 1020-1023 (2004). *
Dong H, Zhu G, Tamada K, Flies DB, Van Deursen JM, Chen L. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity 20: 327-336 (2004). *
Dong J, Lai R, Nielsen K, Fekete CA, Qiu H, Hinnebusch AG. The essential ATP-binding cassette protein RLI1 functions in translation by promoting preinitiation complex assembly. J. Biol. Chem. 279: 42157-42168 (2004). *
Dong WG, Liu SP, Zhu HH, Luo HS, Yu JP. Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitis. World J. Gastroenterol. 10: 606-609 (2004). *
Dong Z, Wei H, Sun R, Hu Z, Gao B, Tian Z. Involvement of natural killer cells in PolyI:C-induced liver injury. J. Hepatol. 41: 966-973 (2004). *
Donmez B, Ozakbas S, Oktem MA, Gedizlioglu M, Coker I, Genc A, Idiman E. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features. Hum. Immunol. 65: 752-757 (2004).
Donn RP, Plant D, Jury F, Richards HL, Worthington J, Ray DW, Griffiths CE. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J. Invest. Dermatol. 123: 484-487 (2004). *
Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J. Leukoc. Biol. 76: 314-321 (2004). *
Donner MG, Warskulat U, Saha N, Haussinger D. Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS. Biol. Chem. 385: 331-339 (2004).
Donninger H, Cashmore TJ, Scriba T, Petersen DC, Janse van Rensburg E, Hayes VM. Functional analysis of novel SLC11A1 (NRAMP1) promoter variants in susceptibility to HIV-1. J. Med. Genet. 41: e49 (2004). *
Dooley TP, Curto EV, Reddy SP, Davis RL, Lambert GW, Wilborn TW, Elson CO. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm. Bowel Dis. 10: 1-14 (2004). *
Doria A, Iaccarino L, Ghirardello A, Briani C, Zampieri S, Tarricone E, Gambari PF. Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis and Bechet disease. Lupus 13: 690-695 (2004).
Doria-Rose VP, Levin TR, Selby JV, Newcomb PA, Richert-Boe KE, Weiss NS. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology 127: 714-722 (2004). *
Doring F, Rimbach G, Lodge JK. In silico search for single nucleotide polymorphisms in genes important in vitamin E homeostasis. IUBMB Life. 56: 615-620 (2004). *
Dorlochter L, Carlsson M, Olafsdottir EJ, Roksund OD, Rosendahl K, Fluge G. Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis. J. Cyst. Fibros. 3: 179-183 (2004).
Dorn SD, Abad JF, Panagopoulos G, Korelitz BI. Clinical characteristics of familial versus sporadic Crohn's disease using the Vienna classification. Inflamm. Bowel Dis. 10: 201-206 (2004). *
Dorr S, Lechtenbohmer N, Rau R, Herborn G, Wagner U, Muller-Myhsok B, Hansmann I, Keyszer G. Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res. Ther. 6: R199-R207 (2004). *
Dorsey RR, Andresen EM, Moore TL. Health-related quality of life and support group attendance for patients with systemic lupus erythematosus. J. Clin. Rheumatol. 10: 6-9 (2004).
Dorwart M, Thibodeau P, Thomas P. Cystic fibrosis: recent structural insights. J. Cyst. Fibros. 3 Suppl. 2: 91-94 (2004).
Doshi M, Watanabe S, Niimoto T, Kawashima H, Ishikura Y, Kiso Y, Hamazaki T. Effect of dietary enrichment with n-3 polyunsaturated fatty acids (PUFA) or n-9 PUFA on arachidonate metabolism in vivo and experimentally induced inflammation in mice. Biol. Pharm. Bull. 27: 319-323 (2004). *
Douglas G, Reilly C, Dooley MA, Page G, Cooper G, Gilkeson G. Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus. J. Rheumatol. 31: 1756-1762 (2004).
Douwes J, Le Gros G, Gibson P, Pearce N. Can bacterial endotoxin exposure reverse atopy and atopic disease? J. Allergy Clin. Immunol. 114: 1051-1054 (2004). *
Dowds TA, Masumoto J, Zhu L, Inohara N, Nunez G. Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J. Biol. Chem. 279: 21924-21928 (2004). *
Downie MM, Sanders DA, Maier LM, Stock DM, Kealey T. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro. Br. J. Dermatol. 151: 766-775 (2004). *
Doyle H, Gass A, Kennison R. Open access and scientific societies. PLoS Biol. 2: E156 (2004). *
Dozmorov I, Knowlton N, Tang Y, Shields A, Pathipvanich P, Jarvis JN, Centola M. Hypervariable genes - experimental error or hidden dynamics. Nucleic Acids Res. 32: e147 (2004). *
Drakes M, Blanchard T, Czinn S. Bacterial probiotic modulation of dendritic cells. Infect. Immun. 72: 3299-3309 (2004). *
Drakes ML, Czinn SJ, Blanchard TG. Isolation and purification of colon lamina propria dendritic cells from mice with colitis. Cytotechnology 46: 151-161 (2004). *
Dranoff JA, Kruglov EA, Toure J, Braun N, Zimmermann H, Jain D, Knowles AF, Sevigny J. Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis. J. Investig. Med. 52: 475-482 (2004).
Dranoff JA, Ogawa M, Kruglov EA, Gaca MD, Sevigny J, Robson SC, Wells RG. Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G417-G424 (2004). *
Drastich P, Ryska M, Trunecka P, Martinek J, Spicak J. Activity and neoplastic potential of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis. Gastroenterology 126: A649 (2004).
Dray X, Bienvenu T, Desmazes-Dufeu N, Dusser D, Marteau P, Hubert D. Distal intestinal obstruction syndrome in adults with cystic fibrosis. Clin. Gastroenterol. Hepatol. 2: 498-503 (2004). *
Drazen JM, Curfman GD. Public access to biomedical research. N. Engl. J. Med. 351: 1343 (2004). *
Dresner-Pollak R, Ackerman Z, Eliakim R, Karban A, Chowers Y, Fidder HH. The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients. Genet. Test. 8: 417-420 (2004).
Dresner-Pollak R, Gelb N, Rachmilewitz D, Karmeli F, Weinreb M. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology 127: 792-801 (2004). *
Driessler F, Venstrom K, Sabat R, Asadullah K, Schottelius AJ. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin. Exp. Immunol. 135: 64-73 (2004). *
Drosos AA, Georgiadis AN, Metafratzi ZM, Voulgari PV, Efremidis SC, Bai M. Sinus histocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with primary Sjogren's syndrome. Scand. J. Rheumatol. 33: 119-122 (2004). *
Du C, Fujii Y, Ito M, Harada M, Moriyama E, Shimada R, Ikemoto A, Okuyama H. Dietary polyunsaturated fatty acids suppress acute hepatitis, alter gene expression and prolong survival of female Long-Evans Cinnamon rats, a model of Wilson disease. J. Nutr. Biochem. 15: 273-280 (2004). *
Du Clos TW, Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol. Res. 30: 261-278 (2004). *
Du ZY, Demizieux L, Degrace P, Gresti J, Moindrot B, Liu YJ, Tian LX, Cao JM, Clouet P. Alteration of 20:5n-3 and 22:6n-3 fat contents and liver peroxisomal activities in fenofibrate-treated rainbow trout. Lipids 39: 849-855 (2004).
Duan RS, Chen Z, Bao L, Quezada HC, Nennesmo I, Winblad B, Zhu J. CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis. Neurobiol. Dis. 16: 630-637 (2004).
Duan YY, Wu J, Zhu JL, Liu SL, Ozaki I, Strayer DS, Zern MA. Gene therapy for human alpha1-antitrypsin deficiency in an animal model using SV40-derived vectors. Gastroenterology 127: 1222-1232 (2004). *
Dubcenco E, Jeejeebhoy KN, Tang SJ, Baker JP. The value of capsule endoscopy in the diagnosis and management of Crohn's disease: report of two cases. Gastrointest. Endosc. 59: 314-316 (2004). *
Dubertret L. Psoriasis: a disease of the quality of life. Rev. Prat. 54: 17-18 (2004).
Dubertret L. Therapeutic negotiation in psoriasis. Rev. Prat. 54: 35-39 (2004).
Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin. Gastroenterol. Hepatol. 2: 731-743 (2004). *
Dubinsky MC. Targeting therapy in pediatric inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 7: 391-405 (2004).
Dubinsky MC. Diffuse jejunoileitis in adolescence. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 70. May 7-8 (2004). *
Dubois RN. Disease prevention: the future is here. Gastroenterology 127: 1289 (2004). *
DuBois S, Kowdley KV. Targeted screening for hereditary haemochromatosis in high-risk groups. Aliment Pharmacol. Ther. 20: 1-14 (2004). *
Ducasse E, Roy F, Chevalier J, Massouille D, Smith M, Speziale F, Fiorani P, Puppinck P. Aneurysm of the pancreaticoduodenal arteries with a celiac trunk lesion: current management. J. Vasc. Surg. 39: 906-911 (2004). *
Duch BU, Andersen H, Gregersen H. Mechanical properties of the porcine bile duct wall. Biomed. Eng. Online 3: 23 (2004). *
Dudda JC, Simon JC, Martin S. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J. Immunol. 172: 857-863 (2004). *
Dudley F. Management of refractory ascites. J. Gastroenterol. Hepatol. 19: S194-S199 (2004). *
Duenas AI, Orduna A, Sanchez Crespo M, Garcia-Rodriguez C. Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. LPS. Int. Immunol. 16: 1467-1475 (2004). *
Duet M, Liote F. Somatostatin and somatostatin analog scintigraphy: any benefits for rheumatology patients? Joint Bone Spine 71: 530-535 (2004).
Duggan P, O'Brien M, Kiely M, McCarthy J, Shanahan F, Cashman KD. Vitamin K status in patients with Crohn's disease and relationship to bone turnover. Am. J. Gastroenterol. 99: 2178-2185 (2004). *
Dugueperoux I, Bellis G, Lesure JF, Renouil M, Flodrops H, De Braekeleer M. Cystic fibrosis at the Reunion Island (France): spectrum of mutations and genotype-phenotype for the Y122X mutation. J. Cyst. Fibros. 3: 185-188 (2004).
Dugueperoux I, De Braekeleer M; The Participating Centres to the French National Cystic Fibrosis Registry. Genotype-phenotype relationship for five CFTR mutations frequently identified in Western France. J. Cyst. Fibros. 3: 259-263 (2004).
Dujardin HC, Burlen-Defranoux O, Boucontet L, Vieira P, Cumano A, Bandeira A. Regulatory potential and control of Foxp3 expression in newborn CD4+ T cells. Proc. Natl. Acad. Sci. U.S.A. 101: 14473-14478 (2004). *
Dulai GS, Jensen DM, Kovacs TO, Gralnek IM, Jutabha R. Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy 36: 68-72 (2004).
Dulos J, Verbraak E, Bagchus WM, Boots AM, Kaptein A. Severity of murine collagen-induced arthritis correlates with increased CYP7B activity: enhancement of dehydroepiandrosterone metabolism by interleukin-1beta. Arthritis Rheum. 50: 3346-3353 (2004). *
Dulundu E, Sugawara Y, Makuuchi M. Revolution and refinement of surgical techniques for living donor partial liver transplantation. Yonsei Med. J. 45: 1076-1088 (2004). *
Dunajska K, Szymczak J. Autoimmune multiglandular syndrome type I - a case study. Pol. Merkuriusz Lek. 17: 625-628 (2004).
Dunham A, Matthews LH, Burton J, Ashurst JL, Howe KL, Ashcroft KJ, Beare DM et al. The DNA sequence and analysis of human chromosome 13. Nature 428: 522-528 (2004). *
Dunn P, Kuo TT, Shih LY, Lin TL, Wang PN, Kuo MC, Tang CC. Primary salivary gland lymphoma: a clinicopathologic study of 23 cases in Taiwan. Acta Ha